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Abstract
In this work the techniques of NMR cryoporometry and cryodiffusometry are developed and
applied to the investigation of porous systems for controlled drug release devices. Both sol-
gel silicas and PLGA microspheres are investigated. The cryoporometry method is developed
from that described in the literature and a robust method for pore size determination is
established. Cryoporometry investigations on sol-gel silicas are compared to data from other
more traditional and better understood porosimetry techniques in order to determine the
cause of hysteresis seen between the freezing and thawing process of an imbibed liquid.
The causes of hysteresis are determined to be both pore shape and pore network related.
Percolation theory is applied to the freezing process within the sol gel silica and shows that
the freezing process occurs as a freezing front that begins in the bulk and progresses in
toward the centre of the pellet. Thus, the freezing curve can be used to determine the size
of the pore entrances. NMR diffusometry techniques are applied to PLGA microspheres at
room temperature and during the freeze-thaw process in cryoporometry, a technique called
cryodiffusometry. These investigations provide information about the micrometer scale
pores within the microspheres and also the characteristics of the polymer matrix structure
at the nanometer scale. Time-resolved cryodiffusometry studies of the PLGA microspheres
show changes in the polymer matrix nominal pore neck and pore body sizes, tortuosity,
and connectivity. These changes can be qualitatively discussed in terms of the drug release
mechanism. The development of this technique and its application to nanometer scale
porosity evolution in polymer matrices is novel and has advanced the understanding of the
freezing process of a liquid imbibed in a porous solid.
i
Acknowledgements
Firstly I should like to thank my supervisors, Dr Sean Rigby and Dr Karen Edler for their
support and advice over the last three years. Your guidance, knowledge and enthusiasm
for science has helped to make my time back in Bath both enjoyable and stimulating, with
lengthy, and at times, animated discussions and suggestions.
Much gratitude is bestowed upon Dr John Lowe, NMR spectroscopist, whose enthusiasm
and plethora of NMR knowledge has been greatly received. Thank you for your support
in my desire to push the boundaries of what can be done with our NMR spectrometers,
enabling me to make significant developments to the cryodiffusometry techniques used.
Thank you to the members of the Rigby and Edler groups for all the discussions (some
about work), help to find things in the lab, or just knowing who to ask about the little
things, without which the big things can’t happen. Thanks to the technical and support
staff of both the Chemical Engineering and Chemistry Departments for your support and
experience.
Thank you to my parents who supported my decision to return to university. Without
their hard work and never-ending patience I would not have had the opportunities that I
have had, and would not be the person that I am. I should also like to thank my brother
for his words of experience and brutal honesty about the life of a PhD student, ensuring
that I kept focused, and for his technical help on finalising the layout of my thesis.
Special thanks go to the friends I have made here, for your friendship and many happy
times. Finally, thank you to my boyfriend, Adrian, for the calming influence and encour-






List of Figures vii
List of Tables xiii
Nomenclature xiv
1 Introduction 1
1.1 Drug delivery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Nuclear Magnetic Resonance (NMR) . . . . . . . . . . . . . . . . . . . . 3
1.3 Thesis structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
2 Cryoporometry Development 7
2.1 Background and theory . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2.2 Method development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.2.1 Preliminary experimental tests on amorphous silica materials . . . . 11
2.2.2 Temperature calibration using methanol . . . . . . . . . . . . . . . 15
2.2.3 Temperature calibration using a thermocouple . . . . . . . . . . . 19
2.2.4 Temperature gradient calibration . . . . . . . . . . . . . . . . . . 21
2.2.5 Experimental procedure for silica pellet materials . . . . . . . . . . 22
2.3 Results and discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
NMR Studies of Controlled Drug Release Devices iii
2.3.1 The equilibration time . . . . . . . . . . . . . . . . . . . . . . . . 23
2.3.2 Freeze-thaw hysteresis . . . . . . . . . . . . . . . . . . . . . . . . 24
2.3.3 Freezing mechanism . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.3.4 Comparison to mercury porosimetry data . . . . . . . . . . . . . . 27
2.4 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3 Cryodiffusometry of Silica 35
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.2 Background and Theory . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.2.1 Further Cryoporometry Theory . . . . . . . . . . . . . . . . . . . 36
3.2.2 Cryodiffusometry . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.2.3 Gas adsorption . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
3.2.4 Mercury porosimetry . . . . . . . . . . . . . . . . . . . . . . . . . 45
3.2.5 Percolation theory . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3.3 Experimental . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.3.1 Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.3.2 Cryoporometry . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.3.3 Cryodiffusometry experiments . . . . . . . . . . . . . . . . . . . . 50
3.3.4 Nitrogen adsorption and mercury porosimetry . . . . . . . . . . . . 50
3.4 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.4.1 Comparing hysteresis from different techniques . . . . . . . . . . . 51
3.4.2 Cryoporometry Results . . . . . . . . . . . . . . . . . . . . . . . . 52
3.4.3 Cryodiffusometry Results . . . . . . . . . . . . . . . . . . . . . . 55
3.4.4 Comparison with nitrogen adsorption-desorption . . . . . . . . . . 60
3.4.5 Mercury porosimetry results . . . . . . . . . . . . . . . . . . . . . 62
3.4.6 Prediction of Gibbs-Thomson parameter using powder mercury in-
trusion and freezing curves . . . . . . . . . . . . . . . . . . . . . 63
3.4.7 Prediction of whole pellet freezing curve from whole pellet mercury
intrusion data . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
3.4.8 Percolation Analysis . . . . . . . . . . . . . . . . . . . . . . . . . 70
3.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
4 PLGA microspheres 79
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
NMR Studies of Controlled Drug Release Devices iv
4.2 Background and Theory . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
4.2.1 PLGA microspheres . . . . . . . . . . . . . . . . . . . . . . . . . 79
4.2.2 Drug release mechanism . . . . . . . . . . . . . . . . . . . . . . . 83
4.2.3 Scanning electron microscopy (SEM) basic theory . . . . . . . . . 85
4.2.4 NMR PFG theory . . . . . . . . . . . . . . . . . . . . . . . . . . 85
4.3 Experimental . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
4.3.1 Double emulsion preparation method . . . . . . . . . . . . . . . . 89
4.3.2 Preparation of Double wall microspheres . . . . . . . . . . . . . . 91
4.3.3 SEM methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
4.3.4 PFG at room temperature . . . . . . . . . . . . . . . . . . . . . . 92
4.4 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
4.4.1 SEM images . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
4.4.2 Fluorine detection . . . . . . . . . . . . . . . . . . . . . . . . . . 98
4.4.3 NMR PFG studies at room temperature, measuring the average
cavity size and comparing to SEM . . . . . . . . . . . . . . . . . . 99
4.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
5 Cryoporometry studies of PLGA microspheres 113
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
5.2 Background and Theory . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
5.3 Experimental . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
5.4 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
5.4.1 Change of aqueous medium . . . . . . . . . . . . . . . . . . . . . 116
5.4.2 Cryoporometry cycles . . . . . . . . . . . . . . . . . . . . . . . . 119
5.4.3 Time-resolved cryoporometry studies on PLGA microspheres . . . . 123
5.4.4 Comparison of microsphere batches in terms of porosity . . . . . . 133
5.4.5 Additional interpretation of cryoporometry data for matrix con-
tained water in PLGA microspheres . . . . . . . . . . . . . . . . . 136
5.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
6 Cryodiffusometry studies of PLGA microspheres 144
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
6.2 Background and Theory . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
NMR Studies of Controlled Drug Release Devices v
6.2.1 Diffusion models in porous systems . . . . . . . . . . . . . . . . . 145
6.2.2 Pore geometry . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
6.2.3 Relaxation effects . . . . . . . . . . . . . . . . . . . . . . . . . . 147
6.3 Experimental . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
6.4 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
6.4.1 Diffusion in salt solution . . . . . . . . . . . . . . . . . . . . . . . 149
6.4.2 Determination of diffusion model for cryodiffusometry experiments . 151
6.4.3 Temperature effects . . . . . . . . . . . . . . . . . . . . . . . . . 158
6.4.4 Presence of monomers in solution . . . . . . . . . . . . . . . . . . 159
6.4.5 Time-resolved cryodiffusometry studies of PLGA microspheres . . . 159
6.4.6 Comparison of cryodiffusometry results for three batches of micro-
spheres . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
6.4.7 Further interpretation of cryodiffusometry results for batch MS041 . 173
6.5 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 177
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
7 Conclusions and future direction 181
7.1 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 181
7.2 Future direction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183
7.2.1 Other materials . . . . . . . . . . . . . . . . . . . . . . . . . . . 183
7.2.2 Other nuclei NMR PFG, relaxometry . . . . . . . . . . . . . . . . 183
7.2.3 Model alternative administration methods . . . . . . . . . . . . . . 183
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 186
NMR Studies of Controlled Drug Release Devices vi
List of Figures
2.1 A typical NMR spectrum of water contained within the pores of silica pellet 12
2.2 A typical freeze-thaw hysteresis for water contained in porous s980g silica
pellet . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.3 A typical freeze-thaw hysteresis for water contained in porous silica pellet
at 3, 6, 9, and 12 minutes equilibration . . . . . . . . . . . . . . . . . . . 14
2.4 NMR experimental set up for calibration experiments 1 . . . . . . . . . . 16
2.5 A comparison of methanol temperature calibration experiments conducted 17
2.6 A comparison of heating and cooling temperature calibration for methanol
capillary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
2.7 Methanol capillary surrounded by pellets temperature calibration . . . . . 19
2.8 Thermocouple temperature calibration on cooling and heating the sample . 20
2.9 NMR experimental set up for calibration experiments 2 . . . . . . . . . . 21
2.10 Results of measured temperatures for the top and bottom of insulated sample 22
2.11 Whole s980g pellet freeze-thaw hysteresis at 3 and 12 minutes equilibration
times . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.12 Whole c30 pellet freeze-thaw hysteresis at 3 and 12 minutes equilibration
times . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.13 Whole, broken and powdered s980g pellet freeze-thaw hysteresis at 12 min-
utes equilibration time . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2.14 Whole and powdered c30 pellet freeze-thaw hysteresis at 12 minutes equi-
libration time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.15 Whole and powdered c30 pellet mercury porosimetry intrusion extrusion
hysteresis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.16 Whole and powdered c30 pellet pore size distribution determined from mer-
cury intrusion and extrusion . . . . . . . . . . . . . . . . . . . . . . . . . 29
vii
3.1 Diagram of forces on a curved meniscus . . . . . . . . . . . . . . . . . . 43
3.2 Diagram of lattice models . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3.3 Two serial freeze-thaw cycles for whole silica pellet sample . . . . . . . . . 52
3.4 Freeze-thaw hysteresis for whole pellet and powdered silica sample A . . . 53
3.5 Freeze-thaw hysteresis for whole pellet and powdered silica sample B . . . 54
3.6 Estimated freezing curve due to single pore hysteresis for whole silica pellet
sample . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
3.7 Log attenuation plot to estimate diffusion coefficient in part frozen whole
silica pellet sample . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
3.8 Log attenuation plot to estimate diffusion coefficient in part frozen powder
silica pellet sample, diffusion time, ∆, 0.05 s . . . . . . . . . . . . . . . . 57
3.9 Log attenuation plot to estimate diffusion coefficient in part frozen powder
silica pellet sample, diffusion time, ∆, 0.15 s . . . . . . . . . . . . . . . . 58
3.10 Plot of observed diffusion coefficient against square root of diffusion time
used to calculate unrestricted intra-particle diffusion coefficient . . . . . . 59
3.11 Diffusion coefficient as a function of temperature . . . . . . . . . . . . . . 60
3.12 Nitrogen adsorption and desorption curves for whole and powder silica pellet
samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
3.13 Mercury intrusion and extrusion curves for whole pellet silica and intrusion
curve for and powdered silica . . . . . . . . . . . . . . . . . . . . . . . . 62
3.14 Mercury intrusion and extrusion curves for powdered silica . . . . . . . . . 63
3.15 Mercury intrusion and fitted freezing curve for powdered silica . . . . . . . 65
3.16 Mercury intrusion and fitted freezing curve sensitivity of kGT and t values . 66
3.17 Pore size distributions determined from freezing and thawing curve data for
whole pellet and powder samples . . . . . . . . . . . . . . . . . . . . . . 67
3.18 Whole pellet freezing curve predicted from mercury intrusion model . . . . 69
3.19 Probability of a pore being frozen and in the percolation cluster against the
probability that a pore being frozen . . . . . . . . . . . . . . . . . . . . . 72
3.20 Percolation model fit to experimentally derived data . . . . . . . . . . . . 73
4.1 Chemical structures of poly(lactic acid) and poly(glycolic acid) . . . . . . . 81
4.2 Reaction scheme for hydrolytic and autocatalytic degradation of PLGA . . 82
4.3 Graph to show the change in calculated effective diffusion coefficient for a
range of values of diffusion times, ∆. . . . . . . . . . . . . . . . . . . . . 88
4.4 Photograph showing microspheres held in aqueous environment by suscep-
tibility plug within the NMR tube . . . . . . . . . . . . . . . . . . . . . . 93
NMR Studies of Controlled Drug Release Devices viii
4.5 SEM image of high molecular weight microspheres with 5-FU model drug
encapsulated, batch MS035 . . . . . . . . . . . . . . . . . . . . . . . . . 95
4.6 SEM image of double-walled microspheres without drug encapsulated, batch
MS011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
4.7 SEM images of a high molecular weight microspheres with and without
encapsulated drug . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
4.8 SEM images of a high and low molecular weight microspheres with 5-FD
as encapsulated drug . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
4.9 SEM images of low molecular weight microspheres with and without 5-FD
as encapsulated drug . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
4.10 Comparison of data collection for increasing gradient strength and random
order . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
4.11 Log attenuation plots for drug encapsulated (MS029) and blank (MS030)
microspheres immediately and around 4.5 hours after immersion . . . . . . 101
4.12 Diffusion coefficient of entrapped water for high molecular weight micro-
spheres for the first 30 hours after immersion into aqueous media . . . . . 104
4.13 Change in diffusion coefficient of entrapped water in terms of the number of
standard deviations from the mean, for high molecular weight microspheres
for the first 250 hours after immersion into aqueous media . . . . . . . . . 105
4.14 Diffusion coefficient of entrapped water for high molecular weight micro-
spheres for the first 250 hours after immersion into aqueous media . . . . 106
5.1 Diagram to show the freezing and thawing mechanism for water contained
in polymer matrix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
5.2 Freeze-thaw hysteresis curve observed for water imbibed in the polymer
matrix of PLGA microspheres . . . . . . . . . . . . . . . . . . . . . . . . 117
5.3 Melting curve for sol-gel silica whole pellet sample for water and 5 % sodium
chloride solution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
5.4 Absolute signal intensity against temperature for microsphere sample, raw
data and corrected for temperature effects . . . . . . . . . . . . . . . . . 120
5.5 Repeat cryoporometry cycles for microsphere batch MS043 at day 1 after
immersion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
5.6 Repeat cryoporometry cycles for microsphere batch MS045 at day 1 after
immersion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
5.7 Cryoporometry freezing curves at increasing immersion times for micro-
sphere batch MS045 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
NMR Studies of Controlled Drug Release Devices ix
5.8 Complete cryoporometry freeze-thaw cycles for batch MS045 on days 1, 60
and 109 after immersion in an aqueous medium . . . . . . . . . . . . . . 126
5.9 Nominal pore neck and pore body size distributions determined from freez-
ing and melting cryoporometry curves for microsphere batch MS045 . . . . 127
5.10 Cryoporometry freezing curve for batch MS043 from days 1 to 92 after
immersion in aqueous media . . . . . . . . . . . . . . . . . . . . . . . . . 129
5.11 Nominal pore neck and body size distributions for microsphere batch MS043 131
5.12 Cryoporometry freezing curves at increasing immersion times for micro-
sphere batch MS041 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
5.13 Nominal pore neck and body size distributions for microsphere batch MS041 133
5.14 Nominal pore neck size changes with immersion time for batches MS041,
43 and 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
5.15 Nominal pore body size changes with immersion time for batches MS041,
43 and 45 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
5.16 An example of the freeze, part thaw, re-freeze and thaw cryoporometry
cycle for batch MS043 after 14 days immersion in aqueous media . . . . . 137
5.17 Adjusted freezing curves for cylindrical and spherical pore shapes compared
to melting curve for microspheres batch MS043 after 1 day immersion . . . 138
5.18 Adjusted freezing and re-freezing curves for cylindrical and spherical pore
shapes compared to melting curve for microspheres batch MS041 after 37
days immersion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
5.19 Example plot of the probability of a pore being frozen against the probability
of a pore water being below its freezing point for microsphere batch MS041,
37 days after immersion . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
6.1 Salt solution adjustment factor as a function of temperature . . . . . . . . 150
6.2 Diffusion coefficient, salt solution adjustment factor and adjusted diffusion
coefficient as a function of temperature . . . . . . . . . . . . . . . . . . . 151
6.3 Diffusion coefficient, salt solution adjustment factor and adjusted diffusion
coefficient as a function of temperature over the experimental temperature
range . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
6.4 Example log attenuation plot for cryodiffusometry data collected MS041,
day 37, ∆ 0.20 s, freezing curve . . . . . . . . . . . . . . . . . . . . . . . 153
6.5 Residual values for 1 and 2 component fit to data for MS041, day 37, ∆
0.20 s, freezing curve . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
NMR Studies of Controlled Drug Release Devices x
6.6 Test for restricted diffusion in freezing and thawing for a 1 component fit
to data for MS041, day 37 . . . . . . . . . . . . . . . . . . . . . . . . . 155
6.7 Free diffusion of water in polymer matrix for 1 component model fit to
freezing and thawing data for MS041, day 37 . . . . . . . . . . . . . . . . 156
6.8 Test for restricted diffusion for 1 and 2 component fit to data for MS041,
day 37, freezing and thawing . . . . . . . . . . . . . . . . . . . . . . . . 157
6.9 Signal attenuation measured at increasing gradient length and in random
order of gradient length . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
6.10 Freezing curve cryodiffusometry log attenuation plots fitted to one and two
component models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
6.11 Thawing curve cryodiffusometry log attenuation plots fitted to one and two
component models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
6.12 Tortuosities of fast and slow components, fraction of fast component and
relative signal intensities during freezing and thawing over time for micro-
sphere batch MS045 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
6.13 Weighted tortuosity during freezing and thawing with modal pore body and
pore neck sizes over time for microsphere batch MS045 . . . . . . . . . . 163
6.14 Tortuosity of fast and slow components during freezing and thawing over
time for microsphere batch MS043 . . . . . . . . . . . . . . . . . . . . . 164
6.15 Weighted tortuosity values during freezing and thawing over time for mi-
crosphere batch MS043 . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
6.16 Tortuosity of fast and slow components during freezing and thawing over
time for microsphere batch MS041 . . . . . . . . . . . . . . . . . . . . . 167
6.17 Weighted tortuosity during freezing and thawing over time for microsphere
batch MS041 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
6.18 Freeze-thaw hysteresis cycles for days 70 and 93 after immersion for batch
MS041 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169
6.19 Change in the fast component tortuosity during freezing and thawing for
batch MS041 at longer immersion times . . . . . . . . . . . . . . . . . . 170
6.20 SEM images of typical low molecular weight PLGA microspheres . . . . . 172
6.21 Fast component contribution to signal attenuation, comparing 1 and 2 di-
mensionally constrained and free diffusion models for MS041, day 37, ∆
0.20 s, freezing curve . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
6.22 Slow component contribution to signal attenuation, comparing 1 and 2
dimensionally constrained and free diffusion models for MS041, day 37, ∆
0.20 s, freezing curve . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
NMR Studies of Controlled Drug Release Devices xi
6.23 Combined signal attenuation model for MS041, day 37, ∆ 0.20 s, freezing
curve . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175
6.24 Microsphere batch MS041 day 37 plot of ln I
I0
+ 4pi2q2D0∆ against K to
estimate separation distance between plates . . . . . . . . . . . . . . . . 176
7.1 Log attenuation plot for Sodium-23 diffusion in a partially frozen PLGA
microsphere sample . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
NMR Studies of Controlled Drug Release Devices xii
List of Tables
3.1 Causes of hysteresis in porosimetry . . . . . . . . . . . . . . . . . . . . . 51
3.2 Summary of calculated diffusion and tortuosity data for whole and powder
silica pellet samples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
3.3 Model parameter values for predicting cryoporometry freezing curve . . . . 69
4.1 Factors that affect release rate . . . . . . . . . . . . . . . . . . . . . . . 84
4.2 Summary of some PLGA microsphere characteristics . . . . . . . . . . . . 94
4.3 Cavity radius determined from diffusion coefficient D2 for changes in esti-
mated value of the bulk diffusion coefficient D1 . . . . . . . . . . . . . . 103
5.1 Neck and pore body sizes summary for microsphere batch MS045 . . . . . 128
5.2 Neck and pore body sizes summary for microsphere batch MS043 . . . . . 130
5.3 Neck and pore body sizes summary for microsphere batch MS041 . . . . . 134
5.4 Approximate percolation threshold values for microsphere matrix freezing
of imbibed water . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
6.1 Cryodiffusometry summary for batch MS041 after 116 days immersion . . . 167
6.2 Summary of cryodiffusometry parameters calculated for PLGA microsphere
batches MS045, MS043 and MS041 . . . . . . . . . . . . . . . . . . . . 171
6.3 Separation distance determined for anisotropically arranged plates with in-





NMR Nuclear Magnetic Resonance
PFG Pulsed Field Gradient
FID Free induction delay
PGSE Pulsed Gradient Spin Echo
PGSTE Pulsed Gradient Stimulated Echo
LED Longitudinal Eddy Delay
BPLED Bipolar Longitudinal Eddy Delay
CPMG Carr-Purcell Meiboom-Gill pulse sequence
r.m.s. Root mean square






SEM Scanning Electron Microscope
xiv
Symbol Definition
β Critical exponent, percolation theory
γ Gyromagnetic ratio of observed nucleus
γl Surface tension of adsorbate in liquid form
γls Surface tension between liquid and solid
δ Length of gradient pulse(s)
δs Difference in chemical shift between methanol peaks
in low temperature methanol calibration equation (ppm)
∆ Diffusion time(s)
p Voidage or porosity of material(no units)
ζ As defined in text,γ2g2δ2(∆− δ/3− τ/2)(sm−2)
Θ Contact angle(degrees)
κ Integral mean surface curvature of pore
ν Critical exponent, percolation theory
ν Degrees of freedom, statistical analysis
ρ Surface relaxivity
ρs Density of solid
σsl Surface energy at solid liquid interface
τ Time for correction between bipolar gradient
pulses(s)
τi Tortuosity for component i (-)
τm Tortuosity of matrix structure (-)
τp Particle tortuosity, or pore network tortuosity (-)
τw Weighted tortuosity (-)
φ Contact angle(degrees)
χ2R Reduced chi-squared ,goodness of fit, as
defined in text(-)
NMR Studies of Controlled Drug Release Devices xv
Symbol Definition
a Salt content adjustment factor for diffusion coefficient(-)
calculation
as Separation distance between parallel plates(m)
A,B,C,D,E, F,G Fitting parameters




di Diameter of ,molten pores(m)
D Diffusion coefficient(m2/s)
Dd Diffusion coefficient of water in deuterated water(m
2/s)
De Effective diffusion coefficient(m
2/s)
Di Diffusion coefficient of component i(m
2/s)
Dw Self diffusion coefficient of water i(m
2/s)
D0 Intra-particle diffusion coefficient, diffusion coefficient
in matrix (m2/s)
DB Bulk diffusion coefficient of water at experiment
temperature (m2/s)
DP Diffusion coefficient for motion perpendicular to the
applied magnetic field(m2/s)
Ds Diffusion coefficient of water in salt solution(m
2/s)
DPFG Diffusion coefficient calculated from PFG experiment(m
2/s)
D′PFG Diffusion coefficient calculated from PFG experiment
adjusted for salt content(m2/s)
E Expected value determined from model calculation
f Fraction of occupied bonds
fc Critical fraction of occupied bonds or percolation threshold value
fd Fraction of deuterated water
fw Fraction of water
F Fraction of occupied bonds in the percolation cluster
g Gradient pulse strength(G/m)
G Gradient pulse strength(G/cm)
∆Hf Bulk enthalpy of fusion per gram of material
i Intercept
I NMR signal intensity (arbitrary unit)
Ia Absolute NMR signal intensity (arbitrary unit)
Iadj Temperature adjusted NMR signal intensity (arbitrary unit)
Im Matrix contained water NMR signal intensity (arbitrary unit)
NMR Studies of Controlled Drug Release Devices xvi
Symbol Definition
Imin Minimum absolute NMR signal intensity (arbitrary unit)
I0 Reference NMR signal intensity (arbitrary unit)
Ip NMR signal intensity for powder silica sample (arbitrary unit)
Ir Relative NMR signal intensity (arbitrary unit)
IT NMR signal intensity at temperature T (arbitrary unit)
Iw NMR signal intensity for whole silica pellet sample(arbitrary unit)
k Model parameter defined in text
kGT Gibbs-Thomson parameter(nmK)
K Model parameter defined in text
li Average pore length(m)
L Average linear dimension of a bond, percolation theory
L95 Lower 95 % confidence interval
M(∆, K) Echo signal intensity for a given value of ∆ and K
n Number of observations
ni Number of molten pore
NA Avogadro’s constant
Nb Number of occupied bonds(below freezing point)
Nf Number of occupied bonds in percolation cluster(frozen)
Np Number of pores
NT Total number of bonds, percolation theory
O Observed value from experiment
p Pressure
p0 Saturation pressure
pf Number of fitting parameters
pi Fraction of water in component i(-)
p(d) Pore size distribution
Ps Capillary pressure
Pcx Pressure on convex side of meniscus
Pcv Pressure on concave side of meniscus
q Model parameter defined in text
rc Core radius(m)
rcavity Cavity radius determined by PFG(m)
NMR Studies of Controlled Drug Release Devices xvii
Symbol Definition
rp Pore radius(m)
rp,ave Average pore radius(m)
rUp Upper pore radius estimate(m)
rLp Lower pore radius estimate(m)
rrms Root mean square displacement(m)
R Universal gas constant
s Slope, gradient
se Standard error
S Surface area of pores (m2)
Sa Specific surface area of solid (m
2g−1)
t Thickness of unfrozen layer(nm)
t5,νstat Value of ‘t’ statistic for 5 % two-tailed test with
ν degrees of freedom
T Temperature(K or °C)
Tref Reference temperature(K or °C)
Tm Bulk melting point(K or °C
Tm(d) Melting point of crystals size d(K or °C
∆Tm Melting point depression(K or °C
∆Tf Freezing point depression(K or °C
T1 Longitudinal relaxation parameter
T2 Transverse relaxation parameter
T ∗2 Transverse relaxation parameter in an inhomogeneous field
T2,bulk Bulk fluid transverse relaxation parameter
U95 Upper 95 % confidence interval
V Volume of pores, or liquid (m3)
Vi Volume of liquid in pores (m
3)
Vm Molar volume of adsorbate in liquid form (m
3)
VN Normalised volume (m
3)
V0 Total volume (m
3)
Wps Reversible work required to separate unit area of solid from
the pore wall
x Pore diameter, pore size(m)
xm Monolayer capacity(cm
3)
Z Coordination number, percolation theory




For centuries man has used elixirs, potions and ointments to treat ailments and diseases.
In recent times, as mans’ understanding of human biology, immunology and disease have
increased, so too, has the sophistication of the medicinal treatments being employed. Prac-
tices in modern medicine are improving all the time, reducing the number of premature
deaths caused by disease and sustaining those with long term health problems to live
longer. Alongside the advances in surgical techniques are the ever increasing number and
complexity of the drugs available for treatment. The means by which a drug is admin-
istered is also evolving, from traditional methods such as oral administration in tablet or
liquid form, sub-cutaneous or intravenous injection, pessary, diffusion through the skin, in-
halation, and more recently controlled drug release from the implantation of a removable
device, to transfer of drugs to the skin released from a patch, biodegradable implants that
release the contained drug over time, bioadhesive materials that release drugs at a target
area, or bio-reactive materials that respond to a given condition, such as pH or glucose
level, within the body and then release contained drug. These systems are referred to as
controlled drug delivery systems, DDS, whereby the release of drug can be prolonged over
a period of time, or targeted to a specific site or condition within the body. A controlled
drug delivery device is defined as a device that releases the treatment over a long period
of time, greater than one day, and at a controlled rate (Saltzmann, 2001). All of these
delivery methods are used, or proposed for use, to administer the continually growing list
of pharmaceuticals approved for human use today. The method of administration is often
dependent on the characteristics of the drug molecule: hydrophobicity or hydrophilicity,
size, shape, active group, pH stability, toxicity.
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The advantages offered by these advanced DDS are significant to those with long term
treatment needs and those with the need for acute short term intensive targeted treatments.
For long term treatment controlled DDS offer a reduction in the number of times the patient
must have the drug administered and, therefore, reducing the disruption to the patients
lifestyle and can increase patient compliance, which will also improve the stability of the
patients condition. Examples of long term treatments that could benefit from such systems
include the treatment of high cholesterol, blood disorders and epilepsy. The advantages
of targeted drug delivery include a reduced dosage, since all the drug is delivered to the
required site, therefore, only affecting the area requiring treatment, also reducing the side
effects seen by the patient, an example of which includes chemotherapy drugs for cancer
treatment. The targeting of a particular tissue can be done by means of direct injection or
implantation of the device at the target area, or bioadhesion of the device to specific cells or
mucus. These methods offer an attractive means of concentrating the drug release at the
target area. Bio-reactive systems could allow for more efficient treatment of conditions such
as diabetes, where the presence of glucose at a specified levels causes the DDS to release
insulin in sufficient quantity, reducing the reliance on the patient continually monitoring
their blood sugar level.
The burst release seen in some biodegradable systems could be both an advantage or
disadvantage depending on the treatment, for some drug therapies, it is necessary to have
a higher initial dose to begin the treatment, whereas for others the initial burst may be
toxic, or may just cause unnecessary additional dumping of a costly active ingredient. One
concern with regards to DDS is the possibility of dose dumping if the system fails, that
is when the entire dosage of drug contained within the system is released at one time,
this could be toxic, or reduce the effectiveness of the treatment, necessitating repeated
administration. The hazards of dose dumping may be reduced by using many small devices
as opposed to one large delivery device, if one micro-device fails the dose dumping effect
should be small and managed within safe guidelines for any toxicity effects. Controlled
delivery devices in addition to being used in-vivo have attracted attention for the potential
to deliver bioactive molecules during the in-vitro growth of tissue within the field of tissue
engineering.
Although the number of potential uses for drug delivery systems is great, the actual
number of products on the market are limited due to a lack of thorough understanding of
the mechanism by which the drug is released. In this work Nuclear Magnetic Resonance
techniques are developed and applied to silica and polymer materials to determine structural
characteristics that influence the mechanism of release of an encapsulated molecule.
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1.2 Nuclear Magnetic Resonance (NMR)
Since the first detection of a Nuclear Magnetic Resonance (NMR) signal in 1945 achieved
by Felix Bloch and Edward Purcell, who both received the Nobel prize for Physics in 1952
(Blumich, 2005), NMR techniques have been developed from simple scientific applications
too many complex and varied applications. Probably the most recognised application is
the multi-dimensional magnetic resonance imaging (MRI) for medicinal applications. NMR
is observed if the nuclei having magnetic properties are excited within a magnetic field, a
resonance signal is emitted as the nuclei relax. The observed resonance signal is dependent
on the environment in which the nucleus is situated and can, therefore, be used to probe
that environment. NMR can be used to determine the identity of a chemical compound by
observing it’s NMR spectrum, or collection of signals from nuclei of different environments.
NMR diffusion studies can be used to determine the diffusion coefficient of a nucleus within
a molecule based on the loss of signal detected due to the motion of the molecule over a
given diffusion time. The relaxation behaviour of a nucleus in a solid is different to that of
the liquid, therefore, a change of state can be observed by either an increase or decrease
in the observed signal intensity. The design of modern NMR experiments comes from
manipulation of these characteristics by utilising different pulse sequences, ie. changes to
the way in which the nuclei are excited and the conditions of the magnetic field the nuclei
experience. In this work the ability to monitor diffusion and the change of liquid to solid
to liquid are utilised, the great potential of NMR is that these techniques can be combined
and used at the same time.
1.3 Thesis structure
This thesis is divided into seven chapters:
 Introduction
 Development of cryoporometry method
This chapter discusses the work done to develop the cryoporometry method for the
investigation of materials for drug delivery. After a critical review of the technique
information available in the literature, it was found that some work was required to
establish a robust method for sample temperature measurement and sample equilibra-
tion. Preliminary experiments are carried out on sol-gel silica materials to determine
if information could be gained from the freezing curve in addition to the melting
curve of the cryoporometry cycle, which had been the focus of previously published
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work. To verify the applicability of the cryoporometry freeze-thaw hysteresis as a
characterisation technique, a comparison with mercury porosimetry data was made.
 Application of cryodiffusometry to silica materials
Further investigations are carried out on silica materials combining cryoporometry and
diffusometry to gain an understanding of the freezing mechanism of the imbibed liq-
uid. Comparing cryoporometry data with nitrogen sorption and mercury porosimetry
has provided an understanding of the causes for the hysteresis seen in cryoporometry
freeze-thaw cycles, the contributions of different effects are discussed. Percolation
theory is applied to the freezing process within the sol-gel silica to determine if the
mechanism of freezing can be described in terms of a freezing front that penetrates
the porous material from the bulk toward the centre of the pellet. The interpretation
of cryodiffusometry applied to silica can be made with the support of nitrogen sorp-
tion and mercury porosimetry, which are not suitable for investigation on the polymer
microspheres discussed later. These investigations provide base ideas for the inter-
pretation of the more complex and evolving polymer matrix structure determination.
 Preparation and characterisation of PLGA microspheres
The structure of Poly(lactic-co-glycolic acid) microspheres and it’s effect on the re-
lease profile of an encapsulated drug molecule is of great interest to improve the design
of such drug delivery devices. Before a study of the structure is conducted, it is im-
portant to know how these microspheres are made and how the preparation method
can effect the macroscale structure of the microspheres. The preparation methods
used for PLGA microspheres are discussed in terms of the effects that the preparation
parameters can have on the characteristics of the microspheres produced, such as
microsphere diameter and pore diameter. Two variations of preparation techniques
are trialled and a variation in preparation parameters are considered. The resulting
microspheres are studied with Scanning Electron Microscopy (SEM) and typical SEM
images are discussed. Some nuclear magnetic resonance (NMR) diffusometry experi-
ments are carried out at ambient temperature and are discussed in terms of diffusion
models within porous media available in the literature.
 Cryoporometry of PLGA microspheres
This chapter describes the application of cryoporometry to investigate the longer term
structural changes in the polymer matrix at the nanometer scale once immersed in
aqueous media. Three batches of microspheres are made with and without encapsu-
lated model drug and with both low and high molecular weight PLGA. These batches
are investigated by cryoporometry over approximately one hundred days, results are
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discussed in terms of structural changes to the nominal pore body and pore neck sizes
determined from the melting and freezing curves. Shielding effects and percolation
properties are also discussed in terms of drug mobility through the polymer matrix.
 Cryodiffusometry of PLGA microspheres
NMR diffusometry experiments are conducted on the microsphere samples during
the freezing and thawing process of cryoporometry cycles. The determination of
appropriate diffusion models and interpretation of tortuosity within the polymer matrix
structure are made. Changes in the observed diffusion characteristics are discussed
in combination with cryoporometry derived pore sizes. The consequential effects of
the changes seen during this time are discussed qualitatively in relation to the drug
release mechanism.
 Conclusions and further work
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Chapter2
Development of the cryoporometry method
2.1 Background and theory
Nuclear Magnetic Resonance (NMR) cryoporometry is the investigation of pore size and
pore size distribution by studying the melting or freezing characteristics of an imbibed liquid
using NMR. It was first published by W. T. Thomson (Lord Kelvin) in 1871 (Thomson,
1871) that there are changes in physical properties of a fluid when it is contained within
a porous solid. This theory was developed by J. J. Thomson (Thomson, 1888) and Gibbs
(Gibbs, 1928) to produce the Gibbs-Thomson equation for melting point depression, 2.1*.
∆Tm = Tm − Tm(d) = 4σslTm
d∆Hfρs
(2.1)
where ∆Tm is the melting point depression in °C for a small crystal of size d in m, Tm is the
bulk melting point and Tm(d) is the melting point of crystals of size d, σsl is the surface
energy of the solid-liquid interface, ∆Hf is the bulk enthalpy of fusion per g of material,
and ρs is the density of the solid.
This equation, 2.1, describes the relationship between the melting point depression
and small crystal diameter, for a crystal within a liquid. If the crystal is formed within a
confined pore, i.e. when the crystal size is limited by the pore size, the wall effects must also
be considered. In cryoporometry it is often assumed that the liquid has weak interaction
with the solid in which it is confined and, therefore, that wall effects are negligible and
pore dimension is the dominating parameter defining the melting point depression (Mitchell
et al., 2008). However, this is not always the case. The phase change liquid to solid within
a porous material can be considered analogous to evaporation of a liquid to a gas during
*As expressed in (Jackson and McKenna, 1990)
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gas desorption from a solid porous material, see Section 3.2.3 on nitrogen adsorption and
desorption. Assuming a cylindrical pore shape, the advancing meniscus between solid and
liquid state is hemispherical. The core radius rc is related to the pore radius rp estimate by
equation 2.2.
rc = rp cosφ (2.2)
where φ is the contact angle of the meniscus with the solid wall and 0 ≤ φ ≤ 180°.
Therefore, combining equations 2.1 and 2.2 gives the Gibbs-Thomson equation for melting
point depression of a solid in confined cylindrical pore, equation 2.3
∆Tm = Tm − Tm(d) = − 4σslTm
d∆Hfρs
cosφ (2.3)
However, the contact angle, φ, is a function of the interactive forces between the liquid
and the wall as described in the work of Young (Adam, 1957) and Dupre´ (1869), this





where Wps is the reversible work required to separate a unit area of solid from the pore
wall.
Although contact angle varies for different systems and it is not always possible to
measure due to small pore sizes and complex networks being investigated, it is often given
an assumed value. For example, in thermoporometry the assumed value is 180 °for the
solid-liquid phase change (Jackson and McKenna, 1990). Alternatively, it is incorporated
into an empirically determined constant within the simplified version of equation 2.3 as in




where kGT is the Gibbs-Thomson parameter and x is the pore diameter in metres.
To determine the pore size distribution within a solid using this relationship a method
of determining the melting point of the imbibed liquid is required. Differential scanning
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calorimetry (DSC) is one method that has been used; it relies on the measurement of energy
released or absorbed during the phase transition and the overall technique is termed thermo-
porosimetry. Quinson and coworkers developed the technique to also include determination
of the surface area of a porous material (Quinson et al., 1986; Quinson, 1987; Quinson and
Brun, 1988). This method of thermoporosimetry has more recently been used to look at
the structure of mesoporous materials, including silicas and polymeric gels (Jackson and
McKenna, 1990; Sliwinska-Bartowiak et al., 2001; Schreiber et al., 2001; Iza et al., 2000).
Thermoporosimetry techniques evolved further in the early 1990s when NMR signal
intensity was suggested as an alternative method for determining the molten fraction of
imbibed liquid within a porous sample during the gradual freezing of the liquid (Strange
et al., 1993). More recently, the advancement of temperature control within NMR systems
has lead to the development of NMR cryoporometry (Webber, 2000; Strange et al., 2003).
Due to the significant reduction in transverse relaxation constant, T2, between liquid
and solid phase of a fluid (Topgaard and Soderman, 2002; Strange et al., 2003) it is possible
to determine the change in the relative volume of molten liquid by measuring the change in
NMR signal intensity. The short relaxation time of the solid results in a decrease of signal
intensity as the temperature is decreased and the liquid begins to freeze, once all the liquid
is frozen there is zero observable signal using certain pulse sequences in a liquid state probe.
Therefore, from knowing the initial signal intensity for 100% liquid and the signal intensity
for 100% solid, a relative value of the quantity of frozen material can be calculated for any
temperature. NMR cryoporometry has become more widely used in the last 15 years, with
studies of pore characteristics of silica gels (Mitchell et al., 2005; Hansen et al., 1996) and
more recently polymer particles (Hansen et al., 2005; Petrov et al., 2006a). Recently a
review of the technique has been published by Mitchell et al. (2008).
The number of published studies using NMR cryoporometry was limited at the start of
this project, and with varying experimental details being used. It was, therefore, important
to establish an experimental procedure that would produce accurate, reproducible results for
the system being studied. Whilst DSC studies used ramped temperature profiles (Jackson
and McKenna, 1990; Iza et al., 2000; Schreiber et al., 2001; Sliwinska-Bartowiak et al.,
2001; Janssen et al., 2004), both ramped (Webber et al., 2001; Valiullin and Furo, 2002;
Valckenborg et al., 2002; Dosseh et al., 2003; Hansen et al., 2005) and stepped, from
0.1—1.0 K/min (Valiullin and Furo, 2002a; Mikhalovska et al., 2006; Petrov and Furo,
2006) profiles have been used for cryoporometry. Equilibration times for step changes in
temperature varied from 2 minutes (Hansen et al., 1996) to 10 minutes (Dosseh et al., 2003)
and a variety of solvents have been used, including water (Schreiber et al., 2001; Janssen
et al., 2004; Hansen et al., 2005), nitrobenzene (Valiullin and Furo, 2002), benzene and
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cyclohexane (Strange et al., 1993; Dosseh et al., 2003; Petrov and Furo, 2006) and cyclo-
octane (Petrov and Furo, 2006). Studies have been done over a range of pore diameters
from 12 A (Hansen et al., 1996) to 500 nm (Gane et al., 2004).
In previous work varying estimates of kGT , the Gibbs-Thomson parameter are given for
water ranging from 420 KA (Hansen et al., 2005) to 850 KA (Valckenborg et al., 2002)
with many giving a value of around 500 ±50 KA (Schmidt et al., 1995; Hansen et al., 1996;
Schreiber et al., 2001; Webber et al., 2001; Hansen et al., 2005; Petrov et al., 2006a) despite
the variety of materials studied. However, for a detailed knowledge of pore structure, it is
vital to know the exact temperature at which the imbibed liquid melts or freezes (Filippov
and Skirda, 2000). It is critical, therefore, to determine the temperature calibration between
the probe set temperature and the temperature experienced within the sample for the system
being studied. Until recently (Mitchell et al., 2008) this subject was, at best, often only
briefly described in the literature (Valckenborg et al., 2001) with temperatures taken as that
of the temperature controller (Mikhalovska et al., 2006; Topgaard and Soderman, 2002;
Mitchell et al., 2005) or referenced against one temperature such as the bulk freezing or
melting point of the imbibed liquid (Petrov and Furo, 2006). The work described below
shows that these are not accurate assumptions.
There is a variance in temperature between the NMR probe temperature controller and
the temperature of the sample, and there is not a simple or predictable relationship between
these two temperatures. Some effort has been made to relate temperature ramping and
controller temperature to the actual sample temperature (Webber, 2000) but this is only
true for samples immersed in the liquid due to the variation in heat transfer properties of
liquids compared to gases. During the development of the experimental method for this
work, described in Section 2.2, consideration to each of these details was made.
By comparing NMR cryoporometry results with those from more traditional, and bet-
ter understood, porosimetry techniques it is hoped that a greater understanding of NMR
cryoporometry can be made. Although the causes of NMR cryoporometry freeze-thaw hys-
teresis are currently not fully understood, a number of causes have been suggested in the
literature, a more detailed description of which is given in Section 3.2.1, Chapter 3.
Mercury porosimetry has been a common method to analyse macroporous (> 50 nm)
and mesoporous (2–50 nm) structures such as catalyst materials and rock. Mercury is a
non-wetting liquid and, therefore, requires an applied pressure to force it into the pores
of such a solid. Greater pressure is required to force mercury into smaller pores. The
magnitude of the applied pressure relates to the size of the pores as described by the
Washburn equation 2.6 (Washburn, 1921),
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where Ps is the capillary pressure, γls is the surface tension of the liquid with the solid at
a contact angle of Θ and rp is the pore radius.
During the intrusion process, mercury is forced into the pores from the outside surface
of the material. Any larger pore that are connected to the outside by a small pore or ‘neck’
will not be filled until the pressure is sufficient for the mercury to penetrate the smaller
pore and the intrusion curve is thus susceptible to shielding effects.
Mercury porosimetry is also susceptible to hysteresis dependent on the pore network
connectivity. During the extrusion of mercury, the pressure reaches a sufficient level to
empty the small ‘neck’ pores but the pressure is too great for the mercury to empty from
the inner larger pores and mercury is retained in the larger shielded pores. Once the mercury
extrusion is disrupted, the mercury remains trapped inside the larger pore even at atmo-
spheric pressure. Further discussion on the physical interpretation of mercury porosimetry,
NMR cryoporometry and the causes of the freeze-thaw hysteresis can be found in Chapter
3.
2.2 Development of experimental procedure
2.2.1 Preliminary experimental tests on amorphous silica materials
To ensure the freezing point was observed, the first step in developing the experimental
method was to determine the temperature range over which the proton spectra would be
taken. To this end, a trial with one of the silica pellet samples, s980g, was carried out.
The pellets were soaked in distilled water and excess water removed, by dabbing on wetted
tissue, before they were placed in a 5 mm diameter NMR tube. Wetted tissue was used
to ensure bulk water is removed without absorbing water contained within the pores. The
sample was then placed in a Bruker 400 MHz NMR spectrometer and cooled by means of the
thermal control system within the spectrometer, which allows the probe temperature to be
adjusted to a set point and maintained at that temperature whilst a spectrum is collected.
Cooling was performed in a stepped fashion, with 1 K steps, and a typical spectrum for the
imbibed water signal is shown in Figure 2.1.
The broad nature of this spectrum, 8 ppm, compared to that of liquid only signal, 0.03
ppm, is due to the multiple solid-liquid-air interface susceptibility effects within the sample.
This experiment gave an estimation of freezing and melting temperatures for the system,
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Figure 2.1: A typical NMR spectrum of water contained within the pores of silica pellet
and allowing for an uncorrected temperature calibration, the range of 298 K to 267 K was
selected to show the freeze-thaw hysteresis of water in this porous silica sample. The silica
samples s980g and c30 are known to have similar pore sizes of 20–40 nm and will, therefore,
require similar temperature ranges to view the freeze-thaw hysteresis, an example of which
can be seen Figure 2.2.
Once the temperature range was established, it was important to determine the required
equilibration times for each temperature set point. The quasi equilibrium nature of the phase
change being studied suggested the use of a step-wise temperature change would be the
most suitable method to gain an accurate account of the quantity of material freezing at
a given temperature. A heating rate of 8 K per hour was suggested (Hansen et al., 2005),
this is equivalent to an equilibration time of 7.5 minutes per 1 K change. Using this as
an estimate, acquisitions were taken using 3, 6, 9 and 12 minutes equilibration for each 1
K change in temperature. Therefore, the temperature profile was such that four spectra
were collected at each temperature. This profile was used for both freezing and thawing
the sample.
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Figure 2.2: A typical freeze-thaw hysteresis for water contained in porous s980g silica pellet
The temperature control, time delays and spectra collection were automated using the
program multi zgvt, this program recalls a list of user defined temperatures and waits a
user defined time delay before acquiring spectra. Thus, the program controls temperature
and data collection at specified intervals after equilibration at a target temperature. This
experiment showed that an equilibration of 6-9 minutes was required for freezing and 9-12
minutes for thawing, in close agreement with the literature (Hansen et al., 2005). Although
the necessary equilibration time should be greatest for this test sample of the whole pellet
sample, with the water within the central part of the pellet being most thermally shielded,
for completeness the repetitions of four spectra at each temperature were initially used
for all new samples. This would highlight any difference in equilibration times between
whole, broken and powdered samples or between different samples. An example of multiple
equilibration time freeze-thaw hystereses can be seen in Figure 2.3.
For each experiment, a large number of spectra were produced that all required process-
ing. The software supplied with the NMR spectrometer (XWIN NMR and more recently
TOPSPIN2) contains automatic programs (au programs) one of which will allow one or
more commands to be carried out on multiple data sets, specifically multicmd. This pro-
gram allows for each processing command to be completed on each data set in series.
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Figure 2.3: A typical freeze-thaw hysteresis for water contained in porous silica pellet at 3, 6, 9,
and 12 minutes equilibration
In summary, the data processing steps for each spectrum include performing the Fourier
Transform of the free induction decay, (FID), carrying out a basic phase correction and
baseline correction. Once processed, the region in which the water peak appears can be
defined and all spectra integrated in this region, using the program multi integ. The relative
signal intensities for each temperature set point could then be calculated and plotted to
show the phase transition.
Initially, a basic pulse and acquire sequence was used, however, this led to a low intensity
broad peak for water, even after complete freezing, as the solid water was still being
detected. In order to remove this broad peak a simple Hahn spin echo sequence was used,
as suggested in the literature (Petrov and Furo, 2006). This sequence is a basic form of the
Carr-Purcell Meiboom-Gill (CPMG) sequence, also used for cryoporometry (Hansen et al.,
1996; Mitchell et al., 2005). The pulse sequences used are detailed in Appendix A.7.
The FID is the raw data signal received by the NMR, this data is processed by Fourier Transform to
give the NMR spectrum.
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2.2.2 Temperature calibration using methanol
It was essential that the temperature inside the sample was known for each spectrum taken
in order to establish the exact temperature at which any change of state occurred. The re-
quired accuracy of the sample temperature is dependent on the value of the Gibb-Thomson
parameter, see equation 2.5, as the greater the accuracy the clearer the determination of
pore diameter. The NMR temperature control unit (BVT3200) has the operating temper-
ature range of 123–423 K with an accuracy of ±0.1 K. It is, however, acknowledged that
the probe thermocouple, used by the temperature control unit, does not give an accurate
measure of the sample temperature due to the heat transfer effects within the probe and
the sample itself (Fritsch, 2000). This temperature difference occurs as a result of the
positioning of the thermocouple within the probe.
Calibrations to account for this difference are often carried out for liquid state NMR
(Geet, 1970). The probe thermocouple is placed below the sample within the flow of gas
used to control the probe temperature and has been calibrated to equate this temperature
to the actual sample temperature for a liquid sample. A commonly used method for a low
temperature calibration (below 298 K) of this thermocouple is a methanol calibration. An
NMR tube containing methanol is placed in the spectrometer and the distance between the
signal of the hydroxyl proton and the methyl protons is measured at different temperatures.
As the temperature decreases, the distance between the 2 signals of the chemical shift
increases according to the equation 2.7.
T = −23.832δ2s − 29.46δs + 403.0 (2.7)
where T is the actual temperature in Kelvin and δs is the difference in chemical shift between
the two methanol peaks in ppm. This equation is valid in the 180—300 K range. For a
liquid sample the methanol calibration gives a sufficiently accurate sample temperature,
however, when the sample is a combination of solid, liquid and gas phase, the heat transfer
dynamics become more complex and the methanol calibration is no-longer adequate.
The following sequence of experiments was carried out as an investigation into the
temperature calibration: Initially, to calibrate the temperature for this system, some of
the silica pellets were soaked in methanol to simulate the experimental procedure and
conditions of the standard water experiment, the experimental set-up for this is shown
in Figure 2.4 A. In this way, an exact temperature profile experienced by the imbibed
liquid could be calculated using the low temperature methanol calibration, equation 2.7.
As expressed in (Geet, 1970)
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Figure 2.4: NMR experimental set up for calibration experiments 1
The results of this experiment can be seen in Figure 2.5. At low temperatures, within
the range of interest for these experiments, it was found that calculated temperatures for
the imbibed methanol were much lower than those suggested by the standard methanol
calibration experiment, methanol in the NMR tube. If any difference was expected, it was
that the imbibed methanol would be at a higher temperature, as the three-phase system
was thought to introduce increased thermal shielding from the cold temperature gas flow
used for temperature control. At this point it was thought that the methanol calibration
equation 2.7 may not be valid for methanol confined within small pores.
The next calibration experiment used a methanol filled capillary of 2 mm outside di-
ameter fitted along the central axis of the 5 mm outside diameter NMR tube. This set
up introduced the additional heat transfer barriers of another layer of glass and air. The
experimental set-up for this is shown in Figure 2.4 B. The simplicity of this set up pro-
vided easier shimming and removed the possible wall effects that may have influenced the
results seen for methanol in the pellets. Results of this experiment also showed a difference
from the standard calibration experiment as shown in Figure 2.5, however, it was seen that
the methanol contained in the pellets and the capillary were in close agreement with each
other. The results from the capillary experiments also showed some discrepancy between
NMR Studies of Controlled Drug Release Devices 16
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Methanol capillary Methanol in pellets
Standard Calibration Linear (Methanol in pellets)
Linear (Methanol capillary)
Figure 2.5: A comparison of methanol temperature calibration experiments conducted
the sample temperature and probe set temperature that was observed to be dependent
on whether the sample was being cooled or heated, results are shown in Figure 2.6. A
repeat of the standard calibration experiment, Figure 2.4 C, was conducted with methanol
in an ordinary 5 mm diameter NMR tube. It was found that this experiment compared well
the capillary experiment. The discrepancy between these results and the previous standard
calibration experiment was found to be caused by varying the cooling rate and gas flow
settings of the temperature control system. As a result of this finding, it was considered
that the temperature experienced within the sample varied not only with the probe set
temperature, but was also a function of the cooling rate, gas flow settings and probe heater
power. Therefore, where practical the set points for cooling rate and gas flow should be
kept constant, however, the probe heater power is the control for adjusting the temperature
and, therefore, cannot be kept constant.
From these experiments, it was determined unfeasible to estimate an absolute temper-
ature calibration for all possible experimental conditions, and it was decided that a better
system would be to directly measure the sample temperature for each experiment. To
do this using the methanol temperature calibration, both methanol and water have to be
present in the same sample tube. To prevent methanol and water physically mixing, the
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Methanol capillary cooling Methanol capillary heating
Linear (Methanol capillary cooling) Linear (Methanol capillary heating)
Figure 2.6: A comparison of heating and cooling temperature calibration for methanol capillary
experimental set-up proposed was a methanol capillary surrounded by broken pellet pieces
imbibed with water, as shown in Figure 2.4 D. As discussed later in Section 2.3.2, there is
no change in the freeze-thaw hysteresis of the water in broken pieces of pellet compared to
that in a whole pellet, until the pieces are less than 30 µm in size. When the pellet pieces
are below this size the internal pore network structure within the pellets is broken and the
effects on the hysteresis change.
Additionally, this sample was difficult to shim and there was overlap of the water peak
and one of the methanol peaks. To overcome this overlap, water was replaced with its
deuterated form so that 2 individual FID signals could be measured. The spin echo pulse
sequence used was modified to allow for a proton excitation at 400 MHz then a deuterium
excitation at 61 Mhz to produce two spectra for each temperature set point. The results
from this experiment can be seen in Figure 2.7, the methanol capillary experiment results
are also shown for comparison.
One important observation from this experiment was that small adjustments in shim-
ming these samples could change the apparent difference in chemical shift for the two
methanol peaks, therefore, changing the observed temperature. These shimming effects
are not relevant for water based freezing experiments as the exact position of the water
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Methanol in capillary surrounded by pellets
Methanol in capillary surrounded by pellets in D2O
Linear (Methanol in capillary surrounded by pellets)
Linear (Methanol in capillary surrounded by pellets in D2O)
Linear (Methanol capillary)
Figure 2.7: Methanol capillary surrounded by pellets temperature calibration
proton chemical shift is not important, only the strength of the signal required. However,
the influence of these effects on the methanol temperature calibration render this method
unreliable for these experiments and an alternative approach is required.
2.2.3 Temperature calibration using a thermocouple
The alternative approach considered was to use a thermocouple inserted into the sample
during the acquisition of the spectra to measure the sample temperature directly. To this
end a ‘t’ type thermocouple, identical to that used within the probe, was sourced from
the manufacturer of the spectrometer, Bruker. This copper-constantan thermocouple was
calibrated against the expected freezing temperature for several water-glycerol mixtures,
according to data from literature (Lane, 1925). The thermocouple was inserted into the
NMR tube and connected directly into the control system, in place of the thermocouple
normally used for temperature control, enabling the control of the temperature via the
BVT3200 system by direct measurement of the sample temperature. Initially a sample of
methanol was used to provide a reference to the temperature read by the thermocouple
and that of the methanol. The thermocouple was placed a few millimeters into the top
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of the sample, outside of the region of the detection coil, to avoid any interference within
the collected FID or any shimming issues. There was agreement to within 0.5 K between
the thermocouple temperature and the calculated temperature from the difference in the
methanol chemical shift, with the main source of experimental error being determination
of the tops of the two methanol peaks. From equation 2.7, peak position accuracy to 5
decimal places in ppm is required for 0.1 K temperature accuracy, realistically 4 decimal
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Methanol capillary cool Thermocouple cool
Thermocouple heat Methanol capillary heat
Linear (Methanol capillary cool)
Figure 2.8: Thermocouple temperature calibration on cooling and heating the sample
A more significant practical issue arose from poor temperature control, the temperature
control system took several minutes to reach a target temperature and would significantly
over-shoot the target temperature. This was the result of the feedback control system
assuming the placement of the thermocouple to be below the sample within the flow of
cool nitrogen used to cool the sample. The insulated position of the thermocouple meant
that the required temperature was overshot and the control system had a ‘sluggish’ response.
Optimising the control system response parameters was not enough to manage accurate
control and the set-up was changed. The probe thermocouple was used to manage the
temperature control system and the second thermocouple within the sample was used as an
independent system to monitor the sample temperature. A comparison of the thermocouple
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temperature readings and the methanol capillary results for cooling and heating are shown
in Figure 2.8. It can be seen that the thermocouple temperatures are consistent on cooling
and heating the sample, whilst the methanol capillary experiments show discrepancies in
temperature during cooling and heating.
2.2.4 Temperature gradient calibration
Figure 2.9: NMR experimental set up for calibration experiments 2
The mechanism of heat transfer between a fluid and solid is dependent on several
parameters including the fluid dynamics and material properties of the system (Coulson and
Richardson, 1999) and is, therefore, considered more complex than heat transfer within a
liquid. Thus, investigations were carried out to determine the temperature gradient within
the sample. The secondary thermocouple was placed on the surface of the silica pellet
sample, as shown in Figure 2.9 A, to give an accurate temperature of the top of the sample
at each probe set point temperature. A similar experiment, where the thermocouple was
placed as the base of the sample, showed a 4 K temperature gradient through the sample.
The heating and cooling of the sample is controlled by the cool nitrogen gas flow over the
sample, which comes from below the NMR sample tube, causing a temperature gradient
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Figure 2.10: Results of measured temperatures for the top and bottom of insulated sample
along the axis of the NMR tube. To reduce this temperature gradient through the sample
the lower end of the sample was insulated from the direct flow of the temperature controlling
gas flow, by placing a susceptibility plug, made from a non-interfering material, beneath
the silica pellets within the NMR tube. The temperature at the top and the bottom of
the sample was measured for a series of probe set temperatures of both increasing and
decreasing temperature as shown in Figures 2.9 B and C. The results for this experiment
seen in Figure 2.10, show a temperature gradient of approximately 1 K over the sample for
this set up. To further reduce this temperature gradient, a second susceptibility plug was
placed on the top of the sample to cover the top end of the receiver coil and fewer pellets
used, as shown Figure 2.9 D. This reduced the temperature gradient to 0.2 K.
2.2.5 Experimental procedure for silica pellet materials
The porous pellets were allowed to soak in laboratory standard deionised water until fully
saturated, at least 20 minutes. Once all the pores were filled with water the pellets were
dabbed onto wetted tissue paper to remove bulk water from the outside of the pellets. The
wetted tissue was used to ensure that excess bulk water was removed, but water within the
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pores was not drawn out from the internal pellet structure. A few of the pellets were then
carefully placed inside a 5 mm outer diameter NMR tube on top of the first susceptibility
plug, the second susceptibility plug was then placed on top with the thermocouple securely
positioned to record the sample temperature. Once the experiment was completed, the
whole pellets were broken and powdered using a mortar and pestle and pieces soaked again
in deionised water and dabbed on wetted tissue. The presence of bulk water would reduce
the relative magnitude of the signal recorded from the water entrapped in the pellets and
upon freezing the presence of too much bulk water could cause the NMR tube to shatter
as the water solidifies and expands. It was, therefore, essential that the excess bulk water
was removed as much as possible from the outside of the pieces of sample.
The samples were studied with a Bruker 400 MHz NMR spectrometer. A simple spin
echo sequence was used and the automated temperature adjustment program, multi zgvt,
was used to follow a sequence of decreasing and increasing temperatures. The temperature
sequence used for the experiments was such that four acquisitions were made at each
temperature, with an equilibration time of 3 minutes between each listed temperature.
This effectively gave equilibration times of 3, 6 , 9 and 12 minutes for each temperature
on both cooling and heating, as described earlier in this chapter.
The spectra were processed as described in Section 2.2.1, and results were transferred
into excel where signal intensity versus temperature plots could be displayed, thus showing
the freeze-thaw hysteresis. For the experiments described in this chapter, where actual
pore size calculations were not required, the probe temperature was considered adequate
for proof of concept.
2.3 Results and discussion
The results included here are preliminary results that were collected before the temperature
gradient along the axis of the NMR tube was discovered. The work described in Chapter 3
uses the experimental method that was developed here.
2.3.1 The equilibration time
Figures 2.11 and 2.12 show the freeze-thaw hystereses for 3 and 12 minutes for two different
sol-gel silica pellets with similar pore sizes, s980g and c30 respectively. It can be seen that
there is a need to allow the sample to equilibrate at a given temperature for a period of time
before taking the spectrum. This is to allow for the sample temperature to reach equilibrium
and to allow time for the formation of, or melting of, ice crystals of the imbibed liquid, the
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Cooling 3 minutes Heating 3 minutes
Cooling 12 minutes Heating 12 minutes
Figure 2.11: Whole s980g pellet freeze-thaw hysteresis at 3 and 12 minutes equilibration times
system thus reaching a steady state. These experiments show that changes within the peak
intensity between 9 and 12 minutes were small, within experimental uncertainty, therefore,
equilibration times of 9–12 minutes were appropriate for these systems. As previously
mentioned in Section 2.2 this equilibration time is close to that suggested by the literature
for an equivalent heating rate of 8 K per hour (Hansen et al., 2005).
2.3.2 Freeze-thaw hysteresis
Figures 2.11 and 2.12 show that there is a hysteresis between the freezing and thawing of
the imbibed liquid in the silica pellets. It is thought that this hysteresis is the result of
the difference in the freezing and melting mechanism due to the restrictions of the pore
structure and pore network.
To demonstrate the effect of pore network restrictions on the freezing and thawing of
imbibed liquid, a series of experiments were conducted with whole, broken and powdered
samples of the two types of silica pellet. By breaking up the pellet the pore network should
be disrupted and the hysteresis should change accordingly, the results for these experiments
are shown in Figures 2.13 and 2.14, in which the curves for 12 minutes equilibration are
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Figure 2.12: Whole c30 pellet freeze-thaw hysteresis at 3 and 12 minutes equilibration times
shown. Data was also collected at 3, 6 and 9 minutes equilibration showing equilibration
was achieved. It can be seen in Figure 2.13 that the freeze-thaw hysteresis for broken
pellets does not differ from that of whole pellets. This is in agreement with previous work
on similar materials (Rigby et al., 2008) which suggests that there is a threshold size for the
pellet piece, below which pore network shielding effect can be removed and above which
no change is seen in the hysteresis. This is useful for experiments where small volumes of
’whole’ pellets are required, broken pieces may be used. Once the pore structure has been
broken up sufficiently, as in the powdered samples, it can be seen that there is a shift in
the freezing point of the liquid within the powdered sample from that of the liquid within
the whole or broken pellet pieces.
2.3.3 Freezing mechanism
Figures 2.13 and 2.14 show liquid freezing at 2–3 K higher for the powder samples than for
whole pellet samples, suggesting larger pores are present in the powder samples, both sam-
ples whole and powder samples contain the same sizes of pores, however, their arrangement
with respect to the bulk water has changed. In the whole pellet the required temperature
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Whole cooling Broken cooling Powder cooling
Whole heating Broken heating Powder heating
Figure 2.13: Whole, broken and powdered s980g pellet freeze-thaw hysteresis at 12 minutes
equilibration time
for the freezing of the imbibed liquid in the smaller external pores is expected to be lower
than that for the larger internal pores and, therefore, requires a lower temperature for the
freezing to progress into the whole pellet pore structure. These results suggest the freez-
ing mechanism for the imbibed liquid is in some part heterogeneous nucleation, with the
freezing front moving into the pellet from the surface. When the pore structure is broken
and all the pores are exposed to the external surface in the powder sample, heterogeneous
nucleation can occur at a higher temperature, as there are no longer narrow pores shielding
the progression of the freezing front into the larger internal pores. The shielding effects of
the smaller pore entrances to the main pore structure have been removed in the powder
samples. It is, however, not possible at this stage to completely rule out that there may
be some contribution of homogeneous nucleation occurring within the pores. As previously
mentioned these results were conducted before the discovery of the temperature gradient
along the axis of the NMR tube, it is however hoped that this effect is seen when repeated
following the final experimental procedure, Section 2.2.5.
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Figure 2.14: Whole and powdered c30 pellet freeze-thaw hysteresis at 12 minutes equilibration
time
2.3.4 Comparison to mercury porosimetry data
Figure 2.15 shows mercury intrusion and extrusion data for whole pellet and powder samples
of c30. It can be seen in Figure 2.15 that for a whole pellet sample mercury first intrudes
when the pressure is equivalent to a pore size of around 0.045 µm, but for the powdered
sample the first intrusion is at an equivalent pore size of 0.056 µm. Since the pore sizes for
both samples are the same, this effect must be due to a change in the arrangement of the
pore structure in the powdered sample compared to the whole sample, and the shielding
effect of small pores being removed. This is also shown when the pore size distribution for
the two samples is plotted from the intrusion data, Figure 2.16a. The powder sample again
shows a maximum volume of pores with a greater diameter than is seen from the whole
pellet sample. The pore diameter distribution calculated from the incremental extrusion,
Figure 2.16b shows the maximum pore to be the same for both samples, of 0.105 µm and
a narrower pore size distribution for the whole sample. The characteristics of the extrusion
of mercury from the whole and powdered samples also differ, Figure 2.15. More mercury
is left entrapped within the whole pellet sample, 55%, compared to the powdered samples,
30%, this again suggests a shielding effect of narrow pore necks with larger pores contained
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Intrusion powder Extrusion powder
Intrusion whole Extrusion whole
Figure 2.15: Whole and powdered c30 pellet mercury porosimetry intrusion extrusion hysteresis
in the inner structure. As this arrangement is disrupted more mercury is able to extrude
from the sample. The step within the extrusion curve for the whole pellet suggests some
discontinuity in the extrusion of the mercury, which is not present for the powdered sample.
Comparison of the freeze-thaw hysteresis is made with the intrusion-extrusion of mercury
for c30. As previously described in Section 2.3.3, there is a difference in the freezing
temperature for whole and powdered sample imbibed liquid. The liquid imbibed in the
whole pellet sample freezes at a lower temperature suggesting a smaller pore size, in a
similar manner to the shift seen for mercury intrusion for whole and powder samples.
Like mercury extrusion, no change is seen in the melting characteristics between whole
and powder samples. The pore size distribution of the whole and powdered pellet samples
being the same, this reinforces the suggestion of a shielding effect being seen in the freezing
process, like that seen for mercury intrusion.
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Figure 2.16: Whole and powdered c30 pellet pore size distribution determined from mercury
intrusion and extrusion
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2.4 Conclusions
This work has established an improved cryoporometry method that provides accurate tem-
perature measurements and, therefore, a robust account of pore size distribution to be de-
termined for model systems. The temperature profile within the sample has been reduced
to a level such that the experimental error in pore size determination is within acceptable
limits. The pore size distribution may then be compared to that found by alternative meth-
ods such as gas sorption and mercury porosimetry, the comparison of which may be used
to estimate the Gibbs-Thomson parameter. In this chapter it has been shown that it is
possible to compare the overall trend of cryoporometry results with mercury intrusion and
extrusion data to form a better understanding of the freezing mechanism involved. Hetero-
geneous nucleation by means of a freezing front that progresses in toward the centre of the
pellet has been suggested as a potential contributory freezing mechanism and one of the
causes of the freeze-thaw hysteresis. Further work has been carried out on silica materials
to reinforce and consolidate these findings, see Chapter 3. From this further work, a better
understanding of the freezing mechanism will be established to enrich the interpretation of
cryoporometry data. The spectra collected from a combination of NMR techniques, cry-
oporometry and pulsed field gradient diffusometry will be used to investigate drug delivery
mechanisms from polymer microspheres. This is discussed later in Chapters 5 and 6.
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Chapter3
Application of the cryodiffusometry
experimental method to sol-gel silica
materials
3.1 Introduction
The work described in this chapter uses the cryoporometry method developed in Chapter
2 to further the understanding of the freezing process of an imbibed liquid within a porous
material. By comparing cryoporometry freeze-thaw hysteresis with better know porosimetry
methods, such as mercury porosimetry and gas sorption it hoped that the causes of the
freeze-thaw hysteresis may be identified. The material used for this work is a commercially
available sol-gel silica pellet which has been previously studied within the group (Rigby
et al., 2008a). It is known to have an ‘ink bottle’ pore structure, where larger pores are only
accessible to the surface or surrounding pore network by narrow pores thus simulating the
body and neck of an ink bottle. Using this model structure allows further interpretation of
the freeze-thaw hysteresis. The difference in freezing and melting mechanism is investigated
using whole pellet and ground-up powder samples. A direct comparison with mercury
intrusion-extrusion hysteresis and nitrogen adsorption-desorption hysteresis has shown that
the freezing curve can provide additional complimentary information to the melting curve
during the investigation of pore network characteristics by cryoporometry.
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3.2 Background and Theory
Silica materials are currently of interest for use as a drug delivery system (Rigby et al.,
2008b). The development of mesoporous silica materials has enabled the tailoring of pore
sizes, pore arrangements, surface chemistry and accessibility to the pore network via re-
sponsive gates (Mal et al., 2003). Thus silica material design has clear advantages over
polymeric systems, in terms of structure and surface property control. Recent studies have
considered a variety of silica materials for drug delivery, such as mesoporous templated sil-
ica (Vallet-Regi et al., 2006), sol-gel silicas (Veith et al., 2004), mesoporous microspheres
(Wang and Caruso, 2005; Zhu et al., 2005) and a combination polymer-silica xerogel (Xue
et al., 2006). Whilst polymer devices have the advantage of proven biocompatability, the
inorganic silica material structure design is better understood and able to host protein and
enzymes with little effect on their characteristic functionality (Hartmann, 2005).
Cryoporometry has previously been compared with other porosimetry techniques such
gas sorption, neutron scattering and liquid intrusion (Gane et al., 2004; Denoyel et al.,
2004; Webber et al., 2001). However, the focus of much of this work has been on the
melting characteristics of the imbibed fluid. Some hysteresis comparisons have been made
by Denoyel et al. (2004), who concludes that the hystereses of gas adsorption-desorption
and freeze-thaw cycles are very comparable, but they do not explain why this is. It has only
been very recently that interest has grown to include the significance of the freezing curve
(Petrov and Furo, 2006; Khokhlov et al., 2007; Vargas-Florencia et al., 2008).
3.2.1 Further Cryoporometry Theory
The fundamental principles of cryoporometry theory were introduced in Chapter 2, this
section describes further ideas that add detail to the complex nature of the freezing mecha-
nism and the freeze-thaw hysteresis. The combination of cryoporometry with NMR diffusion
studies, known as cryodiffusometry, is also explained. Combining these NMR techniques it
is hoped that a more detailed understanding of pore structure for complex materials may
be explored.
Traditionally in thermoporosimetry and early cryoporometry experiments pore size dis-
tributions were determined from the melting behaviour of the imbibed liquid. Typically a
sample was cooled until all the liquid contained was frozen and then gradually heated until
all the liquid had melted again. The melting characteristics were chosen as they were not
subject to the super cooling effects seen during freezing (Strange et al., 1993) and the
mechanism of melting was better understood, as described previously in Section 2.1. The
mechanism for freezing of an imbibed liquid and, therefore, the causes of the freeze-thaw
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hysteresis have been more recently discussed (Petrov and Furo, 2006; Khokhlov et al., 2007;
Vargas-Florencia et al., 2008). It is with a better understanding of the freezing mechanism
that there is the opportunity to gain additional structural information from the characteristic
freezing curve.
Within the literature there are three common theories for the cause of the freeze-thaw
hysteresis, as described by Petrov and Furo (2006):
i An uncontrollable delay by homogeneous nucleation on cooling, like that seen in bulk
liquids. In the absence of nucleation sites such as foreign particles in a bulk liquid, it is
possible to cool the liquid below its freezing point and for it to remain liquid. When the
liquid is further cooled homogeneous nucleation can occur and the liquid freezes, this
phenomena is known as super-cooling. This effect can be seen on a series of independent
experiments, however, the temperature at which super-cooling occurs is not consistent
for any given sample.
ii Pore-blocking effects on penetration of a solid front moving from the outside that causes
an apparent delay in the freezing of the internal pores. For an imbibed liquid, external
pores are in contact with the bulk liquid, which will freeze first, once frozen the bulk
liquid provides a nucleation site for liquid in contact with it. However, for this liquid to
freeze the temperature must reach the value appropriate for the pore size it is contained
within. If a larger inner pore is shielded from the bulk by a smaller pore, the inner
pore can only freeze when the temperature is low enough to freeze the smaller pore,
as predicted by the Gibbs-Thomson equation 2.1, thus shifting the freezing curve to
smaller apparent pore sizes.
iii The shape of the pore determines the shape of the meniscus between liquid and solid
state during melting and freezing. Whilst the propagation of freezing within the pore
occurs along the axis of the pore, it is thought that the melting front of the pore
propagates from the pore wall radially toward the pore center. Thus, the hysteresis is
due to some shape factor that accounts for the difference in the propagation of these
two fronts.
In addition there is support within the literature for the idea that the freezing mechanism
may be a combination of two or more of the above mechanisms acting together:
 Janssen et al. (2004) suggest that the freezing mechanism within a porous solid is a
combination of heterogeneous and homogeneous nucleation. Ice forms at the open
ends of the pores and then gains access to the pore network, such that freezing
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progresses inward by heterogeneous nucleation. In addition, some homogeneous nu-
cleation occurs within the pores that are connected to the surrounding network by
micropores, and supercooling occurs before the freezing front gains access. The in-
fluence of the delayed nucleation affects the calculated pore size determined from the
freezing behaviour, therefore, the melting curve is more reproducible and most often
used for pore diameter calculations.
 Petrov and Furo (2006) describe hysteresis in terms of a free-energy barrier between
metastable state and stable states, describing melting as a function of curvature of
the pore surface, whilst freezing is a function of surface to volume ratio of the pore.
The model derived in this work for a single pore hysteresis gives the relationship
between freezing and melting point depression, equation 3.1, where κ is the integral
mean surface curvature and V
S












 Khokhlov et al. (2007) use mesoporous etched silicon materials to experimentally
determine the freezing process. The known size, geometry and arrangement of pores
lead them to conclude that the freezing mechanism within pores is a combination
of both pore blocking effects of the freezing front penetrating the pore network,
and homogeneous nucleation of pores that are sufficiently shielded within the pore
network, where spontaneous nucleation can occur before the ice front reaches the
pore.
It is widely considered within the literature that a pore containing a frozen liquid has a
non-frozen layer between the solid frozen core and the pore walls (Quinson and Brun, 1988;
Schmidt et al., 1995; Hansen et al., 1996; Iza et al., 2000; Schreiber et al., 2001; Janssen
et al., 2004; Khokhlov et al., 2007). This has lead to a modified Gibb-Thomson equation,
as expressed in Schreiber et al. (2001), equation 3.2,
∆Tm =
kGT
2(rp − t) (3.2)
where kGT is the Gibbs-Thomson constant, rp is the pore radius and t is the thickness of
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the non-freezing surface layer. Typical values of kGT and t for water are 25–57.3 nmK
and 0.35–0.38 nm respectively (Schmidt et al., 1995; Schreiber et al., 2001; Webber et al.,
2001; Vargas-Florencia et al., 2007).
It is not always possible to gain an a priori value for the Gibbs-Thomson constant for any
given system, therefore, it is necessary to calibrate this parameter with another porosimetry
technique such as mercury porosimetry, as will be shown in Section 3.4.6.
In common with other porosimetry techniques, cryoporometry data requires some ma-
nipulation to calculate a pore size distribution, p(d). The measured parameters of melting
point depression, ∆Tm, and signal intensity, I, are inversely proportional to pore size, x, and
directly proportional to volume of liquid, v , respectively. Thus, the pore size distribution
is determined from the change in NMR signal intensity during melting or freezing (Strange
et al., 1993).
The cumulative pore volume, v, is a function of pore diameter. Therefore, the volume
of pores with a diameter between x and x+ ∆x is dv
dx
∆x. As the NMR signal intensity, I,




∆x holds true. The pore
size distribution as a function of the change of signal intensity, is derived using the chain














equation 3.3 gives the pore size distribution equation in terms of NMR signal intensity,











Cryodiffusometry is the combination of cryoporometry with NMR pulsed field gradient
(PFG) diffusion studies. The study of diffusion by NMR began it’s development in the 1950s
with the works of Hahn (1950) and Carr and Purcell (1954). Further developments included
the use of spin echoes (Stejskal and Tanner, 1965) and stimulated spin echo (Tanner,
1970) sequences for studying diffusion coefficients. Most modern diffusion sequences are
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derivatives of these two sequences (Kerssebaum, 2002). A comparison of some of the most
popular sequences for use in Diffusion Ordered Spectroscopy (DOSY) has been published
by Avram and Cohen (2005), including the Pulsed Gradient Spin Echo, (PGSE), the Pulsed
Gradient Stimulated Echo (PGSTE), the Longitudinal eddy current delay (LED) and the
Bipolar gradient with Longitudinal Eddy Current Delay (BPLED) sequences. Avram and
Cohen (2005) discuss the type of pulse sequence used and its effect on water signal decay,
including how the exponential behaviour observed may be different with the introduction
of the longitudinal eddy delay if that delay is greater than around 4 ms, such that a second
slower component diffusion may be seen that is not observed without the eddy delay. Such
an effect was not observed in this work where the eddy delay was 5 ms, and in some
cases mono exponential decays were observed, therefore, deviation from mono exponential
behaviour observed are not attributed to this effect.
The acquired data from PFG experiments shows an attenuation in signal amplitude for
the required nucleus as a result of diffusion of the nuclei within the observed diffusion time.
The attenuation of the signal intensity follows an exponential curve, equation 3.5, where
signal intensity, I, is a function of I0, the reference intensity, D, the diffusion coefficient,
γ, the gyromagnetic ratio of the observed nucleus, g, the gradient strength, δ the length of
the gradient, ∆ the diffusion time and τ the correction time for the phasing and dephasing
between bipolar gradients *.
I = I0 exp (−Dγ2g2δ2(∆− δ/3− τ/2)) (3.5)
This equation can be used to calculate the diffusion coefficient of the observed nucleus
in a homogeneous system, where the desired nucleus is effectively in one phase and the log
attenuation plot, Ln(I/I0) against ζ = γ
2g2δ2(∆− δ/3− τ/2), is linear.
Combining cryoporometry and diffusometry provides the ability to assess the diffusion
characteristics of a part molten, part frozen sample, this can provide additional pore struc-
ture information, and the arrangement of ice within that structure. PFG experiments carried
out at equal signal intensities on the freezing curve for whole and powder samples should
indicate if there is a difference in the distribution of ice during the freezing process for
these two samples. The effective diffusion coefficient, De, is a measure of how the water is
diffusing within the porous network. The tortuosity of the pore network, τp, is a measure
of the potential deviation from a linear path that a diffusing molecule may experience. The
greater value of tortuosity, the more complex the path of the diffusing molecule, imply-
ing a more complex network. The relationship between effective diffusion coefficient and
*As expressed in (Kerssebaum, 2002)
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where DB is the bulk diffusion coefficient at the experimental temperature and p is the
voidage or porosity of the material.
The diffusion coefficient calculated from NMR PFG studies, DPFG, contains a contribu-
tion from the spin density which is directly related to the voidage (Hollewand and Gladden,
1995), and is related to the effective diffusion coefficient by equation 3.7.
De = pDPFG (3.7)
The combination of equations 3.6 and 3.7 allow the determination of tortuosity from





The bulk diffusion coefficient of water can be estimated for a given temperature using
measured values found in literature (Mills, 1973; Holz et al., 2000). To estimate the value
of bulk diffusion at sub-cooled temperatures an extrapolation of the line of best fit for
literature data is made. It is not possible to measure the bulk diffusion coefficient at sub-
cooled temperatures used for these experiments, as bulk water will freeze. Validity of the
application of this method is discussed later in Section 3.4, but the estimation of the bulk
diffusion coefficient allows a quantitative analysis of tortuosity to be made. If a significant
difference is seen in the tortuosity between freezing of whole and powder sample, this implies
a difference in the arrangement of the ice and thus, a difference in the dominant freezing
mechanism.
The calculated root mean square (rms) displacement, rrms, of a molecule for the dif-
fusion time studied, according to the Stokes-Einstein equation 3.9 is approximately 10–20
µm. Therefore, it is expected that within the whole pellet sample, pellet diameter of ap-
As expressed in (Hollewand and Gladden, 1995)
For spherical pores described by Hollewand and Gladden (1995)
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proximately 2–3 mm, a statistically insignificant number of molecules will encounter the
boundary layer of ice around the pellet during the diffusion time. However, if the pellet size
was of the order of 1–2 times the rms displacement distance it is possible that a significant
number of molecules will encounter and interact with the boundary layer ice. To com-
pensate for this effect, the unrestricted intra-particle diffusion shall be estimated using the
short time diffusion model for porous media derived by Mitra et al. (1993). According to
equation 3.10, a plot of the measured diffusion coefficient, DPFG, against the square root
of the diffusion time, ∆
1
















is the surface to volume ratio of the boundary surface, ie. the pore walls and ice
walls.
3.2.3 Gas adsorption
Gas adsorption relies on the physical and chemical attraction between a solid surface, the
adsorbent, and gas molecules, the adsorbate, at some defined pressure. Considering the
physical attractive forces, or van der Waals’ forces, the amount of gas adsorbed to the
surface of the solid is a function of pressure, temperature and the properties of the solid
and gas (Gregg and Sing, 1982). The amount of gas adsorbed on the solid surface can be
measured in terms of a reduction in pressure within the system, or an increase in weight
of the solid sample. The gas will adsorb first to the solid surface as a monolayer, i.e. a
layer that is one molecule thick, then additional layers of gas build onto the monolayer to
form a multilayer §. Within a porous material the gas layers continue to fill the pore until
the pressure is sufficient that the gas condenses into a ‘liquid-like phase’. The pressure at








where p is the pressure, p0 is the saturation pressure of the gas at the given temperature,
§Adsorption model of Brunauer, Emmett and Teller as described in Gregg and Sing (1982)
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( p
p0
is termed the relative pressure,) γl is the surface tension of the adsorbate in liquid
form, Vm is the molar volume of the adsorbate in liquid form, rp is the pore radius, R is
the universal gas constant, T is the temperature and φ is the contact angle between the
liquid and the wall of the pore. The contact angle, φ, is often given an assumed value of
0, i.e. that the liquid wets the pore wall, in reality the contact angle changes (Gregg and
Sing, 1982) as the pore fills and the pore shape varies, it is, therefore, difficult to determine
directly within the small porous networks being studied.
Figure 3.1: Diagram of forces on a curved meniscus
In common with cryoporometry freeze-thaw hysteresis, there is a hysteresis between the
adsorption and desorption isotherms within a mesoporous material, due to the different
mechanisms involved in the two processes. Adsorption begins at the wall of the pore and
progresses toward the centre of the pore, and is generally assumed independent of the pore
network. When the adsorbed gas layer is sufficiently thick that the gap between opposing
layers is small enough, capillary condensation occurs within the pore. The gas adsorption
within a pore can, therefore, be considered as starting at the pore wall and progressing
radially into the core of the pore. In capillary condensation the gas-liquid meniscus travels
along the axis of the pore to the pore surface where it eventually flattens with increasing
pressure and the bulk gas becomes saturated. For desorption to occur a curved meniscus
must re-form between the condensed liquid in the pore and the gas phase of the bulk,
this requires a reduction in the bulk pressure. For a curved meniscus in equilibrium, the
forces on either side must balance, as shown in Figure 3.1. The sum of pressure on the
concave side of the meniscus, Pcv, is equal to the sum of the pressure on the convex side
of the meniscus, Pcx, and the surface tension, therefore, Pcx ≤ Pcv. This effect is greatest
for a hemispherical meniscus, therefore, during desorption the pressure is reduced and the
meniscus at the surface of the pore begins to curve until it reaches a hemispherical dome
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protruding into the pore. The surface tension enables the pore to remain filled with liquid
which is in equilibrium with the gas at pressures below it saturation pressure. After forming
the meniscus, further decreases in pressure cause the adsorbent to evaporate according to
the size of pore in which it is contained. This is similar to the freezing front penetrating the
pore within cryoporometry. The pressure difference required to create the meniscus is also
inversely proportional to the radius of the pore, according to equation 3.11. For ink-bottle
style pores exposed to the bulk via smaller pores, the relative pressure required to form the
meniscus is dominated by the outer pore, the adsorbed gas can only begin to evaporate
when the pressure is sufficient to form a meniscus within the smaller outer pore, at which
point the whole pore will empty. The desorption isotherm is, therefore, shifted toward the
smaller pore sizes and subject to pore shielding effects (Rigby and Fletcher, 2004).
The surface area of the material may be determined by gas adsorption using the
Brunauer, Emmett and Teller (BET) equation 3.12. The BET equation is applied to the
start of the adsorption branch for relative pressure values typically between 0.05 and 0.35,
when it is assumed that the adsorption of gas is building as a multilayer on the surface of
the solid (Gregg and Sing, 1982).
p









where xm is the monolayer capacity and c is BET constant. xm and c can be determined




, with slope, s and intercept, i , according









The monolayer capacity can be used to determine the specific surface area, Sa, according




NAAm × 10−20 (3.15)
¶As expressed in Gregg and Sing (1982)
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where Sa is the specific surface area of the solid in m
2g−1, xm is the monolayer capacity in
cm3 of adsorbate per gram of solid, NA is Avagadro’s constant (6.02× 1023), 22414 is the
volume in cm3 of 1 mole of gas at standard temperature and pressure (273.15K and 1 atm)
and Am is the molecular cross-sectional area of the adsorbate in A
2, which for nitrogen at
77 K is given as 16.2 A2 (Gregg and Sing, 1982).
3.2.4 Mercury porosimetry
Further to the theory explained in Chapter 2, a more in depth discussion of mercury
porosimetry follows. Recent work (Rigby and Edler, 2002) has advocated the use of more
refined equations relating pore size to applied pressure for mercury intrusion, equation 3.16
and extrusion, equation 3.17 in silica materials. Equations 3.16 and 3.17 are empirically
derived from the Washburn equation, 2.6 (Rigby and Edler, 2002) and account for changes
in contact angle and surface tension relative to pore radius, thus removing their contribution
to the hysteresis (Rigby and Fletcher, 2004). The validity of pore radii for equations 3.16













where rp is the pore radius in nm and p is the pressure in MPa.
The causes of hysteresis between mercury intrusion and extrusion are relatively well
understood (Rigby et al., 2002; Rigby and Edler, 2002; Rigby and Fletcher, 2004) it has
been shown that hysteresis is dependent upon contact angle, surface tension and network
structure (Rigby et al., 2002). Using equations 3.16 and 3.17 to remove contact angle
and surface tension hysteresis, the resultant observed hysteresis is due to structural effects.
One such effect is pore shielding, this occurs when larger internal pores are connected to
the network or bulk by smaller pores, ie. pores so called ‘ink-bottles’. For mercury to
intrude into larger internal pores via connecting small pores, a greater applied pressure
is required, therefore, the apparent volume of small pores is increased. During extrusion
the applied pressure decreases and mercury extrudes from small external pores, however,
pressure is not sufficiently low to allow extrusion from larger internal pores, the mercury
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ganglion ‘snaps’ and mercury is retained within the larger pores. The mercury remains
permanently entrapped within these pores. If the network structure is sufficiently disrupted
by grinding the solid into a powder where the pieces are small enough that all of the larger
pores are directly exposed to the outside surface, it is possible to remove these shielding
effects (Rigby et al., 2002, 2008a). For the silica materials used here, pieces smaller than
30-40 µm are sufficient to remove these shielding effects.
3.2.5 Percolation theory
Percolation theory has previously been used to determine pore connectivity and study pore
blocking effects seen in nitrogen sorption and mercury intrusion hysteresis of porous mate-
rials (Seaton, 1991; Murray et al., 1999). In this work the percolation theory described by
Seaton (1991) has been adapted for use with the freezing curve data from cryoporometry
experiments. If the pore network is considered as a lattice model of bonds and nodes, such
that the pores are identified as bonds and the connections between pores as nodes, any
porous network can be modelled as a lattice with a given number of bonds and nodes, see
Figure 3.2.
Figure 3.2: Diagram of lattice models
A lattice is described in terms of, L, an average linear dimension of the bond and, Z,
the coordination number, i.e. the number of bonds that connect to one node. A percolation
cluster is the term used to describe a network of bonds that provide a pathway for mass or
energy to traverse from one side of the lattice to the other.
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When describing percolation in a network, a bond may be described in three ways,
unoccupied, occupied but not in the percolation cluster, and occupied within the percolation
cluster. To describe the thermodynamic mechanism of freezing within a porous network,
the three bond types are defined in terms of pore content as:
 An unoccupied pore contains liquid above it’s freezing temperature, therefore, no
progress of the freezing front is possible
 An occupied pore contains liquid below it’s freezing temperature, therefore, the freez-
ing front could progress along this bond, but it is not part of the percolation cluster
and not in contact with the freezing front, the liquid contained cannot freeze
 An occupied bond within the percolation cluster is a pore containing solid (ice), the
liquid is below its freezing point and in contact with the freezing front, thus, the
contained liquid has frozen
Percolation theory states there is a critical value of occupied bonds that must exist for
a percolation cluster to be formed, i.e. the fraction of occupied bonds, f , reaches a critical
value, fc, see Figure 3.2. The fraction of occupied bonds is equal to the probability of a
bond being occupied. The probability, F , of a bond being part of the percolation cluster is
related to the probability of a bond being occupied, f , as shown in equation 3.18,
L
β





where the critical exponents of β and ν are 0.41 and 0.88 respectively.
In order to show that there is a penetrating freezing front which moves into and through
the porous network from the bulk outside the freezing mechanism is modeled by percolation
theory. To model the freezing of water in the pore network, it must be said that the liquid
contained in a pore will only freeze if it is below it’s freezing temperature and is in contact
with the freezing front, i.e. it is an occupied bond that is part of the percolation cluster.
The probability of a bond being occupied, f , is the ratio of number of occupied bonds to
total number of bonds, equation 3.19. The probability of a bond being in the percolation
cluster, F , is the ratio of the number of occupied bonds in the percolation cluster (pores





As expressed in Seaton (1991)
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where Nb is the number of pores below freezing point, NT is the total number of pores and
Nf is the number of pores frozen.
From cryoporometry freezing data for the powder sample of the macroscopically het-
erogeneous material, it is possible to calculate the probability of a bond being occupied,
f , as shielding has been physically removed, freezing is determined by pore size. The pow-
der melting curve, if adjusted for shape factor hysteresis assuming a cylindrical geometry
(Petrov and Furo, 2006) may also be used to determine, f . The cryoporometry signal inten-
sity, I, is directly proportional to the volume, Vi, of liquid contained in the pores, therefore,








where li is the average pore length.
If li is assumed to be constant and independent of the pore diameter, it can be cancelled
from numerator and denominator when calculating f and F . Once f and F have been
calculated it is possible to estimate values of L and Z, using equation 3.18. If L is large
and Z small, then a greater hysteresis can be seen than if L is small and Z is large.
3.3 Experimental
3.3.1 Materials
The silica pellets are commercially available sol-gel silicas, s980a**, the pellets have pore
sizes in the 5–10 nm range, with heterogeneous pore networks that include ink-bottle style
pores (Rigby and Edler, 2002). As described earlier in Section 3.2.4 it is possible to break
the pore network within the pellet and remove any shielding effects by breaking up the
pellets into pieces smaller than 30–40 µm.
**Produced by Shell
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3.3.2 Cryoporometry
The objective was to obtain freeze-thaw characteristics for whole and powdered samples of
the model silica pellet with ink bottle geometry. Furthermore, a comparison of the whole
and powder sample freeze-thaw cycles with nitrogen sorption and mercury porosimetry data
was made. The experimental procedure for the cryoporometry method was improved from
that already used within the literature, as described earlier in Chapter 2. The developments
included an increased accuracy of sample temperature measurement and a reduction in the
temperature gradient along the sample length.
The silica pellets used have a bimodal pore distribution with modal pore diameters
of around 5 nm and 10 nm. For experiments on whole pellets, pellets were immersed in
ultrapure water for at least 24 hours. Ultrapure water, of resistivity of 18 mΩ at 25 °C,
was obtained from a millipore water purification system. After immersion, two pellets were
removed and placed between two susceptibility plugs within a 5 mm outer diameter thin-
walled NMR tube. The upper susceptibility plug had a coaxial hole of 1.1 mm diameter
through which the thermocouple could be placed in direct contact with the top silica pellet.
Powdered samples were produced using 20–30 pellets which were ground by hand with
a mortar and pestle. Powder grains were examined by light microscopy to determine their
approximate size to be less than 30 µm, at which size, the pore network is sufficiently
disrupted and all pores are exposed to the external surface (Rigby and Edler, 2002). This
grinding procedure ensures that any shielding effects seen in whole pellet is removed from
the powder sample. Powder samples were immersed for at least 24 hours in ultrapure water
and dabbed gently on damp tissue to remove some excess bulk water. This was carried
out to prevent the NMR tube from cracking during the freezing expansion of bulk water,
however, a sufficient amount of bulk water remained as a nucleation point for freezing. A
small plug of wet powder approximately 2 mm high was placed between two susceptibility
plugs, within the NMR tube. The thermocouple was placed in contact with the top of the
silica powder through the hole in the top susceptibility plug, and the top of the thermocouple
was secured at the top of the NMR tube using blu-tak. The thermocouple temperature
was recorded at 10 s intervals, by connecting it to a second temperature control unit and
computer.
All NMR experiments were carried out on a Bruker Avance 400 MHz spectrometer with a
static field strength of 9.4 T, yielding a resonance frequency of 400.13 MHz for 1H nucleus.
The BVT3200 temperature control unit within the NMR probe utilises a controlled flow of
cool nitrogen gas evolved from liquid nitrogen in combination with a heating element below
the sample in the gas flow stream. This system is able to adjust and maintain a temperature
with ± 0.1 K accuracy in the range of 123–423 K. Preliminary experiments similar to those
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described in Chapter 2 were carried out to determine appropriate experimental parameters:
Temperature set point range of 271–265 K for freezing and 269–273 K for thawing and
equilibration time of 20 minutes. A simple spin echo sequence is used in preference to the
basic pulse-acquire sequence as it accounts for small magnetic field inhomogeneities that
are present within the sample, therefore enhancing the quality of the signal obtained. An
echo time of 10 ms, was used.
The temperature was step changed through a series of three freeze-thaw cycles. After
each temperature change, the sample was allowed to equilibrate for 20 minutes before the
acquisition was taken. Initially, samples were fast cooled until all the sample was frozen,
then slowly warmed in steps, 0.5–2 K, until all of the pore water was molten, demonstrated
by a plateau in signal intensity below the bulk freezing temperature. The sample was then
slowly cooled and warmed twice more, before complete thawing on the last warming series.
At each step change the signal intensity and sample temperature were recorded.
3.3.3 Cryodiffusometry experiments
Pulsed field gradient (PFG) experiments were conducted at points of equal signal inten-
sity on the freezing curve for both whole and powder samples. By modification of the
multiple temperature automated program to include a series of three PFG experiments at
different temperatures during the freezing process it was possible to acquire data at equal
signal intensities for both samples. At the pre-chosen temperatures PFG experiments were
conducted after the spin echo acquisition. The pulse sequence used for PFG experiments
was a pulsed field bipolar gradient stimulated echo with longitudinal eddy delay (PGSTE-
BPLED), as discussed in Section 3.2.2. The experimental parameters used were diffusion
time, ∆, of 0.15 s, gradient length, δ, of 0.002 s, a bipolar correction delay, τ , of 0.0001
s and a gradient field strength, g, of 0.674 to 32.030 G/cm. Each experiment had 8 data
points collected, of 16 scans each. Signal attenuation was used to calculate the diffusion
coefficient and comparative tortuosities of the molten water, as described in Section 3.2.2.
3.3.4 Nitrogen adsorption and mercury porosimetry
Nitrogen adsorption and mercury porosimetry data had previously been collected within
the group using the following experimental procedure: Nitrogen adsorption measurements
were taken using a Micromeritics ASAP 2400 apparatus, the sample was evacuated at 250
°C for 24 hours before adsorption and desorption isotherms were measured at 77 K. The
sample was then allowed to reach room temperature, 298.9 K, before being transferred to
the mercury porosimeter under a nitrogen atmosphere. Mercury porosimetry measurements
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were taken using a Micromeritics Autopore IV 9420. The sample was evacuated to 6.7 Pa
to remove physisorbed gases before measurements were taken. At each pressure change,
equilibration times of 15 and 100 seconds were used, no significant differences of intruded
volume were found between these times. Blank corrections to account for compressibility
effects of the penetrometer were made as suggested by the manufacturer of the porosimeter.
The materials retained structural integrity during these experiments.
3.4 Results and Discussion
3.4.1 Comparing hysteresis from different techniques








N2 whole Yes Yes Yes V − Pr Yes
N2 powder Yes Yes No* V − Pr No
Hg whole Yes No** Yes V − Pa Yes
Hg powder No No** No* V − Pa Yes
Cryo whole Yes Yes*** Yes I − T Yes
Cryo powder Yes Yes*** No* I − T No
* Pore shielding effects are removed by breaking the whole pellet sample into a powder.
** Single pore hysteresis is present in mercury porosimetry in the form of contact angle
and surface tension hysteresis, these effects are removed by applying equations 3.16 and
3.17.
*** Single pore hysteresis can be removed from cryoporometry data according to theory
of Petrov and Furo (2006).
Key
N2= Nitrogen adsorption desorption
Hg= Mercury intrusion and extrusion
Cryo= Cryoporometry freeze-thaw
V = Volume gas adsorbed or mercury intruded
Pr= Relative pressure
Pa= Pressure applied
I= NMR Signal intensity
T= Temperature
Table 3.1: Causes of hysteresis in porosimetry
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In order to understand the causes of hysteresis in the cryoporometry freeze-thaw process,
it is important to understand the mechanisms of hysteresis in the other techniques that are
used for comparison. Table 3.1 provides a summary of the causes of hysteresis in the
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1st thaw 2nd freeze 2nd thaw 3rd freeze 3rd thaw
Figure 3.3: Two serial freeze-thaw cycles for whole silica pellet sample
Figure 3.3 shows two serial freeze-thaw cycles of a whole silica pellet sample, signal
intensity is proportional to the volume of pores in the liquid phase at a given temperature.
The lines connecting the data points in Figure 3.3 are included only as a guide. To remove
the effect of the presence of bulk water, the signal intensity has been normalised to account
for pore contained water only, a relative signal intensity of unity implies all pore water is in
the liquid phase, and a relative signal intensity of zero, all pore water is in the solid phase.
A relative signal intensity greater than one implies that bulk water is also in the liquid state.
On first cooling the sample from room temperature, super-cooling of the bulk water is
seen, therefore the sample is frozen quickly in just three steps. The temperature at which
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the super-cooled freezing of the bulk water occurs is sufficiently low that the imbibed water
also freezes simultaneously with the bulk. As the sample is warmed the imbibed water begins
to melt and the signal intensity observed increases, the signal intensity plateau below the
bulk melting temperature is indicative that all imbibed water has melted and only the bulk
water remains frozen. From this point the sample is cooled again to re-freeze the pore
water, providing information on the freezing characteristics of the imbibed water, without
the effect of supercooling in the bulk. The freeze-thaw hysteresis is observed, and the cycle
repeated. On the third warming the sample is thawed completely. The second and third
cycles overlay each other, within experimental uncertainty, therefore, it is observed that the
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Whole Freeze Powder Freeze
Whole Thaw Powder Thaw
Figure 3.4: Freeze-thaw hysteresis for whole pellet and powdered silica sample A
Figures 3.4 and 3.5 shows the freeze-thaw hysteresis for both whole and powdered silica
pellet for two independent samples, A and B. There are two key features to note from
these results. Firstly there is no change, within experimental error, to the melting curve of
the whole and powdered samples. Secondly, the freezing curve for the whole pellet sample
shows an overestimation of the volume of the smaller pores than is shown by the powder
sample, i.e. the upper section of the freezing curve for the whole pellet sample is shifted
toward lower temperatures.
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Whole freeze Powder freeze Whole thaw Powder thaw
Figure 3.5: Freeze-thaw hysteresis for whole pellet and powdered silica sample B
If freeze-thaw hysteresis were due only to single pore hysteresis, then by applying the
theory of Petrov and Furo (2006) described in Section 3.2.1, it should be possible to predict
the freezing curve from the melting curve. The melting curve of either powder or whole
pellet sample could, therefore, be used to predict the freezing curve that can be expected
due to single pore hysteresis according to equation 3.1. If a cylindrical pore shape is assumed
and the melting curve of the whole pellet sample is used to determine the expected freezing
curve, the results can be seen in Figure 3.6. The estimated freezing curve for the whole
pellet sample is in good agreement with the actual freezing curve of the powder sample,
and showing some difference to the whole pellet freezing curve at larger pore sizes. This
suggests that the freeze-thaw hysteresis for the whole pellet sample has more than one
contributory factor. Close agreement between the estimated freezing curve and the actual
powder freezing curve suggests that single pore effects alone, cause the hysteresis within the
powder sample. The changes caused to the pore network arrangement within the powder
sample have been shown previously to remove the shielding effects seen in gas adsorption and
mercury porosimetry (Rigby et al., 2008a). By direct comparison to mercury porosimetry
data the second cause of the freeze thaw hysteresis may be identified as predominantly pore
shielding effects , it is, therefore, proposed that the freeze-thaw hysteresis for the whole
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Whole Freeze Powder Freeze Whole Thaw
Powder Thaw Freeze estimate
Figure 3.6: Estimated freezing curve due to single pore hysteresis for whole silica pellet sample
pellet sample is subject to both pore shielding effects on the propagation of a freezing front
into the pore network and is a function of the single pore hysteresis as proposed by Petrov
and Furo (2006).
3.4.3 Cryodiffusometry Results
PFG experiment results for whole pellet and powder silica samples were collected at similar
relative signal intensities where a significant difference is seen in the freezing curve position
for the two samples. The diffusion coefficient of the molten component of each sample
was calculated from the gradient of the log attenuation plot, as described in Section 3.2.2.
Figures 3.7 shows the log attenuation plot for a whole pellet sample, the diffusion coefficient
for the molten fraction is given by the negative value of the gradient. The root mean square
(rms) displacement of a molecule during the diffusion time for the whole pellet sample is
around 20 µm, therefore, the fraction of molecules that may interact with the bulk ice at
the surface of the 2-3 mm pellet is considered negligible.
PFG experiments on powder sample were conducted at two different diffusion times,
0.05 s and 0.15 s with rms displacements of around 9 and 12 µm respectively. The particle
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Whole at 268.4 K Whole at 268.7 K
Linear (Whole at 268.4 K ) Linear (Whole at 268.7 K)
Figure 3.7: Log attenuation plot to estimate diffusion coefficient in part frozen whole silica pellet
sample
size of the powder samples is of the order of 20 µm, therefore, the fraction of molecules
that likely to interact with the bulk ice at the surface of the particles is significant and
will affect the value of the diffusion coefficient observed. The log attenuation plots for
these two experiments are given in Figures 3.8 and 3.9. The observed diffusion coefficients
determined from these experiments are plotted against the square root of the diffusion time,
as shown in Figure 3.10, to estimate the diffusion coefficient at zero observation time, the
intra-particle diffusion coefficient, from the intercept in accordance with the theory of Mitra
et al. (1993) described previously in Section 3.2.2.
The diffusion coefficients estimated for the whole and powder samples can then be
used to determine tortuosity for each system. Any difference in the distribution of the ice
pockets within the samples at equal relative signal intensities should be seen as a change
in tortuosity between whole and powder samples. If ice pockets within the samples are
distributed differently, the freezing mechanism of the two samples is different.
To calculate the tortuosity, the free diffusion coefficient at different temperatures must
be known. The relationship between temperature and free diffusion coefficient for water
above the bulk melting temperature can be found in the literature (Holz et al., 2000; Mills,
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Powder at 269.6 K
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Powder at 269.6 K Powder at 269.7 K
Linear (Powder at 269.6 K) Linear (Powder at 269.7 K)
Figure 3.8: Log attenuation plot to estimate diffusion coefficient in part frozen powder silica pellet
sample, diffusion time, ∆, 0.05 s
1973). To estimate the value of the free diffusion coefficient for water at temperatures below
the bulk melting point, a model of diffusion coefficient as a function of temperature was
found using literature data and extrapolated back to the temperatures of interest, as shown
in Figure 3.11. The extrapolation extended 24 K below the lowest known value of diffusion
coefficient, therefore, to estimate the level of expected error from the extrapolation a similar
model was fitted to data that was 24 K above the lowest known value, this model was used
to estimate diffusion coefficients of known values at lower temperature. The greatest error
in this model, at lowest diffusion coefficient was found to be less than 3 %, providing
confidence in the low temperature extrapolation of the model. A third order polynomial
fit to all the data points in the literature, given by equation 3.22, was chosen as the low
temperature model. This model showed good agreement with the ambient temperature
model developed by Holz et al. (2000) to estimate the free diffusion coefficient based on
temperature for the range 0–100 °C.
DB = 6.98× 10−17T 3 + 3.03× 10−13T 2 − 1.42× 10−10T + 1.59× 10−8 (3.22)
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Powder at 269.7 K Powder at 269.6 K
Linear (Powder at 269.6 K) Linear (Powder at 269.7 K )
Figure 3.9: Log attenuation plot to estimate diffusion coefficient in part frozen powder silica pellet
sample, diffusion time, ∆, 0.15 s
where DB is the estimated bulk diffusion coefficient at a given temperature, T , K. The
tortuosity values for whole and powder samples were calculated, according to equation 3.8,
from the measured diffusion coefficients and the estimated free diffusion coefficient. A
summary of calculated diffusion coefficients and tortuosities for whole and powder samples
is presented in Table 3.2.
By linear interpolation of the diffusion coefficient for the whole pellet sample, between
relative signal intensities of 0.67 and 0.88 the intra-particle tortuosity at a relative signal
intensity of 0.75 is determined to be 2.10. This can be compared to that for the powder
sample at a relative signal intensity of 0.75, which is 2.51. This suggests a difference in the
spatial distribution of the molten liquid and frozen pockets of ice within the two samples.
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Powder at 269.6 K Powder at 269.7 K
Linear (Powder at 269.6 K) Linear (Powder at 269.7 K)
Figure 3.10: Plot of observed diffusion coefficient against square root of diffusion time used to
calculate unrestricted intra-particle diffusion coefficient


















Whole 268.4 9.64 0.15 0.67 4.50 20.1 2.14 2.14
Whole 268.7 9.75 0.15 0.88 4.70 20.6 2.07 2.07
Powder 269.6 10.1 0.05 0.71 2.58 8.8 3.91 2.55
Powder 269.6 10.1 0.15 0.71 1.57 11.9 6.42 2.55
Powder 269.7 10.1 0.05 0.75 2.61 8.8 3.88 2.51
Powder 269.7 10.1 0.15 0.75 1.57 11.9 6.44 2.51
Table 3.2: Summary of calculated diffusion and tortuosity data for whole and powder silica pellet
samples
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Moderate temp Holz measured data All Data
Holz model Poly. (Moderate temp) Poly. (All Data)
Figure 3.11: Diffusion coefficient as a function of temperature
3.4.4 Comparison with nitrogen adsorption-desorption
Nitrogen adsorption-desorption results previously collected within the group for whole and
powdered silica pellets are shown in Figure 3.12 (Rigby et al., 2008b), the data is presented
as the volume of gas adsorbed against the relative pressure. The relative pressure is related
to the pore size according to the Kelvin equation 3.11. As described earlier in Section 3.2.3
the desorption isotherm is susceptible to pore shielding effects and, therefore, thought to
be comparable to the freezing curve of cryoporometry. The powder sample desorption and
freezing curves in Figures 3.12 and 3.4 show a similar shift toward higher temperature, or
relative pressure, than the curves for the whole sample. The desorption curve for the powder
sample has not only shifted, but the angle of the desorption knee has been smoothed, this
shows desorption commencing at higher relative pressures which equates to larger pore sizes,
and a broader pore size distribution. Both of these features are also seen in the freezing
curve of the powder sample when compared to the whole pellet sample.
The hysteresis gap between adsorption and desorption for the powder sample has also
become narrower, a feature synonymous with mercury porosimetry results when pore shield-
ing factors have been removed. The remaining cause of hysteresis for the powder sample
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Figure 3.12: Nitrogen adsorption and desorption curves for whole and powder silica pellet samples
has been suggested to be single pore hysteresis (Rigby et al., 2008a), similar in nature to
that in cryoporometry described by Petrov and Furo (2006). For gas sorption the single
pore hysteresis can be described in terms of the difference in the mechanisms for adsorption
and desorption. During the adsorption of gas the layers build from the pore wall toward the
centre and condensation occurs, whereas during desorption the gas-liquid meniscus must
form at the end of the pore and travel axially along the pore for evaporation to occur.
Adsorption of the monolayer and initial multilayers of gas are insensitive to spatial
arrangement within the pore network, therefore, comparison of these regions for powder
and whole pellet samples should show any changes to the pore network structure that may
be the result of the grinding process. No significant difference was seen in the BET surface
area for whole and powder samples, or in the multilayer adsorption region between 0.03
and 0.70 on the relative pressure scale, thus showing there was no significant change seen
in the pore network as a result of the whole pellet being ground up.
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whole intrusion whole extrusion powder intrusion
Figure 3.13: Mercury intrusion and extrusion curves for whole pellet silica and intrusion curve for
and powdered silica
Mercury porosimetry data for whole and powder silica pellet samples had previously been
collected within the group (Rigby and Edler, 2002) and is now compared with cryoporometry
results collected in this work. Mercury porosimetry gives the volume of intruded mercury
against the applied pressure, for both intrusion and extrusion curves. The applied pressure
can be converted to an equivalent pore radius using equations 3.16 and 3.17. The volume
intruded for the whole pellet sample was renormalised to account for intra-particle intrusion
within the powder sample, to enable a direct comparison of the whole and powder sample
results. Figure 3.13 shows the whole intrusion and extrusion curves and powder intrusion
curve as a function of pore radius. Renormalized intrusion and extrusion volumes for the
powder sample are shown in Figure 3.14. The powder intrusion and extrusion curves are
in good agreement with each other, showing no hysteresis. The hysteresis seen for the
whole pellet intrusion-extrusion is not conserved within the powder sample data, therefore,
it is suggested that the hysteresis seen in the whole pellet sample is a consequence of pore
shielding, and is removed by breaking up the pore network and opening all pores to the
surface of the material. Contact angle and surface tension hysteresis often seen in mercury
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Powder Intrusion Powder Extrusion
Figure 3.14: Mercury intrusion and extrusion curves for powdered silica
3.4.6 Prediction of Gibbs-Thomson parameter using powder mer-
cury intrusion and freezing curves
To calibrate the Gibbs-Thomson parameter for this system, the powder sample intrusion
curve and powder freezing curve are compared, the powder curves provide data that is not
influenced by pore shielding effects. To compare the two data sets they are plotted on
the same axes, renormalised volume intruded or frozen against pore radius. From mercury
intrusion data, the pore radius can be calculated from equation 3.16 and renormalised
volume, VN is calculated in terms of the total volume intruded, V0, according to equation
3.23, where V is the volume of mercury intruded at a given pore size.
VN = 1− V
V0
(3.23)
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From the cryoporometry freezing curve the renormalised volume VN can be calculated





The freezing point depression is related to melting point depression according to equa-




for open-ended cylindrical pores (Petrov and Furo, 2006). At each
temperature point of the cryoporometry freezing curve, an equivalent melting point depres-
sion is calculated, the melting point depression is then related to the pore radius according





By changing the values of kGT and t in equation 3.25 it is possible to fit the cry-
oporometry freezing data directly onto the mercury intrusion data for the powder silica
sample, as shown in Figure 3.15. The values of kGT and t are found to be 24 nmK and
0.4 nm respectively, in agreement with values found in the literature (Schmidt et al., 1995;
Vargas-Florencia et al., 2007).
The sensitivity of the fit to the estimated values of kGT and t can be seen in Figure
3.16. The fit of the model to the data is most sensitive to kGT .
The pore size distribution for freezing and thawing curves can now be estimated by
substituting the Gibbs-Thomson parameters into equation 3.4. The pore size distribution
estimates from the freezing and thawing curves for whole and powder samples are shown
in Figure 3.17. Also shown in Figure 3.17 are the adjusted freezing pore size distribution,
with single pore hysteresis effect removed (Petrov and Furo, 2006). The modal pore size
for the freezing curve is smaller than that for the thawing curve, and the width of the pore
size distribution is also narrower for the freezing curve estimates. If single pore hysteresis
effects are removed, the adjusted freezing pore size distributions for the powder sample
has the same range as the thawing curve, 18.5–5.9 nm, but a bimodal distribution with
peaks at 12.9 nm and 8.9 nm, compared to a unimodal distribution peaking at 11.6 nm for
actual thawing. For the whole pellet sample, the adjusted freezing pore size distribution has
a smaller range than the thawing curve, 15.6–7.3 nm compared to 18.1–8.3 nm and also
shows a bimodal distribution with peaks at 11.2 nm and 8.9 nm compared to the unimodal
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Mercury intrusion Cryoporometry freezing fitted
Parameters fitted to modified 
Gibbs-Thomson Equation
K = 24 Knm
t =0.4 nm
Figure 3.15: Mercury intrusion and fitted freezing curve for powdered silica
thawing curve peak at 13.4 nm, which is still significantly larger than those of the freezing
curve.
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Mercury intrusion Cryoporometry freezing fitted
K+10% K-10%
Parameters fitted to modified 
Gibbs-Thomson Equation
K = 24 Knm
t =0.4 nm

















































Mercury intrusion Cryoporometry freezing fitted
t+10% t-10%
Parameters fitted to modified 
Gibbs-Thomson Equation
K = 24 Knm
t =0.4 nm
(b) Sensitivity to t
Figure 3.16: Mercury intrusion and fitted freezing curve sensitivity of kGT and t values
3.4.7 Prediction of whole pellet freezing curve from whole pellet
mercury intrusion data
From the hysteresis relationships shown in Table 3.1, it is possible to predict the cry-
oporometry freezing curve for the whole pellet sample, using mercury intrusion data, for
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whole thaw Powder thaw
Powder adjusted freeze whole adjusted freeze
(b) Adjusted freeze-thaw data
Figure 3.17: Pore size distributions determined from freezing and thawing curve data for whole
pellet and powder samples
both powder and whole samples and the cryoporometry freezing data for the powder sam-
ple. A comparison of the powder freezing curve and powder intrusion curve can be used to
account for the single pore hysteresis seen in cryoporometry and not seen in the analysed
mercury intrusion data. The whole pellet mercury intrusion data, affected by pore shielding
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hysteresis, can then be used to estimate the additional hysteresis caused by pore shielding
that is seen in the whole pellet freezing curve and not in the powder. The following steps
are used to estimate the whole pellet freezing curve:
i Powder freezing curve data is modelled to define the freezing point depression as a
function of the signal intensity, ∆Tf = f(I), equation 3.26. The shielding effects have
been removed from powder data, but single pore hysteresis is still present. This model




1 +B(1− I) + C (3.26)
where A, B and C are fitting parameters.
ii Powder intrusion curve data is modelled to define the signal intensity (or volume in-
truded) as a function of the pore radius, I = f(r), equation 3.27. Mercury intrusion
data for the powdered sample shows no hysteresis, therefore, the relationship is required
only to estimate the expected signal intensity in a cryoporometry freezing curve as a
function of pore radius from the mercury intrusion data,
I =
D(r +G)
1 + E(r +G)
+ F (r +G) (3.27)
where D, E, F and G are fitting parameters.
Together these two relationships are used to estimate the cryoporometry freezing point
depressions expected at a given pore radius from mercury intrusion data, where single
pore hysteresis effects apply in cryoporometry freezing mechanism, but not in mercury
intrusion.
iii The whole pellet sample suffers from shielding effect hysteresis, this is true in both
mercury intrusion and cryoporometry freezing data. The whole pellet mercury intrusion
data is, therefore, used to predict the freezing curve for the whole pellet. Using the
relationships ∆Tf = f(I) and I = f(r) described above, mercury intrusion data with
no single pore hysteresis can be converted into cryoporometry data that is subject to
single pore hysteresis. Mercury intrusion data for the whole pellet sample inherently
includes pore shielding hysteresis, which is carried through to the estimate of the whole
pellet freezing curve.
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Table 3.3: Model parameter values for predicting cryoporometry freezing curve
The fitting parameters used in equations 3.26 and 3.27 are given in Table 3.3, and
the predicted whole pellet freezing curve is shown on Figure 3.18. Actual freezing curves
for whole and powdered samples are also shown with the predicted freezing curve for the


































Predicted powder freeze whole freeze
Figure 3.18: Whole pellet freezing curve predicted from mercury intrusion model
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3.4.8 Percolation Analysis
The freezing mechanism for imbibed liquid within porous material has now been shown
to suffer from shielding effects as seen for mercury porosimetry and nitrogen adsorption.
Percolation theory may, therefore, be applied to the propagation of the freezing front
in cryoporometry synonymously with the intrusion of mercury and desorption of nitrogen
(Murray et al., 1999). The theory outlined in Section 3.2.5 is applied to cryoporometry
data, to determine the percolation parameters L and Z, the characteristic length of a bond
and the co-ordination number. Firstly, the powder freezing curve was used to determine
the probability of a bond being occupied (pore containing water below its freezing point)
at any given temperature using the modified Gibbs-Thomson equation 3.2. Accordingly,
a layer of water at the pore wall does not freeze, and integral intensities are indicative of
the core radius, rc. For each point on the freezing curve, an equivalent core radius can be
determined by equation 3.28, the pore radius, rp, can then be calculated using the core





rp = rc + t (3.29)
The change in integral signal intensity, dI is proportional to the volume of ‘cores’ that
have frozen, Vc, therefore, to calculate the pore volume frozen, Vp, at each temperature an











where the superscripts U and L represent the upper and lower estimate of radius for the
change in temperature that induces a change in signal intensity, subscripts p and c represent
pore and core attributes respectively.
To convert the volume change of frozen pores into a change in the number of frozen
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The number of pores that have frozen in the powder sample is equivalent to the number of
pores containing water below its freezing point at a given temperature for the whole pellet





The cumulative values of the number of pores below their freezing point at decreasing
temperature is equivalent to the probability, f , of a bond being occupied at a given tem-
perature T . From the definition of f and F in equations 3.19 and 3.20, it follows that
the ratio of F
f
can be determined in terms of the difference in signal intensity at a given









The probability, F , that a pore has frozen, i.e. is below its freezing point and in the





A plot of F against f is shown in Figure 3.19, if no percolation effect were present F would
be equal to f for all values of F , as indicated by the solid line. However, the data points
plotted show, in accordance with theory, that below a certain value of f , fc, then f is less
than F , and above fc, the percolation threshold, then f is equal to F . From Figure 3.19,
fc is approximately 0.3.
A plot of L
β




ν is fitted to the generalised function given by
Seaton (1991) and is shown in Figure 3.20. The values of L and Z estimated by this fit
are 9 and 3.8 respectively.
It has previously been show that the application of percolation theory is appropriate to
nitrogen desorption and mercury intrusion for sol-gel silica materials, and the mechanisms
for these processes are controlled by pore blocking (Rigby and Fletcher, 2004,a). Here, a
comparison of whole pellet and powdered pellet sample freezing curves are used as a means
to determine the type of nucleation that dominates the freezing mechanism. No difference
in the freezing curve of the whole and powdered samples would be indicative of purely ho-
mogeneous nucleation, this type of nucleation is independent of the arrangement of pores
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Figure 3.19: Probability of a pore being frozen and in the percolation cluster against the probability
that a pore being frozen
within the network. A combination of homogeneous and heterogeneous nucleation would
give a freeze-thaw hysteresis that was significantly more narrow than that observed for the
mercury intrusion-extrusion of a whole pellet sample, where the hysteresis is dominated by
pore blocking effects. As neither of these conditions apply here, this suggests the freezing
mechanism in the sol-gel silica material is dominated by heterogeneous nucleation. Perco-
lation theory may, therefore, be justly applied to the freezing mechanism of the imbibed
liquid within this material.
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Figure 3.20: Percolation model fit to experimentally derived data
3.5 Conclusions
The robust cryoporometry experimental method developed in Chapter 2 has been used to
show that a freeze-thaw hysteresis exists between the freezing and thawing process of an
imbibed liquid in a porous silica material. This hysteresis is reproducible once supercooling
effects have been removed, this is achieved by ensuring the bulk solution remains frozen
during the cycle of freezing and thawing of the imbibed liquid. The repeatability of the
freezing and thawing curves prove that the material is not damaged or altered by the freeze-
thaw process and provides an opportunity to use the freezing data to gain additional pore
characteristic information.
Cryodiffusometry results for part frozen powder and whole pellet samples have shown a
change in the tortuosity at equivalent fractions of imbibed ice and molten water, therefore,
suggesting a difference in the distribution of molten and solid water regions for the two
samples. This provides evidence that the mechanism by which the imbibed water freezes is
different in the powder and whole pellet sample, where the pore shielding effects have been
removed in the powder sample. The causes of the freeze-thaw hysteresis are, therefore,
different for the shielded and unshielded pore network.
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Comparison with mercury porosimetry data has shown cryoporometry freeze-thaw hys-
teresis to be the result of both single pore hysteresis and pore shielding effects. With analysis
of whole pellet and ground powder samples of the silica material it has been possible to
remove the pore shielding contribution of the hysteresis in both mercury porosimetry and
cryoporometry enabling the confirmation of the cylindrical single pore hysteresis model for
the freezing mechanism as suitable to be applied to this material (Petrov and Furo, 2006).
The Gibbs-Thomson parameter has been estimated for this system and is in agreement with
values in the literature for similar systems.
The mechanism for freezing of imbibed liquid has been shown to be affected by pore
shielding in a similar way to that of gas desorption and mercury intrusion, it is, therefore,
suggested that the freezing of the imbibed liquid occurs as a freezing front that penetrates
the pore network from outside of the material. Using mercury intrusion data an estimated
freezing curve for the whole pellet sample has been derived. This predicted curve is found
to lie between the actual freezing curve for powder and whole pellet samples. The pore
shielding effects seen for whole pellet samples suggest that the freezing curve is, therefore,
indicative of the size of the pore entrances, or necks, whilst the melting curve is indicative
of the actual pore body size.
It has also been shown that it is possible to apply percolation theory to the penetration
of the freezing front into the whole pellet sample and to calculate the percolation threshold
and the characteristic parameters for the pore network.
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Chapter4
Preparation and characterisation of
Poly-(lactic-co-glycolic acid) (PLGA)
microspheres for drug delivery
4.1 Introduction
This chapter introduces PLGA microspheres as a drug release system and describes some of
the preparation methods and characterisation techniques used to study these microspheres.
The aims of these studies were to compare physical changes to the microsphere structure
at the micrometer scale when slight variations were made to the preparation technique and
to establish a robust preparation method. This knowledge will be used to aid interpretation
of further Nuclear Magnetic Resonance (NMR) experiments described in Chapter 6. Mi-
crospheres were made by double emulsion solvent evaporation technique and characterised
by Scanning Electron Microscopy (SEM), and Pulsed Field Gradient (PFG) NMR.
4.2 Background and Theory
4.2.1 PLGA microspheres
Polymer microspheres are spherical structures made from one or more polymers, they range
in size from a few micrometres to several hundred micrometres. The internal structure of the
microspheres is dependent on the preparation technique, but may be hollow, contain micron
scale spherical ‘bubble-shaped’ pores, or be solid polymer matrix. During the preparation of
microspheres it is possible to encapsulate molecules that will be released as the microspheres
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react to a change of environment, and eventually degrade. The actual structure and size
distribution of any given batch of microspheres will be dependent on many factors including
the number and type of polymers used, the preparation technique, and the encapsulated
molecule, if one is used.
Polymer microspheres have been of interest for their potential use as controlled drug
release device for many years. The idea to use biodegradable polymers for controlled drug
delivery was first suggested in the 1960s, where the choice of polymer was determined
by biocompatibility (Freiberg and Zhu, 2004). PLGA has been a popular candidate for
developing a controlled Drug Delivery System (DDS) for many research groups because of
its proven history within medical applications as, for example, a degradable suture material
(Benoit et al., 2000). This experience and previous approval for internal medicinal use
reduces the effort required on the legislative development of this material as a DDS. One
advantage of polymers, like PLGA, is the ability to manipulate the time it takes for the
polymer to biodegrade by varying its composition. An understanding of the degradation
mechanism and its role in the release of an encapsulated molecule is key to the ability
to tailor a given polymer for different applications. Another advantage of biodegradable
polymers as a DDS is that the device will not require removal from the patient after the
drug has been released (Noorsal et al., 2005). The degradation products are non-toxic and
metabolised to carbon dioxide and water, or excreted from the body via the kidneys (Liu
et al., 2003).
Other potential applications for microsphere based DDS include implanting microspheres
within the scaffolding matrix used for in vitro tissue growth (Ungaro et al., 2006). Within a
complex three dimensional structure good cell growth relies on a controlled release of growth
hormone and nutrients to simulate in-vivo conditions. The distribution of these molecules
is often restricted by poor mass transport in conventional tissue engineering systems, or
bioreactors, particularly in bone tissue engineering where the support structures required
for growth are often large and complex. The potential to implant microspheres loaded with
hormones and nutrients throughout the scaffold used to support and grow the tissue cells
has been suggested as a viable option to improve in-vitro tissue growth (Kempen et al.,
2006). PLGA DDS have also been suggested as an improved method for the treatment of
neuro-oncology, and degenerative disorders such as Parkinson’s disease, Alzheimer’s disease
and Huntington’s disease (Benoit et al., 2000). Direct injection of the DDS into the brain
tissue eliminates the need for a drug to cross the blood-brain barrier, which can be difficult
for many drug molecules and impossible for proteins. The design of bioadhesive polymers
that bind to specific sites such as mucus, mucoadhesion (Lehr, 2000) are also of interest
for targeted drug delivery (Peppas and Sahlin, 1996; Vasir et al., 2003). More recently,
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another alternative application for controlled drug delivery has been investigated, to design
device that would increase its retention time within the stomach by floating on the surface
of the stomach fluids (Arora et al., 2005).
The chemical structures of poly(lactic acid) and poly(glycolic acid) are shown in Figure
4.1. PLGA is a co-polymer derived from a combination of these two monomers. The
monomer ratio, lactic acid to glycolic acid, can be manipulated during the synthesis of
the co-polymer and subsequently changes the properties of the polymer. The mechanism
for PLGA degradation occurs by the succession of water uptake into the polymer matrix,
carboxylic acids are then produced from chain scission which can then go on to catalyse
the ester bonds (Li et al., 2008). The reaction schemes for the hydrolytic degradation and
the autocatalytic degradation of PLGA are shown in Figure* 4.2. The mass transport of
water and the carboxylic acid groups within the polymer matrix are, therefore, fundamental
to the progress of the polymer degradation.
Figure 4.1: Chemical structures of poly(lactic acid) and poly(glycolic acid)
Characteristics of microspheres such as porosity, pore size and microsphere diameter
are closely related to the preparation method used and can have significant effects on the
subsequent drug release profile. For example, microspheres made by double emulsion show
that increasing the polymer concentration in the organic phase decreases the pore size and
porosity, but increases the mean diameter of the microspheres (Mao et al., 2007). Also,
decreasing the volume of aqueous phase in the primary emulsion decreases the porosity
of the microspheres but has negligible effect on the pore size (Mao et al., 2007). Pore
size distribution can be affected by homogeniser speed during the formation of the primary
emulsion, at faster homogeniser speeds the modal pore size decreases and the width of the
pore size distribution is reduced, but there is little change in the porosity (Ehtezazi et al.,
*Based on Vey et al. (2008)
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Figure 4.2: Reaction scheme for hydrolytic and autocatalytic degradation of PLGA
1999). Preparation temperature affects the size of the microspheres produced as the solvent
evaporation speed changes (Yang et al., 2000; Messaritaki et al., 2005; Allison, 2008). For
polymer nanospheres, it has also been shown that the choice of solvent for the organic
phase containing the polymer can affect the size of the sphere produced, with the addition
of acetone to Dichloromethane (DCM) a decrease in the size of spheres produced was
observed (Niwa et al., 1993). The interfacial tension between organic phase and aqueous
medium decreased with increasing addition of acetone, improving drug encapsulation of 5-
Fluorouracil (Niwa et al., 1993). Siepmann et al. (2004) have observed an increase in drug
release rate with an increase in microsphere diameter, relating to the increase in porosity
of larger spheres which overcomes the increase in the diffusion pathway that is associated
with larger spheres. Cohen et al. (1991) have categorised the different microspheres based
on the time over which they release encapsulated drug and equated this to the microsphere
porosity (Yang et al., 2000).
Microspheres can be made by various preparation techniques, according to Freiberg and
Zhu (2004) the methods of microsphere synthesis can be divided into two categories:
1. Polymerisation of monomers, known as an emulsion suspension or dispersion tech-
nique.
2. Synthesis from linear polymers, known as a solvent evaporation or double emulsion
technique, also spray drying.
There are several papers that specifically discuss the preparation methods and techniques
for polymer microsphere preparations, these include: Weert et al. (2000); Yang et al.
(2000); Ruan and Feng (2003); Freiberg and Zhu (2004); Wang et al. (2004); Freitas et al.
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(2005); Mao et al. (2007). The most popular method for experimental scale preparation
of microspheres is the double emulsion, water/oil/water, technique. The first emulsion is
water in oil, the second emulsion uses the first emulsion in another water phase. The double
emulsion technique typically produces microspheres with microporosity within the polymer
matrix, which provides an additional access network for the external media to penetrate the
microspheres, and for drug molecules to be released.
Composite double-wall microsphere preparations have also been described in the litera-
ture by Eng et al. (2005); Lee et al. (2002); Leach and Mathiowitz (1998). The properties
of such systems are more complex due to the range of combinations of polymers that may
be chosen for their fabrication. Long term considerations should be made for the scale up of
the preparation technique used if microspheres are to be produced on a commercial scale. A
review of technologies for large scale production by extraction-evaporation techniques and
the effects of different parameters on the microspheres has been considered by Freitas et al.
(2005). They concluded that simple design, ease to sterilise and a straight forward scale-up
make micromixers a strong candidate for large scale aseptic microsphere manufacture by
solvent evaporation.
4.2.2 Drug release mechanism
Typical delivery devices, currently discussed in the literature, are matrix tablets, polymer
microspheres, coated tablets or microspheres, nanospheres and larger implant devices. Drug
release studies have commonly identified three stages of drug release, initial burst, sustained
release, and a reduced level of release. The theories behind the mechanisms responsible
for the release of a drug from within a polymeric based delivery device include diffusion
controlled release, polymer matrix degradation controlled release, or a combination of the
two. The three stages of the release profile are described in terms of the suggested release
mechanisms:
1. Initial burst release.
The release of molecules either loosely attached to the surface of the microspheres or
released from the pores open to the surface of the microsphere. The initial swelling
of the microspheres when placed in an aqueous environment can open and close the
pores within the microsphere, including those on the surface, controlling the initial
drug release. A large fraction of the contained drug can be released at this stage.
This stage is thought to be controlled by the drug mobility within the medium.
2. Sustained period of slow release.
Molecules within the inner pores and just inside the matrix of the polymer are released
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as the polymer continues to swell and begins to degrade. This stage is thought to be
controlled by the drug mobility within the polymer matrix.
3. Reduced level of release.
Small amounts of molecules that are tightly bound within the inner matrix structure
of the polymer are eventually released in the final stages of the polymer degradation.
This stage is thought to be controlled by the polymer degradation.
Whilst there is agreement within the literature that these three stages exist, it is believed
that the presence of, or length of any of these stages is characteristic of the microsphere
system being studied. A recent study suggests that the three stages of the release profile
identified are solely controlled by the evolution of the polymer matrix (Allison, 2008),
therefore, an understanding of the matrix structure and its evolution with time is key to
determining the release mechanism. Once the matrix evolution is understood, greater
control of the release profile may be considered at the design stage for a particular system
or application.
Factors that affect the release rate can be drug related, polymer related, or as mentioned
previously, related to the physical characteristic determined by the microspheres preparation.
The polymer and drug related factors are listed in Table 4.1. Although much work has been
done to understand the release kinetics of drug molecules (Peppas, 1983; Ritger and Peppas,
1987; Batycky et al., 1997) and latterly protein molecules (Sandor et al., 2001; Koennings
et al., 2007) from controlled delivery devices, far less has been done to understand the
mechanisms that determine the release profile.
Polymer Related Drug Related
Type of polymer
Molecular weight
Single or multiple co-block polymer





Drug molecular size and diffusivity
Presence of nucleophilic groups
Polymer-drug interactions Polymer-drug interactions
Table 4.1: Factors that affect release rate
The importance of the initial burst release has been recognised (Huang and Brazel,
2001) but the actual mechanisms involved are still poorly understood. More recent work has
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attempted to address this gap in knowledge by investigating the burst release (Messaritaki
et al., 2005; Luan et al., 2006; Jaraswekin et al., 2007; Koennings et al., 2007; Kang
and Schwendeman, 2007). The burst release can be considered either an advantage or
disadvantage of this type of drug delivery system. For some drugs a high initial dose
is required to initiate treatment, therefore, a controlled burst release could start such a
regimen. Conversely, for other drugs a large dose may have toxic effects on the surrounding
tissue, or the body as a whole, therefore, a burst release would be undesirable and could
potentially be dangerous for the patient. Either scenario requires a thorough understanding
of the cause of the initial burst release to ensure its effect is controlled.
4.2.3 Scanning electron microscopy (SEM) basic theory
Electron microscopy is a common method used to study the structure of polymer micro-
spheres. Microscopy is the science of forming an image from an object, that image is often
magnified. Optical microscopes using light date back to the seventeenth century. They
require a system of lenses to focus and magnify the image of an object. Electron microscopy
uses a beam of high velocity electrons, generated from an electron gun and focused by elec-
tromagnetic fields. Electrons interact with the object and can be scattered by the object,
or enter the object and cause the release of secondary electrons or x-ray energy. Secondary
electrons and scattered electrons are detected by a photomultiplier, the signal from which
is used to build the image displayed on a cathode ray tube, or more recently, via software
on a computer screen. The advantages of electron microscopy over light microscopy are
that electrons have a much shorter wavelength than light, therefore, resolution and depth
of field are increased. Scanning of an object is possible with electrons since the beam of
charged electrons can easily be directed by the manipulation of electromagnetic fields. SEM
can produce images of the surface structure of a material with a theoretical resolution of 5
nm (Goodhew and Humphreys, 1988).
4.2.4 NMR PFG theory
Nuclear magnetic resonance pulsed field gradient studies have previously been used to study
the behaviour of water within a materials as diverse as wheat germ tissue (Callaghan et al.,
1979) and sandstone (Fordham et al., 1994). From these studies structural information
about average pore size and shape can be assessed by the type of diffusion observed.
This techniques has been used with PLGA microspheres to estimate the average size of
the ‘bubble’ pores observed during the swelling stage that occurs after immersion in an
aqueous medium (Messaritaki et al., 2005). If there is restricted diffusion of water within
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the ‘bubble’ pores, the estimation of the cavity size is representative of average ‘bubble’
pore size, see section below on restricted diffusion.
The origins and use of NMR PFG have been discussed in Chapter 3, further discussion
on the interpretation of diffusion studies for non-linear log attenuation plots is discussed in
this chapter. The work of Callaghan (1991) has greatly contributed to the development
of diffusion models when the motion of the diffusing molecule is restricted (Callaghan
et al., 1979) or constrained within one or two dimensions (Callaghan et al., 1983) and
the influence of gradient field strength on diffusion within porous media (Callaghan et al.,
1991a). Hollewand and Gladden (1995) have also developed models for diffusion in porous
media, where the signal attenuation is affected by the porous media in which the diffusing
liquid is contained and the observed diffusion behaviour is interpreted as contributions from
different components, or phases of the investigated molecule which have different diffusion
coefficients. One such study of the changes in diffusion behaviour in bicontinuous polymer
emulsions defined two components as free water and water associated with the surfactant
molecule at different water content values (Challa et al., 2003).
Relaxation effects
For a system where the diffusion is slow compared to the relaxation behaviour of the
molecule, it is possible to measure the diffusion coefficient using the stimulated echo se-
quence rather than the spin echo. The stimulated echo has two 90 °pulses in place of the
180 °pulse in the spin echo sequence, the first 90 °pulse stores the magnetisation and phase
shift along the z-axis before the second 90 °pulse, after which the stimulated echo occurs
(Hollewand and Gladden, 1995).
Multi-component fit
A linear log attenuation plot suggests diffusion of a single component in a homogeneous
environment, the relationship between signal attenuation and the diffusion coefficient is
discussed in Chapter 3, equation 3.5. The deviation from linearity of the log attenuation
plot for liquid within a porous structure was investigated by Hollewand and Gladden (1995).
Diffusion measurements were shown to be sensitive to the structure of the porous material
in which the liquid is contained, where the root mean square (rms) displacement of the
molecule during the experiment is comparable to the pore size. This suggests that one of the
causes of heterogeneity in the diffusion coefficient is an effect of the structure of the porous
medium. A discrete multicomponent model was derived by Hollewand and Gladden (1995),
equation 4.1, where the heterogeneity in the apparent diffusion coefficient is attributed to i
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components, each containing the fraction, pi, of observed nuclei, with the actual diffusion
coefficient, Di. ζ is characteristic of the experimental parameters, as defined for equation
3.5.
I = I0Σpi exp (−Diζ) (4.1)
Restricted diffusion
Non-linearity of the log attenuation data for the diffusion of fat and water in cheese was
attributed to the diffusion being restricted (Callaghan et al., 1983). Restricted diffusion
was suggested to be the cause of the deviation from linearity seen at longer diffusion times,
where the rms displacement is of the same order or greater than the dimension of the
restricting structure. For a spherical pore, the typical cavity radius, in which the diffusion
has been restricted, can be calculated based on the diffusion time, ∆, and the length of the
gradient pulse the nucleus is exposed to, δ (Callaghan et al., 1983) equation 4.2 , where
rcavity is the cavity radius in meters, both ∆ and δ have the units of seconds.
rcavity = (5D(∆− δ/3))0.5 (4.2)
For the pulse sequence used in this work, the value of half the bipolar correction time, τ
2
should strictly be included in equation 4.2, but is very small compared to the diffusion time
and gradient length, therefore, it is not considered significant in the estimate of the cavity
size.
Choice of diffusion time
For the relationship in equation 4.2 to hold, ∆ must be sufficiently large for the diffusion
of all molecules to be restricted. The effective diffusion coefficient calculated from a one
component fit, equation 3.5 will be characteristic of the average motion of all molecules
and, therefore, will be a combination of free diffusion and restricted diffusion. With a very
small value of ∆, i.e. a short diffusion time, none of the molecules will be restricted as
none of the molecules will have sufficient time to reach the walls of the pores. The effective
diffusion coefficient measured is that of a molecule in free solution. Conversely, if ∆ is
sufficiently large all the molecules contained within the pores will contact the pore walls
and thus undergo restricted diffusion. The effective diffusion coefficient measured is that of
molecules trapped inside the pores and can be used to calculate the pore size as in equation
4.2. At any value of ∆ between these extremes, the effective diffusion coefficient is a
As expressed by Messaritaki et al. (2005)
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representative combination of free and trapped molecules. The choice of ∆ is, therefore,
critical if pore size is to be calculated from the effective diffusion coefficient determined by
a one component fit model, equation 3.5. The relationship between the effective diffusion
coefficient and the diffusion time for a given batch of microspheres is shown in Figure 4.3.
For this microsphere batch it can be seen that even at very small diffusion times, 0.01 s,
the effective diffusion coefficient is significantly affected by the microsphere pore structure,
the free diffusion coefficient for this system is expected to be 1.88 × 10−9 m2s−1. The
gradual slope behaviour of the effective diffusion coefficient with the diffusion time shown
in Figure 4.3 suggests that there is a broad range of pore sizes observable in this batch of
microspheres, from approximately 9 µm, and that a plateau of totally restricted diffusion
occurring at long diffusion times ≥ 0.09 s is at around 0.6× 10−9 m2s−1, which coincides

































Figure 4.3: Graph to show the change in calculated effective diffusion coefficient for a range of
values of diffusion times, ∆.
The effect of diffusion time on the observed diffusion coefficient is considered when
determining the appropriate model for interpreting the NMR PFG data, as described in
the experimental Section 4.3.4. The experimental Section 4.3.1 describes the preparation
methods for the PLGA microspheres and the considerations that are made with respect to
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ensuring the number of variables changed between each batch is limited.
4.3 Experimental
PLGA of two different inherent viscosities, one with a high average molecular weight of ap-
proximately 135000 D and the other with a low average molecular weight of approximately
14000 D were obtained from Lakeshore Biomaterials. Both batches had a 50:50 monomer
ratio of lactic to glycolic acid. The model drugs 5-Fluorouracil (5-FU) and 5-Fluoro-
5’Deoxyuridine (5-FD) were obtained from Sigma Aldrich, and 4-(trifluoromethyl)umbelliferone
(TFMU) was obtained from Fluka. Dichloromethane (DCM) and acetone were obtained
from Fisher and PVA from MP Biomedicals. Ultra pure water (resistivity 18 MΩ) was gen-
erated from a Milli-Q water purification unit. The homogeniser used was an Ultra Turrax
IKA T18 basic homogeniser.
4.3.1 Double emulsion preparation method
The chosen method for microsphere preparation is a double emulsion water-oil-water (w/o/w)
solvent extraction evaporation method, as described in Messaritaki et al. (2005). The mi-
crosphere preparation steps were as follows:
1. 300–600 mg of PLGA was dissolved in a DCM and acetone mixture consisting of 2.4
ml and 0.6 ml respectively, to make a 10-20 % w/v solution; this was the oil phase.
2. Approximately 30 mg of model drug ( 5-FU, 5-FD or TMFU ) was dissolved in 0.6
ml 1N ammonium hydroxide for 5-FU or 0.6 ml water for 5-FD or TFMU. To this
10 µl of 0.4 % w/v polyvinylalcohol (PVA) was added as a surfactant; this was the
internal water phase.
3. These two phases were emulsified by homogenization for 60 s at 13500 pm.
4. This emulsion was immediately transferred into the external aqueous phase at room
temperature, 180 ml of 2 or 4 % w/v PVA and stirred by a basic lab stirrer for
between 3 and 18 hours to allow for the complete evaporation of DCM and acetone.
5. The microspheres formed were then filtered and washed 3 times with distilled water
to remove PVA residues and any non-encapsulated drug.
6. The microspheres were then air dried within a fumehood for at least 48 hours.
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As discussed previously in Section 4.2, there are many preparation parameters that are
thought to have an effect on the physical characteristics of the microspheres produced and
subsequently alter the drug release profile. During the preparation of a given batch of
microspheres considerations for these effects were made:
 Preparation temperature
Primarily the temperature of the hardening bath, is thought to affect the size of the
microspheres as it changes the rate of evaporation of the solvent. Unless otherwise
stated, all preparations were carried out using PVA solution that had equilibrated to
lab temperature (25± 1°C.)
 Polymer molecular weight
This affects the viscosity of the organic phase which will change the behaviour of
the emulsion characteristics. Two batches of PLGA were purchased with different
inherent viscosities that equate to molecular weight averages of 135000 D and 14000
D, denoted as high molecular weight and low molecular weight respectively.
 Polymer ratio
Affects the structure of the polymer and, therefore affect its properties such as degra-
dation mechanism. Both polymers purchased were of a 50:50 monomer ratio of lactic
acid and glycolic acid.
 Polymer degradation
Degradation is dependent on molecular weight and storage conditions. The molec-
ular weights were as described above. Both batches of polymer were stored in the
same conditions, a sealed container stored in a freezer (-18 °C). After preparation,
microspheres were stored in sealed containers in a refrigerator (2–5 °C).
 Homogeniser speed and duration
These affect the first emulsion characteristics and, therefore, the porosity of the
microspheres. The same speed setting and time for homogenising was used for each
sample unless otherwise stated.
 The choice of surfactant for primary or secondary emulsion and their concentration
The surfactant affects the formation of the macropores in the primary emulsion and
the microspheres in the secondary emulsion. The primary emulsion surfactant and
concentration was unchanged. For the secondary emulsion, the choice of surfactant
was kept constant as PVA, but the concentration was adjusted for some samples from
4 % w/v to 2 % w/v, as stated.
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 The choice of solvent for organic phase containing polymer
The volatility of the organic solvent affects the speed of the formation of the micro-
spheres and subsequently can change the size of the microspheres produced. Acetone
was added to DCM at the same ratio for each batch unless otherwise stated. For two
batches ethyl acetate was used as the solvent, instead of DCM with acetone.
 Encapsulated drug characteristics
Different drug molecules interact with the polymer and the solvents used in the
preparation in different ways. Microspheres were made with two types of model
drug, 5-Fluorouracil (5FU) and 5-Fluoro-5’Deoxyurridine (5-FD) and a fluorescent
molecule, 4-(trifluoromethyl)umbelliferone (TFMU). Some batches of microspheres
were made without any drug encapsulation, for this the inner water phase was 0.6 ml
water and 10 µl of 0.4 % w/v PVA.
4.3.2 Preparation of Double wall microspheres
Two batches were also made by a different method, in which a series of organic phases
were added to the internal water phase, this emulsion was then added to final water phase
to make double walled microspheres. It was possible to make blank microspheres by this
method, but microspheres would not form when trying to encapsulate 5-FU, see Section
4.4. The steps for this preparation were as follows:
1. Three organic phases were prepared:
(a) 50 mg high molecular weight PLGA in 1 ml DCM
(b) 200 mg high molecular weight PLGA in 1 ml DCM
(c) 200 mg low molecular weight PLGA in 1 ml DCM
2. Two aqueous phases were prepared:
(a) 100 µl internal phase of 10 µl 0.4 % w/v PVA and 90 µl water
(b) Second aqueous phase 160 ml of 2.5 % w/v PVA
3. The first organic phase and the internal water phase were homogenised at 6500 pm
for 60s
4. The second organic phase was added and further homogenised at 9500 pm for 60s
5. The third organic phase was added and further homogenised at 9500 pm for 60s
NMR Studies of Controlled Drug Release Devices 91
CHAPTER 4. PLGA MICROSPHERES EXPERIMENTAL
6. This emulsion was then added to the second aqueous phase and stirred for approxi-
mately 3 hours.
7. The microsphere were then filtered, washed 3 times with distilled water and air dried
as for the standard double emulsion technique described previously.
4.3.3 SEM methods
Two methods were used for taking SEM images of the polymer microsphere internal and
external structure. In the first method images were taken using the cryogenic stage facility
of the JEOL JSM6310 microscope. A hydrated sample of microspheres was placed between
two sample plates and fast frozen by immersion in liquid nitrogen. Once frozen and placed
within a cryogenic chamber of the SEM the top sample plate was ripped off in an attempt
to fracture some of the microspheres. The sample was then sputter coated with gold to
complete the electric circuit required for electron transfer. For some batches it was not
possible to fracture the microspheres in this way, therefore an alternative method was used.
This alternative method used the JSM6480LV SEM, without cryogenic stage facility. A
sample of dry microspheres were mounted within the surface of an adhesive drop on the
top of a small resin block. The top of the resin block was then cut to an approximate 1
mm square tip using a razor blade. Fine slices, less than a micron in thickness, were then
cut from the top of the resin block using a microtome. The slices of adhesive containing
microspheres were mounted onto an aluminium dish and sputter coated for 4-5 minutes
before being imaged on the microscope.
4.3.4 PFG at room temperature
A generous amount, ≥ 50 mg, of a given batch of microspheres was placed in a 5 mm
thin-walled NMR tube, to which a 1 % H2O in D2O (Aldrich ≥ 99.9%) was added until
there was sufficient volume to cover the region of the receiver coil, approximately 3 cm
height. The D2O is both a reference for the NMR spectrometer and a diluent of the H2O
signal. Due to the initial floating nature of many of the microspheres it was necessary to use
a susceptibility plug to force the microspheres below the surface of the solution and within
the area of the receiver coil, see Figure 4.4. The sample was placed into the spectrometer
and PFG experiments were carried out at varying time intervals after the initial immersion
of microspheres into aqueous media. The PGSTE-BPLED pulse sequence was used for this
experiment, the same as was used previously for silica cryodiffusometry, see Chapter 3. A
series of eight spectra were taken at increasing gradient strengths between 0.674 to 32.030
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G/cm and a diffusion time of 0.05 s, gradient length and bipolar correction time of 0.002 s
and 0.0001 s, respectively. The number of scans for each spectrum was 16, with 16 dummy
scans used at the beginning of each experiment. It is assumed that the magnetic field is
uniform (Brand et al., 2006) and there is no cross-relaxation with the polymer (Peschier
et al., 1996).
Figure 4.4: Photograph showing microspheres held in aqueous environment by susceptibility plug
within the NMR tube
As the structure of the microspheres evolve with time immersed in an aqueous media,
the measured diffusion coefficient is sensitive to time, in addition to temperature. Due to
the time required to collect the data a compromise between the number and the quality of
the data points must be made. It takes longer to collect more scans which would increase
the quality of each data point, during which time changes in the polymer microspheres may
have occurred and the diffusion coefficient will also have changed. Increasing the number
of data points would also increase the experiment time with similar consequences. The
temperature of the sample may rise significantly with a large number of scans and this too
would affect the observed diffusion coefficient. The final parameters chosen were to collect
8 data points of 16 scans each. The collection of this data takes approximately 18 minutes;
a short enough time period not to show significant changes in the diffusion coefficient,
due to structural changes of the microsphere, which are observable on the scale of hours.
Heating effects on the sample from application of repeated radio frequency pulses had little
effect on the signal attenuation observed, as described later in Section 4.4.3.
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4.4 Results and Discussion
4.4.1 SEM images
A series of SEM images were taken of different batches of microspheres, each batch made
with one variation in the preparation method, e.g. With and without encapsulated drug
(blank). As discussed in Section 4.2, there are many variables in the preparation technique
that can affect the final structure of the resulting microspheres. A summary of some of the
batches of microspheres produced and their resulting structures are given in Table 4.2. The
SEM images shown in this section are typical representative examples of the images taken
for the batch of microspheres being described.
Batch Molecular Drug Solvent Sphere diameter Pore diameter Method
weight from SEM/µm from SEM/µm
MS006 High None DCM 10-100 1-10+ DE, 2 % PVA
MS011 High& Low None DCM c. 50 2-3 DW
MS018 High 5-FU Ethyl acetate 10-500+ external DE, 2 % PVA
upto 5
MS023 High TFMU DCM & acetone 50-500 external DE, 2 % PVA
1-2
MS035 High 5-FU DCM & acetone 25-200 1-25 DE, 4 % PVA
MS036 High None DCM & acetone 20-150 10-20 DE, 4 % PVA
MS041 Low None DCM & acetone 20-100+ 1-10 DE, 4 % PVA
MS042 Low 5-FD DCM & acetone 30-100 5-10 DE, 4 % PVA
MS043 High 5-FD DCM & acetone 50-200 5-20 DE, 4 % PVA
MS045 Low 5-FD DCM & acetone 10-100 5-10 DE, 4 % PVA
Key DE = Double Emulsion, DW = Double Wall
Table 4.2: Summary of some PLGA microsphere characteristics
Figure 4.5 is an SEM image of microspheres made from high molecular weight polymer
with the model drug 5-FU encapsulated, the image shows the spherical nature of the micro-
spheres with varying sizes of approximately 10–150 µm diameter. Some microspheres have
been cross-sectioned and it is possible to see the ‘bubble’ pores created within the polymer
matrix. These ‘bubble’ pores vary in size and spatial distribution within the polymer ma-
trix, and show inter-batch variability. These characteristics are typical of most microsphere
batches made by the double emulsion technique in this work.
In comparison, Figure 4.6 shows an example double-walled microsphere with a much
higher porosity than those made by the double emulsion technique. The internal structure of
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Figure 4.5: SEM image of high molecular weight microspheres with 5-FU model drug encapsulated,
batch MS035
Figure 4.6: SEM image of double-walled microspheres without drug encapsulated, batch MS011
the double walled microspheres shows a more homogeneous distribution of pores separated
by much thinner walls of polymer matrix than other batches. The pores are less spherical
and more angular than those produced by the double emulsion technique. Near the external
surface a boundary layer can be seen between the internal structure and that of a porous
surface layer. The surface layer has a porous structure similar to that of the central region
of the microsphere.
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(a) With 5-FU encapsulated batch
MS035
(b) With 5-FU encapsulated batch
MS035
(c) No drug encapsulated batch MS036 (d) No drug encapsulated batch MS036
Figure 4.7: SEM images of a high molecular weight microspheres with and without encapsulated
drug
Comparison of drug encapsulated and blank microspheres made with high molec-
ular weight polymer
Figures 4.7a, 4.7b, 4.7c and 4.7d show SEM images of high molecular weight microspheres
made with encapsulated 5-FU, batch MS035, and without encapsulated drug, batch MS036,
respectively. The internal aqueous phase for encapsulated 5-FU contains 1 N NH4OH with
0.4 % PVA and for the blank microsphere this phase was water with 0.4 % PVA. Whilst
the overall size of these example microspheres show similar diameters (80–100 µm), the
‘bubble’ pores within the microspheres show a significant difference with the introduction
of encapsulating 5-FU. The microspheres with encapsulated drug show a greater number of
smaller ‘bubble’ pores, these pores are distributed closer to the surface of the microsphere
than for the blank microsphere. The drug encapsulated microsphere has many ‘bubble’
pores close to the surface causing a surface porosity, this provides an access route into
and out of the microsphere for the external medium and encapsulated drug. Connections
between the pores are also visible, providing pathways within the porous network of the
microsphere. In contrast, the blank microspheres show little, or no, surface porosity and a
thick matrix wall between the surface and the internal bubble pores. Connections between
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the ‘bubble’ pores can be seen, providing pathways within the porous network. Whilst all the
images of drug encapsulating microspheres show the same trend in porosity, it is observed
that for some of the blank microspheres there is little or no porosity at the micrometer
scale, as shown in Figure 4.7d.
Comparison of low molecular weight microspheres with high molecular weight
microspheres, both with 5-FD encapsulated
Samples of microsphere batches MS043 and MS045 made from high and low molecular
weight respectively, both encapsulated with the model drug 5-FD, were imaged by SEM,
typical images are shown in Figures 4.8a, 4.8b, 4.8c and 4.8d. From the SEM images it can
be seen that both high and low molecular weight batches show varying ‘bubble’ pore sizes
with connecting spaces between pores that form networks of ‘bubble’ pores. The thickness
of the matrix walls between the ‘bubble’ pores are, on average, slightly thicker for the low
molecular weight microspheres, and the ‘bubble’ pores are smaller.
(a) High molecular weight microspheres
batch MS043
(b) High molecular weight microspheres
batch MS043
(c) Low molecular weight microspheres
batch MS045
(d) Low molecular weight microspheres
batch MS045
Figure 4.8: SEM images of a high and low molecular weight microspheres with 5-FD as encapsu-
lated drug
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Comparison of low molecular weight microspheres with and without encapsulated
drug 5-FD
Figures 4.9a and 4.9b are typical SEM images of blank microspheres made with low molec-
ular weight polymer, showing narrower pore walls and more connections between ‘bubble’
pores than the 5-FD encapsulated low molecular weight microspheres, shown in Figures
4.9c and 4.9d. The blank microspheres show a high level of porosity with bubble pores in
the order of ≤ 10 µm, with comparatively narrow walls between the ‘bubble’ pores.
(a) Drug encapsulated microspheres
batch MS041
(b) Drug encapsulated microspheres
batch MS041
(c) Blank microspheres batch MS045 (d) Blank microspheres batch MS045
Figure 4.9: SEM images of low molecular weight microspheres with and without 5-FD as encap-
sulated drug
4.4.2 Fluorine detection
Both model drugs used for encapsulation, 5-FU and 5-FD, contain fluorine which can be
detected using NMR of fluorine-19 nucleus. A spectrum was taken of each drug molecule
dissolved in water in order to locate the chemical shift of the fluorine for each drug molecule.
The peak of fluorine was at -169.3 ppm for 5-FU and at -165.99 ppm for 5-FD with reference
to trichlorofluoromethane. Experiments with a batch of 5-FU encapsulated microspheres
has shown that when microsphere are first immersed in water there is no free moving drug
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in solution. After 16 days, free moving 5-FU is found to be present. Experiments on the
water soluble 5-FD molecule does not show the presence of 5-FD after immersion in aqueous
media after 30 days. This suggests that 5-FD has either not been released in this period,
or it may not be encapsulated into the polymer microspheres. It is possible that the higher
solubility of 5-FD in water caused it to be washed out of the polymer during the hardening
phase of the preparation, whereas 5-FU, being less soluble in water remained entrapped
within the microspheres. The drug 5-FD contains nitrogen and should be detectable by
elemental analysis of carbon, hydrogen and nitrogen. Two batches of microspheres, one
containing 5-FD and one blank, were analysed by this method and no difference was seen
in the nitrogen content for the two batches, suggesting that encapsulation is too low to
detect, or 5-FD is not present in the microspheres. However, as can be seen from the SEM
images, the presence of 5-FD in the preparation of the microspheres does appear to affect
the internal structure of the microspheres produced.
4.4.3 NMR PFG studies at room temperature, measuring the av-
erage cavity size and comparing to SEM
Temperature effects
Each set of data is collected in order of increasing gradient strength and as the experiment
progresses, the sample is subjected to an increasing number of radio frequency pulses.
The cumulative effect of these pulses can cause the sample temperature to increase, thus
affecting the measured signal attenuation. To identify if any temperature effects are seen
during the experiment time, a set of data points were collected manually in random order
of changing gradient strength, as suggested by Hollewand and Gladden (1995). Figure 4.10
shows the results of collecting the data points in order of increasing gradient strength and
random order of gradient strength.
It can be seen in Figure 4.10 that there is very little difference in the two sets of
collected data. The values for randomly ordered individual data points vary from sequential
data points by at most +4 %, but many of the values lie with +1 %, the average error
being +2 %. The increasing temperature effect is seen as a reduction in the signal intensity
seen, which increases the calculated diffusion coefficient. An error in the measured signal
intensity of 2 % equates to an error of around 2–2.5 % in the diffusion coefficient for a one
component model. This error is smaller than the experimental error expected for diffusion
coefficient calculated using a one component model fit of data. Therefore, the effect of
temperature is not considered significant for these experiments.
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Figure 4.10: Comparison of data collection for increasing gradient strength and random order
Choice of diffusion model
The signal attenuation measured gave non-linear log attenuation plots, with systematic
deviation from linearity, as can be seen in the example plots shown in Figure 4.11. Figure
4.11 shows the log attenuation plots for two batches of high molecular weight microspheres,
drug encapsulated (MS029) and blank (MS030) at time zero and at around four and a
half hours after immersion in an aqueous medium. The non-linearity shown in the data
suggests either restricted diffusion, a multi-component system, or, a combination of the
two systems. A multi component system is proposed here, as water is contained within
three environments, the bulk, the ‘bubble’ pores and the polymer matrix. Assuming that
the diffusion coefficient of the water contained in the matrix is several orders of magnitude
smaller compared to that in the bulk and the ‘bubble’ pores and the proportion of water
contained within the matrix is small ( 2%), the signal attenuation will be dominated by
the bulk and ‘bubble’ pore components. The multi-component model is, therefore, reduced
to a two component fit, free water and water trapped within the ‘bubble’ pores of the
microspheres, equation 4.3, where D1 and D2 are the diffusion coefficients of water in free
As described by Messaritaki et al. (2005), using the notation of ζ
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MS029 Time 0 MS029 Time 4.3 hours
MS030 Time 0 MS030 Time 4.5 hours
Linear (MS029 Time 0)
Figure 4.11: Log attenuation plots for drug encapsulated (MS029) and blank (MS030) micro-
spheres immediately and around 4.5 hours after immersion
solution and trapped water within the pores of the microspheres respectively. The fraction
of water in the free solution phase is denoted as p, therefore, (1 − p) is the remainder
fraction of water that is assumed to be in the second phase, trapped water within the
microsphere pores.
I = I0(p exp (−D1ζ)+(1− p) exp (−D2ζ)) (4.3)
The chosen diffusion time is such that both unrestricted diffusion in the bulk and restricted
diffusion in the ‘bubble’ pore phase is possible, as discussed in Section 4.2.4. For the
diffusion time studied, the rms displacement of water in the bulk is 24 µm and within the
‘bubble’ pores is of the order of 9.3–10.0 µm for drug encapsulated microspheres and 7.6–
8.9 µm for blank microsphere. From SEM images of identically prepared batches studied
with NMR PFG the ‘bubble’ pores diameter is 1–25 µm for drug encapsulated microspheres
and 10–20 µm for blank microspheres . The average cavity radii determined from PFG,
calculated by equation 4.2 for the microspheres immediately after immersion equates to
average diameters of 17 µm for drug encapsulated microspheres and 14 µm for blank
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microspheres, which agrees with the upper limit of the ‘bubble’ pore diameter seen by
SEM. One explanation for the difference seen between SEM and PFG determined diameter
is that the SEM images are of dry microspheres whilst the PFG experiments are carried out
on wet microspheres.
Calibration of the bulk diffusion coefficient for water in a water and deuterium
oxide mixture
To reduce the number of free parameters within the two-component fit, the free diffusion
coefficient of water may be estimated, thus, the number of variables is three, the entrapped
water diffusion coefficient, D2, the fraction of free water, p and the reference signal inten-
sity, I0. The value of the free water diffusion coefficient, D1, for use in multicomponent
modelling for PFG experiments can be determined both experimentally and theoretically as
described below.
Experimental determination of bulk water diffusion coefficient
A sample of the D2O : H2O solution used for the ambient temperature PFG experiments
was placed in an NMR tube and the free diffusion coefficient of water was measured. The
parameters used were the same as those used for ambient condition PFG experiments.
Theoretical determination
Values of the self-diffusion of both water and deuterated water at various ambient tem-
peratures are given by Mills (1973). These values can be used to calculate the diffusion
coefficient for each solvent at a given temperature. An overall diffusion coefficient for a
mixture of the two solvents can be calculated using equation 4.4,
D1 = fw ×Dw + fd ×Dd (4.4)
where D1 is the overall diffusion coefficient of the mixture at temperature T , Dw and Dd
are the self-diffusion coefficient of pure water and deuterated water at a temperature T ,
and fw, fd are the fraction of water and deuterated water present in the mixture.
Both methods have been used to determine the bulk diffusion coefficient of water, D1
for a 1 % H2O in D2O mixture. The measured value of 2.17×10−9m2s−1 was significantly
higher that the calculated value of 1.88×10−9m2s−1, a difference of 15 %. Possible causes
for this discrepancy could be that the fraction of water in the D2O is incorrect, or the
temperature at which the diffusion coefficient was measured was greater than that used
for the theoretical calculation. If the error was purely due to an incorrect value of fw,
then applying the measured diffusion coefficient to equation 4.4, the value of fw would be
around 0.7, much higher than the assumed value of 0.01, in order to compensate for the
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difference found. If the error was purely due to temperature, then the difference equates to
around +4 to 5 K. During the cryodiffusometry experiments described later in Chapter 6, a
sample temperature increase of 3 to 4 K was found at a probe set temperature of 298 K. It
is, therefore, suggested that the greatest contribution to the error between the theoretical
value and the measured value of diffusion coefficient is temperature, with a possible smaller
contribution from the error in the fraction of water in D2O. In calculations, therefore, the
measured value of diffusion coefficient is used as an estimate for the free water diffusion
coefficient for the system. Under controlled temperature conditions, the diffusion coefficient
for pure water was measured. It was found that the experimental value for Dw agreed with
theoretical value to within ±0.1× 10−9m2s−1, giving an error of less than 5 %.
A sensitivity analysis was carried out to investigate the effects of changing D1 on the
predicted values of the diffusion coefficient of the entrapped water, D2, the second com-
ponent. It was found that a 10 % increase in D1 can increase D2 by an average of 25 %,
and a 10 % decrease in D1 can cause an average decrease in D2 of 63 %, however, a 5
% decrease in D1 causes an average decrease in D2 of 37 %. The effect on the estimated
cavity size caused by a change in the set value of D1 can be seen in Table 4.3.
Batch D1 × 109m2s−1 Calculated cavity size range over experiment time / µm
Drug encapsulated 2.1 8.5–9.1
Drug encapsulated 1.9 4.2–7.0
Blank 2.1 7.0–8.1
Blank 1.9 2.0–7.6
Table 4.3: Cavity radius determined from diffusion coefficient D2 for changes in estimated value
of the bulk diffusion coefficient D1
Comparison of blank and 5-FU encapsulated high molecular weight microspheres
studied by PFG at 298 K for 250 hours after immersion in aqueous media
For both the drug encapsulated and blank microspheres a significant increase in the diffusion
coefficient of the ‘bubble’ pore contained water is seen in the first five to seven hours after
immersion, see Figure 4.12. Significance was defined such that the difference between the
calculated diffusion coefficient and the mean of the diffusion coefficient, between six and
eighteen hours, was greater than five times the standard deviation. The absolute values for
the diffusion coefficients are different for the two batches, however the magnitude of the
change seen in this initial period is very similar, an increase of 0.08 × 10−9m2s−1. It has
previously been suggested that these changes in the diffusion coefficient are indicative of the
polymer swelling in the aqueous media and, therefore, the ‘bubble’ pores increasing in size
(Messaritaki et al., 2005). For drug encapsulated microspheres the average ‘bubble’ pore
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Figure 4.12: Diffusion coefficient of entrapped water for high molecular weight microspheres for
the first 30 hours after immersion into aqueous media
radius increases from 8.5 to 9.1 µm in the first six hours and in the blank microsphere the
average ‘bubble’ pore radius increases from 7.0 to 7.9 µm in the first six and a half hours.
Following this initial period, the diffusion coefficient remains at a steady value, within five
standard deviations from the mean, until around thirty hours after immersion, as shown in
Figure 4.13.
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Figure 4.13: Change in diffusion coefficient of entrapped water in terms of the number of standard
deviations from the mean, for high molecular weight microspheres for the first 250 hours after
immersion into aqueous media
From Figure 4.14 it can be seen that, for the drug encapsulated microspheres, a further
increase in diffusion coefficient occurs between thirty and fifty hours, followed by a decrease
after a hundred hours. The blank microspheres show a steady diffusion coefficient until
fifty hours and then less stability of diffusion coefficient after fifty hours, possibly indicating
instability in the polymer structure at this time. It is possible that these changes are an
early sign of polymer degradation affecting the structure of the polymer, although at this
time, no degradation of the microspheres is noticeable to the eye.
The increase in diffusion coefficient within the ‘bubble’ pores of the polymer matrix
suggests the average mass transport for water is improving with immersion time. As the
mobility of water increases, drug molecule or polymer degradation product diffusivity within
the network of ‘bubble’ pores within the microsphere should improve. Combining these
findings with the additional experiments in Chapter 6, looking at water mobility within the
polymer matrix structure, a better understanding of the polymer evolution and subsequent
drug release should be possible.
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Figure 4.14: Diffusion coefficient of entrapped water for high molecular weight microspheres for
the first 250 hours after immersion into aqueous media
4.5 Conclusions
The SEM images of the microsphere internal structure provide a source of comparison
for the physical characteristics determined from the PFG experimental data. Agreement
between observed ‘bubble’ pore sizes and estimated cavity sizes validate the appropriate
use of the chosen PFG model and its interpretation. Confidence in the methods applied to
the interpretation of PFG data is important for later cryodiffusometry experiments, where
the length scale under investigation is beyond that of the resolution of SEM.
The selected preparation method of double emulsion technique has been used success-
fully to produce both blank and drug encapsulated microspheres with high molecular weight
PLGA. Low molecular weight blank microspheres and 5-FD containing microspheres have
also been achieved, although encapsulation of 5-FD is has not been confirmed. Double
walled microspheres without encapsulated drug have also been successfully produced. The
flexibility and success of using the double emulsion method, makes this the preparation
method of choice for this work. Whilst some inter- and intra-batch variations are expected,
microsphere sizes and shapes are within expected values. With microspheres ranging in di-
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ameter from tens of micrometers to a few hundred micrometers. Pore sizes are of generally
of the order of 20 µm and less with heterogeneous distribution. Pores show interconnections
providing pathways for transport within the ‘bubble’ pore network.
Microspheres produced have successfully been imaged by SEM, and NMR PFG diffusion
coefficients measured, from which the cavity radii calculated agree with those seen in SEM.
Whilst it has been possible to encapsulate the model drug 5-FU into the microspheres of
high molecular weight polymer, it has not been possible to produce microspheres of low
molecular weight with 5-FU encapsulated. It has been noticed that there are affects on
the pore and microsphere structure when a model drug is encapsulated, or is present in
the preparation of the microsphere. The presence of 5-FD in the preparation has shown
changes in the internal microsphere structure despite no evidence of encapsulation in the
dried microspheres. Further investigations into the structural evolution of PLGA matrix at
the nano-scale are required to form a better understanding of the mechanism behind the
release of drug molecules from such systems.
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Chapter5
Cryoporometry studies of PLGA
microspheres
5.1 Introduction
Cryoporometry is applied to the investigation of the structure of PLGA microspheres, for
use as controlled drug delivery devices. Microsphere samples are immersed in an aqueous
media and the water contained in the PLGA matrix is frozen and melted to study the pore
size characteristics. Changes in the freezing point of the imbibed water show changes to
the polymer matrix structure at increased immersion times. Three batches of microspheres
are studied over a period of approximately one hundred days, batches are of high and
low molecular weight polymer with encapsulated drug, and low molecular weight without
encapsulated drug. Cryoporometry provides a means to study the nanoscale matrix structure
of the polymer microspheres in terms of both the access channels, or pore necks, and pore
body sizes.
5.2 Background and Theory
Cryoporometry has previously been used to study nanoporous materials such as silicas
(Schreiber et al., 2001; Valckenborg et al., 2001), titania films (Vargas-Florencia et al.,
2007) and some polymeric materials (Hansen et al., 2005; Petrov et al., 2006a) providing
pore size information gathered from the melting characteristics of the imbibed liquid. Petrov
et al. (2006a) used cryoporometry to study the polymer swelling over four days, investigating
pore sizes of 30–70 nm (assuming a Gibbs-Thomson parameter of 50 nmK). The measured
temperature was calibrated to the actual sample temperature using the bulk melting point
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only, as discussed previously in Chapter 3 this is not as accurate as direct measurement of
the sample temperature with a thermocouple.
Here, cryoporometry is applied to examine the structural changes in the polymer matrix
of PLGA microspheres over longer time periods (≥ 90 days) in order to better understand
the mechanism behind drug release behaviour from such a system. The complex structure of
the polymer matrix will be described in terms of pore neck sizes determined from freezing
characteristics and the pore body sizes determined from the melting characteristics, as
described previously in Chapter 3. Changes in the pore sizes can be used in a qualitative
assessment of the causes of the drug release mechanism from such materials. The neck size,
or size of the access channels, restrict the motion of larger molecules into and out of the
polymer matrix. The cavities between the polymer chains, in which a drug molecule may
be encapsulated, can influence the pathway the molecule must travel through the matrix,
before being released into the bulk medium. Polymer swelling and degradation are thought
to dictate the release of an entrapped molecule as described in Chapter 4, however, with
structural studies at the nanoscale level it is hoped that a greater understanding of the
polymer matrix will aid design of new drug release systems.
On first freezing the microspheres, the bulk and ‘bubble’ pore contained water are
supercooled and freeze together. The freezing front can progress from the bulk into the
‘bubble’ pore network through the micrometer scale connections between the ‘bubble’ pores.
These connections are clearly visible in the SEM images discussed in Chapter 4. The second
stage of the freezing of water contained in the polymer matrix, now progresses through a
series of freezing fronts that originate from the external surface of the microsphere and the
surface of the ‘bubble’ pore ice. The freezing fronts move through the matrix probing the
necks, or access channels, that form a pathway into the matrix until all the matrix contained
water is frozen, as described in Chapter 3. As the sample temperature is increased, the
matrix contained water begins to melt in order of increasing pore size in which it is contained,
see Figure 5.1. If the sample is only partially thawed, pockets of ice contained in the larger
pore bodies within the matrix remain frozen, whilst the smallest pore body contained water
is melted. From this point a reduction in temperature sees the freezing fronts progressing
from these ice pockets within the matrix in addition to those from the external bulk and the
‘bubble’ pores. The observed neck size on re-freezing is larger than that seen during the first
freezing process, suggesting that the smallest access channels have already been passed by
the freezing front. Therefore, these smaller access channels lie between the bulk or ‘bubble’
pore and the internal matrix. When considering drug release, these smaller access channels
are significant in controlling the progress of the drug molecule from the internal polymer
matrix into the release medium. Where as the larger pore necks will control movement of
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Figure 5.1: Diagram to show the freezing and thawing mechanism for water contained in polymer
matrix
the drug molecule within the internal polymer matrix. Once within the release medium, the
drug pathway out of the microsphere is determined by diffusion within the release medium
through the micrometer scale ‘bubble’ pore network.
5.3 Experimental
Microspheres were prepared by double emulsion technique as described earlier in Chapter
4. From a given batch of microspheres approximately 10–20 mg were placed into a 100 µm
pipette tip sealed at the lower end with parafilm. The pipette tip had been cut down in
length such that its maximum diameter would fit into a 5 mm thin-walled NMR tube. The
aqueous test medium was then added to the microspheres within the pipette tip and the
top of the tip was sealed with parafilm. The sealed pipette tip was then placed between
two susceptibility plugs within the NMR tube. The microspheres and aqueous media were
placed into the pipette tip rather than directly into the NMR tube to protect the NMR
tube from shattering when the aqueous medium froze and expanded.
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The thermocouple was placed through the axial hole in the top susceptibility plug,
piercing the parafilm seal over the top of the pipette tip, and was in direct contact with the
aqueous solution containing the microspheres. In contrast to previous ambient temperature
experiments, the aqueous media for cryodiffusometry did not contain any deuterium oxide.
This increased the overall signal intensity seen for the partially frozen sample and removed
any effects on cryoporometry results caused by the difference in melting point of deuterium
oxide, 3.8 °C, and water, 0 °C. Differences in the freezing and melting mechanisms between
water and deuterium oxide caused by the greater mass of deuterium was, therefore, removed.
Freeze-thaw cycles were carried out on the PLGA microsphere samples contained within
the pipette tips. A simple spin echo pulse sequence, as described in the appendix Section
A.7, was used with an echo time of 10 ms. The sample was cooled and warmed with
step changes of 1 K in the region of interest. The sample was allowed to equilibrate for 9
minutes at each temperature before an acquisition was taken. This equilibration time had
been determined by previous experiments as being sufficient for the microsphere sample to
reach an equilibrium state.
On some cycles the sample was part thawed and refrozen to investigate possible shielding
effects between the bulk or bubble pores and the internal matrix structure. Which was
thought may affect the drug release profile in terms of the mass transport within the matrix
and out of the matrix into the release media.
5.4 Results and Discussion
5.4.1 Change of aqueous medium
Initial cryoporometry curves of water imbibed microspheres showed supercooling of the bulk
and ‘bubble’ pore contained water followed by the freezing of water within the polymer
matrix. On warming the sample, very little melting was seen below the bulk melting
temperature, therefore, very little information could be gained from the melting curve.
An example of the freeze-thaw curves observed with water can be seen in Figure 5.2. To
eliminate the possible insulating effects of ice on the temperature experienced in the polymer
matrix, very long equilibration times of more than 3 hours were used on the thawing curves.
No further melting was seen at these extended equilibration times before the bulk began
to melt, therefore, very little of the melting curve for microspheres immersed in pure water
could be seen. Water was replaced by a sodium chloride solution, the presence of salt in
bulk water has the effect of lowering the freezing point temperature, for a 5 % w/v sodium
chloride solution the bulk freezing temperature is 270 K (Najibi et al., 2006). By suppressing
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Figure 5.2: Freeze-thaw hysteresis curve observed for water imbibed in the polymer matrix of
PLGA microspheres
the bulk melting point it is expected that the melting point depression for imbibed fluid
will be increased and more of the melting curve may be observed. An experiment with
the sol-gel silica material used in Chapter 3 showed the melting curve for the whole pellet
sample was depressed by 2 K with 5 % w/v sodium chloride solution and maintained the
same profile as water, see Figure 5.3.
The addition of salt requires further consideration with regards to its possible effects
on the freezing mechanism and any interaction with the polymer. Salt exclusion can occur
during freezing, where by, a compartment of water within the salt solution begins to freeze
and the salt is forced to the non-freezing compartment of the solution, this compartment,
therefore, becomes more concentrated and its freezing point is reduced further. On further
decreasing the temperature, a second compartment of the water or weak saline begins
to freeze and forces the salt into a yet more concentrated compartment. The effect of
salt exclusion is to increase the temperature range over which the freezing of a solution
occurs from a finite value to an extended range of freezing temperatures of many degrees
(Najibi et al., 2006). On melting, the higher concentration solutions melt first, followed by
those compartments of less concentrated solution, thus increasing the temperature range
NMR Studies of Controlled Drug Release Devices 117





































5 wt% NaCl solution water water depressed 2K
Figure 5.3: Melting curve for sol-gel silica whole pellet sample for water and 5 % sodium chloride
solution
observed for melting. This effect will depend on the distribution of the salt ions within
solution and would, therefore, change the freezing and melting curve observed for each
repeated experiment. The effect of salt exclusion is not seen in the freezing of the salt
solution within the silica pellets shown in Figure 5.3, as the shape of the freezing curve
observed for salt solution is the same as that for water within experimental error. Any effect
of salt exclusion would increase the range of the observed freezing behaviour.
It is also acknowledged that there may be some interaction between the salt and poly-
mer. In these experiments looking at drug release systems it is considered that this effect
may mimic any interactions of ions present within the blood or tissue, providing a better
understanding of the behaviour of these systems in vivo. Therefore, salt solutions were
used for the following studies of PLGA microsphere in this chapter and the cryodiffusome-
try studies in Chapter 6. In addition, changes in the salt concentration with time must also
be considered. These changes may be the result of evaporation of water from the solution
or salt interactions with the polymer and would cause a systematic decrease in the freezing
and melting point of the bulk solution. Bulk freezing is subject to supercooling, and no
such effect is seen in the bulk melting point.
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5.4.2 Cryoporometry cycles
The cryoporometry results for three different batches of microspheres are presented and
discussed, low molecular weight with 5-FD encapsulated, MS045, high molecular weight
with 5-FD encapsulated, MS043, and low molecular weight without encapsulated drug,
MS041. Whilst cryoporometry results provide structural information, diffusometry results
provide mass transport information, and when combined the two techniques give a more
complex interpretation of how the structure and mass transport are related within the PLGA
microsphere systems. Cryodiffusometry results for these batches are discussed in Chapter
6. To this end, it is expected that a drug release profile may be better understood and the
design of such drug delivery systems may be optimised.
Calculation of relative signal intensity
Absolute signal intensity, Ia, for a given experiment is calibrated to give the relative signal
intensity, Ir, at a given temperature. The relative signal intensity is calculated in terms
of the absolute signal intensity for the matrix contained water that remains unfrozen after
bulk supercooling, Im, and the minimum absolute signal intensity when all the water is
frozen, Imin, as in equation 5.1. Thus, a relative signal intensity of 1 represents all the
matrix contained water as molten and a relative signal intensity of 0, all water is frozen.
Ir =
Ia − Imin
Im − Imin (5.1)
The NMR signal intensity is affected by temperature, a correction can be made based
on the Curie Law (Mitchell et al., 2008). The signal intensity at a given temperature, IT ,
can be calculated relative to the signal intensity at a reference temperature, 273 K, I273,
and the temperature, T , as expressed in equation 5.2*.
IT = I273 × 273
T
(5.2)
According to this equation the signal intensity should increase with a decrease in temper-
ature, for a totally molten sample, this effect is seen. However, this relationship does not
account for the change in signal intensity due to portions of the sample freezing as tempera-
ture decreases. The absolute signal intensity measured, Ia, may be adjusted for temperature
*As expressed in Mitchell et al. (2008)
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in a similar manner, Iadj, equation 5.3, where Tref is the reference temperature.
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Figure 5.4: Absolute signal intensity against temperature for microsphere sample, raw data and
corrected for temperature effects
The significance of this effect was investigated for the observed freezing curves for a
microsphere sample, the raw data and corrected data curve can be seen in Figure 5.4, the
reference temperature used was 246.1 K, a mid-value in the region of interest. It can be
seen in Figure 5.4 that over the range of interest the effect of temperature on the signal
intensity is small compared to the change in intensity due to sample freezing, and is less than
experimental fluctuations. This effect has negligible impact on the pore size distribution
obtained from cryoporometry data and is, therefore, not included in the calculations of
relative signal intensity, defined previously, equation 5.1.
Estimate of experimental error values
The microsphere samples immersed in aqueous media had a greater sample depth than the
silica pellet samples investigated in Chapter 3, but have better heat transfer properties,
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therefore, it was considered reasonable to use the measured temperature variation in the
silica samples as the error in the measured temperature for the microsphere samples, ±0.2
K. Greater accuracy was not required for differentiating the pore sizes determined from
cryoporometry. For a temperature error of ±0.2 K, the calculated error in pore size was
a maximum of ±0.05 nm within the range of interest. Changes seen in pore size were
generally much greater than this error.







































1st cycle 2nd cycle
Figure 5.5: Repeat cryoporometry cycles for microsphere batch MS043 at day 1 after immersion
After initial immersion in aqueous media consecutive cryoporometry cycles were con-
ducted to establish the repeatability of the cryoporometry cycles. Figure 5.5 shows two
cycles for microsphere batch MS043 at day 1 of immersion, good agreement is seen on
the thawing curve suggesting that the structure has not been disrupted by the freeze-thaw
process, and that salt exclusion is not present. After the bulk and ‘bubble’ pore containing
water has frozen, it can be seen that there is a shift in the freezing curve toward a lower
temperature for the second cycle, corresponding to a smaller neck size. Between the two
cycles there is a short period of time, a few hours, in which the aqueous medium is in the
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liquid state, therefore, the shift of the freezing curve observed is assigned to a change in the
pore neck sizes during this early stage of immersion. As discussed previously in Chapter 4,
a significant change in the diffusion behaviour and the estimated cavity size is seen in the
early immersion studies of PLGA microspheres. It is understood that polymer chains relax
in aqueous media and the polymer is said to swell (Messaritaki et al., 2005), this would
affect the arrangement of the polymer chains and, therefore, the structure that is observed
at the nanometer scale. The magnitude of the change is small but still significant, as the
change in freezing temperature seen is greater than twice the experimental error expected






































1st cycle 2nd cycle 3rd cycle 4th cycle
Figure 5.6: Repeat cryoporometry cycles for microsphere batch MS045 at day 1 after immersion
Consecutive freeze-thaw cycles on day 1 after immersion for a second batch of micro-
spheres, MS045, are shown in Figure 5.6. For this batch, a time delay of 7 hours between
the first and second cycles was experienced, when the microspheres were immersed in fully
molten aqueous media. A decrease in absolute signal intensity is observed, a sign of the
void fraction, or volume of water observed in the matrix has changed. The third and fourth
cycles were conducted without further time delays and show excellent agreement in terms
of thawing curve position and relative signal intensity. A shift in the freezing curve is seen
between the second and third cycles but no change is seen between the third and fourth
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cycle. This suggests that structural change occurs between the second and third cycle,
but not between the third and fourth cycle. These experiments provide confidence that
the results obtained show time dependent changes in structure that are not artifacts of the
experimental technique. The repeatability of the cryoporometry cycle is also demonstrated
when negligible change in the structure has occurred.
Intra-batch variability of cryoporometry cycles was assessed by comparing results ob-
tained for different samples from the same batch at the same immersion time. Negligible
differences were observed in those samples tested, suggesting that samples were represen-
tative of the batch from which they were taken, see Appendix Section A.2 for an example
data set.
5.4.3 Time-resolved cryoporometry studies on PLGA microspheres
Time-resolved cryoporometry studies on Low molecular weight PLGA micro-
spheres with encapsulating drug 5-FD, batch MS045
Microspheres were made with low molecular weight 50:50 PLGA by double emulsion evap-
oration technique, with the model drug 5-FD encapsulated in the internal aqueous phase
as described previously in Chapter 4. Cryoporometry cycles were conducted on a sample
of micropsheres immersed in 5 % w/v sodium chloride solution at increasing times after
immersion. Freezing curves of these cycles are shown in Figure 5.7, for clarity data points
have been connected by dashed lines as a guide to the eye. Also, the data is presented
on two Figures, 5.7a for days 1—34, and 5.7b for days 42–109. The results for the first
day of immersion are shown on both Figures 5.7a and 5.7b as a reference. As discussed
in Chapter 3 the freezing curve is indicative of the network entrances, or necks, within the
pore structure, therefore, any changes in the freezing curve are attributed to changes in
the matrix pore necks. When describing pore necks in the matrix this refers to the gaps
in the backbone of the polymer chains, or entrance points between the polymer chains,
through which the water molecules may pass. It is thought that these openings provide ac-
cess channels for transport of molecules through the polymer matrix. An encapsulated drug
molecule must also pass through these channels if it is to traverse the matrix and eventually
be released. Therefore, the size of these channels may control the route of passage for an
encapsulated drug molecule.
There are two significant changes observed over time after the immersion of micro-
spheres, firstly the change in temperature at which the majority of the matrix water freezes,
and secondly, the number of stages in which the matrix contained water freezes. In Figure
5.7a it can be seen that there is a shift in the temperature at which the matrix contained
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Day 1 Day 42 Day 60 Day 109
(b) Days 42—109
Figure 5.7: Cryoporometry freezing curves at increasing immersion times for microsphere batch
MS045
water freezes, between days 1 and 20 the freezing temperature decreases suggesting a de-
crease in the modal neck size. The error bars for temperature measurement are shown
for the data collected on day 1, but are the same for all days, ±0.2 K, the changes seen
are outside of experimental error and can, therefore, be discussed as structurally driven
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changes. Subsequently, the freezing temperature of the matrix contained water increases
between days 20 and 27, then decreases again between days 27 and 34, these changes vary
in magnitude and can be seen throughout the time of immersion.
The increase and decrease in size of the pore neck suggests the pore necks, or access
channels, are opening and closing with the movement of the polymer chains, in agreement
with theory for burst release suggested by Allison (2008). In the context of a potential
drug release mechanism the opening and closing of such access channels is an important
concept. The movement, or breaking, of the polymer chains and the opening and closing
of the access channels is considered to be a key factor in the control of movement of the
drug molecule through, and eventually out, of the polymer matrix into the bulk fluid. This
is especially the case for larger molecule drugs that are sterically hindered. The changes
discussed in this section are the differences seen between observation times, additional
changes may occurs between observation times that are not seen.
Another change observed in the characteristic freezing curve for the matrix contained
water over time is the number of step changes in the relative signal intensity. Each step
decrease in the relative signal intensity as temperature decreases, after supercooling of the
bulk, is indicative of a modal neck size within the polymer matrix, for one step change such
as that seen on day 1, the pore size distribution is unimodal. The change in the number
of modal neck sizes can also suggest changes in the structural arrangement of the polymer
chains within the matrix. At long immersion times, greater than 100 days, there is a change
in the shape of the freezing curve to a more gradual freezing of the matrix contained water,
without any significant step changes, this implies a continuous distribution of pore necks.
Thus, suggesting a much less ordered matrix structure than at earlier immersion times
where a unimodal or bimodal neck distribution is seen. The neck and body sizes observed
are average values and may, therefore be affected by changes in the number of pores and
the pore size distribution.
Whilst the neck size shows changes during the immersion time studied, no significant
change is seen in the pore body size until long immersion times of greater than 100 days, at
which point it is thought that structural degradation has sufficiently disrupted the matrix
to change the spacing between polymer chains. A wider pore neck size distribution may
change the complexity of the path travelled by a drug molecule. Larger pore necks provide
an easier route for the encapsulated molecule, whilst smaller pore necks may prevent or
divert the passage of the encapsulated the molecule. The net effect will be dependent on
the size of the encapsulated molecule and any skewness in the pore neck size distribution.
The complete freeze-thaw cycle at day 1, day 60 and day 109 are shown in Figure 5.8 for
comparison. The repeatability of the melting curve at days 1 and 60 shows that the freeze-
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Day 1 freeze Day 1 thaw Day 60 freeze
Day 60 thaw Day 109 freeze Day 109 thaw
Figure 5.8: Complete cryoporometry freeze-thaw cycles for batch MS045 on days 1, 60 and 109
after immersion in an aqueous medium
thaw process does not change the structure of the microspheres, and salt exclusion does
not occur, or has negligible affect. Both of these effects, if present, would cause changes
to the position of the melting curve. Repeated freezing would be expected to increase
the pore size due to the repeated swelling of water during the freezing process that could
disrupt and fracture the polymer matrix structure. An increase in pore size would increase
the observed melting temperature, such an effect is not seen. Salt exclusion effects would
be different on each melting and, therefore, the melting temperature would shift both up
and down in value as a result, the range of the melting curve would also be expected to
change, this effect is also not observed for the matrix contained water in any samples tested
in this work.
The value of the Gibbs-Thomson parameter used for the pore size estimation is that
determined previously for silica in Chapter 3. Although this is not an exact value for the
polymeric system, it is sufficient for the purpose of observing changes in pore size. It is
not possible to determine an exact value of the Gibbs-Thomson parameter for polymer by
comparison with mercury porosimetry or nitrogen adsorption, due to its fragility and large
range of pore sizes. Nitrogen adsorption was attempted on a batch of microspheres and
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(b) Body size
Figure 5.9: Nominal pore neck and pore body size distributions determined from freezing and
melting cryoporometry curves for microsphere batch MS045
despite careful preparation and handling of the microspheres to remove water traces, the
nitrogen adsorption was unsuccessful, and the results are given in the appendix Section
A.1. The pore neck size distribution determined from the freezing curves can be seen in
Figure 5.9a, the pore body size determined from the melting curves can be seen in Figure
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5.9b. Full cryoporometry cycles were conducted at days 1 and 20, where the sample was
frozen and then thawed completely. After day 27 the cryoporometry cycle was modified
to include a partial thaw and re-freeze of the sample after the initial freezing and before
the complete thawing. This was to investigate the possible presence of shielding effects
during the first freezing process of the microspheres. Evidence of shielding would suggest
the presence of smaller pore necks that slow the progression of the freezing front from the
external media. These smaller necks could potentially prevent the release of a large drug
molecule into the external release medium, whilst larger necks within the pore matrix allow
more free movement internally. Modal pore neck and pore body sizes for batch MS045
determined from freezing, re-freezing and melting curves are summarised in Table 5.1.
Time Cycle Neck Diameter/nm Pore Diameter/nm Comments
Day 1 1st full 1.92 3.17 unimodal
Day 10 1st full 1.80-1.89 3.17 unimodal
Day 20 1st full 1.74 3.20 unimodal
Day 27 1st freeze 1.84 3.06 bimodal,c. 1.5
Day 27 Re-freeze 2.6
Day 34 1st freeze 1.60 3.11 bimodal,c. 2.2
Day 34 Re-freeze 2.6
Day 42 1st freeze 2.14 3.10 bimodal,c. 1.4
Day 42 Re-freeze 2.6
Day 60 1st freeze 1.67 3.21 bimodal,c. 1.4
Day 60 Re-freeze 2.6
Day 102 1st freeze 1.21-2.31 2.22+ broad distribution
Day 102 Re-freeze 2.34
Table 5.1: Neck and pore body sizes summary for microsphere batch MS045
The neck size shown in the first freezing process is indicative of the controlling minimum
neck size between the internal polymer matrix and the release medium through which a
drug molecule must pass to be released. The neck size shown by the re-freeze curve is
representative of the average pore neck within the internal porous polymer matrix through
which the drug molecule may travel, but does not get released to the external medium. An
element of shielding is, therefore, observed for this sample of microspheres. To this end,
shielding effects can be said to contribute to the observed freeze-thaw hysteresis. Other
potential contributions to the hysteresis for polymer microsphere systems are discussed later
in this section.
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Time-resolved cryoporometry studies of high molecular weight PLGA microspheres































Day 1 Day 14 Day 25 Day 31
Day 59 Day 88 Day 92
Figure 5.10: Cryoporometry freezing curve for batch MS043 from days 1 to 92 after immersion
in aqueous media
A second batch of microspheres, MS043, made by double emulsion technique, with
high molecular weight 50:50 PLGA and model drug 5-FD encapsulated is studied over
time. Freezing curves for MS043 at increasing immersion times in aqueous media are
shown in Figure 5.10. The freezing curve for day 14 shows a larger neck size than at day
1, a possible sign of the polymer swelling and the polymer chains moving position relative
to one another. At day 25 the freezing curve shows a smaller pore neck size than day 1,
indicating the pore necks have reduced in size. By day 31 the nominal neck size has grown
again, but is smaller than at day 14. At longer immersion times, day 59 onwards the neck
size appears to return to a value close to that originally observed on day 1, a similar value is
also observed at day 88, possibly indicating that the polymer has settled to a steady state,
with little fluctuation, over this time period. This state begins to change again after 92
days, where there appears to be two nominal neck sizes, possibly due to the start of the
degradation of the polymer chains, which may provide additional access channels into and
out of the polymer matrix.
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Time Cycle Neck Diameter/nm Pore Diameter/nm Comments
Day 1 1st full 1.90 3.11 unimodal
Day 2 2nd full 1.85 unimodal
Day 14 1st freeze 2.13 3.22 bimodal becoming
visible c.1.6
Day 14 Re-freeze 2.47 bimodal visible c.1.8
Day 25 1st freeze 1.80 3.38 bimodal visible c.2.4
Day 25 Re-freeze 2.58
Day 31 1st freeze 1.96 3.17
Day 31 Re-freeze 2.44
Day 59 1st freeze 1.93 3.27
Day 59 Re-freeze 2.69
Day 88 1st freeze 1.91 2.95
Day 88 Re-freeze 2.33
Day 92 1st freeze 2.45 2.89
Day 92 Re-freeze 2.47
Table 5.2: Neck and pore body sizes summary for microsphere batch MS043
Nominal neck size distributions and pore body size distributions derived from the freezing
and melting curves for batch MS043 can be seen in Figures 5.11a and 5.11b, respectively.
A summary of the modal pore neck sizes determined from the freezing curves is given in
Table 5.2.
Time-resolved cryoporometry studies of Low Molecular Weight PLGA micro-
spheres without encapsulated drug, batch MS041
Microsphere batch MS041, made by double emulsion evaporation technique with low molec-
ular weight 50:50 PLGA, without the model drug in the internal aqueous phase, which
contained water and 0.4 % PVA, were immersed in 5 % w/v sodium chloride solution. Cry-
oporometry cycles were conducted at increasing immersion times for over 100 days, freezing
curves are shown in Figures 5.12a and 5.12b. At earlier immersion times, less than 25 days,
changes are observed in the pore neck size similar to those seen for batch MS045, also of
low molecular weight, where the pore necks appear to open and close before returning to
their original size. Between days 25 and 51 the pore neck size stabilizes and fluctuations
observed are within experimental error, the neck size remains close to that observed at
day 1. Between day 51 and 70, the pore necks increase in size and show a broader dis-
tribution, then decrease in size by day 93 and increase by day 105. Following this second
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(b) Nominal pore body size
Figure 5.11: Nominal pore neck and body size distributions for microsphere batch MS043
stage of opening and closing, by day 116 there are four modal pore neck sizes across the
whole range of those previously observed. The pore neck size distributions determined from
freezing curve data are shown in Figure 5.13a. The pore body size also shows a change
with this batch, for days 1 to 25 the body size remains constant, between days 25 and
37 the body size decreases significantly, but remains this size until day 116.The pore body
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105 day freeze 116 day freeze
(b) Days 70–116
Figure 5.12: Cryoporometry freezing curves at increasing immersion times for microsphere batch
MS041
size distributions determined from the melting curve data are shown in Figure 5.13b. A
summary of the pore neck and body sizes are given in Table 5.3.
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(b) Nominal pore body size
Figure 5.13: Nominal pore neck and body size distributions for microsphere batch MS041
5.4.4 Comparison of microsphere batches in terms of porosity
Nominal modal pore neck and pore body sizes at increasing immersion times for all three
batches of microspheres are shown in Figures 5.14 and 5.15 respectively. For all three
batches studied here the nominal pore neck sizes start at just less than 2 nm at day 1, then
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Time Neck Diameter/nm Pore Diameter/nm Comments
Day 1 1.77 3.13 unimodal
Re-freeze 2.72
Day 10 2.70 Not available* unimodal
Day 14 1.98 3.21 unimodal
Day 25 1.77 3.19 unimodal
Day 32 1.82 Not available* unimodal
Day 37 1.70 2.88 unimodal,
shift in pore body size
Re-freeze 2.65
Day 51 1.78 2.87 unimodal
Day 70 Ave 1.97–2.12 2.91 modal peak widens
Day 93 1.60 2.91 Additional neck peaks
at 2.14-2.24 nm
Day 105 1.72,2.15 2.81-2.99 bimodal
Day 116 2.20,1.70,1.40,1.24 2.88+ 4 modes of neck size and
pore size distribution change
* Not available due to premature experiment termination by equipment failure
Table 5.3: Neck and pore body sizes summary for microsphere batch MS041
the greatest initial changes are seen in the low molecular weight batches MS045 and MS041.
The batch with the model drug used in the preparation, MS045, shows continual opening
and closing of pore necks throughout the study, until long immersion times greater than
100 days at which point the observed structure appears to have changed at the nanometer
scale. In comparison the batch without the model drug, MS041, shows an initial opening of
the pore necks and then returns to the size seen at day 1, subsequent experiments suggest
a relative steady state then exists for a period of around 40 days, before the necks re-open
and close and the structure continues to change. The high molecular weight batch with
encapsulated drug, MS043, shows some initial change in the pore necks at the early stage of
the study, upto 30 days after which the necks remain unchanged. In terms of drug release
potential, it is thought that the pore necks can control the release of a molecule into the
release medium and the transport of the drug molecule through the matrix. Opening of
pore necks provides an exit for the drug molecule to be released, closing of pore necks
restricts, or prevents, passage of the drug molecule. At periods of no change in pore neck
size, the drug release profile will depend on the relative size of the nominal pore neck and
the drug molecule, release may be unrestricted, partially restricted or totally restricted.
Pore body sizes at the start of the study were also found to be very similar for all three
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Figure 5.14: Nominal pore neck size changes with immersion time for batches MS041, 43 and 45
batches, at around 3 nm. No significant change in pore body size was seen for batch MS045
until long immersion times of more than 100 days. For batch MS041, a step change in
the pore body size was seen during the period of little change in the pore neck size at
around 20–37 days, therefore, suggesting a different structural evolution mechanism, where
changes were occurring within the structure of the polymer matrix that did not affect the
neck size. This may imply that the presence of the model drug during the preparation of
the microspheres affected the polymer structure and, therefore, changing the mechanism
of its evolution, as suggested in the literature (Freiberg and Zhu, 2004). In contrast batch
MS043 shows more change in the pore body size than the pore neck size over the time
studied. This is suggestive that the higher molecular weight polymer degradation may
progress differently and have greater effect within the body of the matrix pores during the
initial stages than is seen within the low molecular weight polymer. This difference could
have a significant effect on the drug release profile observed.
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Figure 5.15: Nominal pore body size changes with immersion time for batches MS041, 43 and 45
5.4.5 Additional interpretation of cryoporometry data for matrix
contained water in PLGA microspheres
Scanning loops
The partial thaw re-freeze cycle shown in Figure 5.16 can provide additional information
on the shielding effects of the neck structure connecting the internal polymer matrix with
the bulk or ‘bubble’ pore. Larger neck sizes are seen after the partial thaw, suggesting a
reduction in the shielding compared to that seen during the first freezing process. In some
cases it is observed that this ‘unshielded’ pore neck size remains constant for longer periods
of time, for example for low molecular weight polymer drug encapsulated batch MS045.
Changes are observed for high molecular weight polymer, again suggesting more change
to the internal polymer structure for high molecular weight PLGA microspheres than seen
for low molecular weight batches. The presence of larger pores which remain frozen within
the matrix on initial thawing provide additional nucleation sites in the re-freeze process. In
terms of drug movement within and through the matrix, this suggests there may be regions
where the drug molecule can move around freely, but this movement is restricted by the
matrix ‘necks’ that connect this region to another region, or the bulk. A drug molecule,
NMR Studies of Controlled Drug Release Devices 136












































































Figure 5.16: An example of the freeze, part thaw, re-freeze and thaw cryoporometry cycle for
batch MS043 after 14 days immersion in aqueous media
therefore, may remain trapped within this region until the neck has opened sufficiently to
allow the drug to progress to the next region of the matrix, into the ‘bubble’ pore or, out to
the bulk. Once the drug molecule is in the bulk media, it has effectively been ‘released’ from
the matrix. This supports earlier findings by Messaritaki et al. (2005) that different regions
within the polymer matrix have different release profiles. The re-freeze pore necks observed
for high molecular weight batch MS043 are similar in size to those for the low molecular
weight batch MS045, however, this high molecular weight batch shows more changes with
immersion time, which are not seen for MS045.
Nanometre scale geometry
As described in Chapter 3 the work of Petrov and Furo (2006) describes the hysteresis
between the freezing and thawing of a liquid imbibed in a porous medium in terms of the
pore shape. Applying this theory to the freeze-thaw hysteresis seen for the polymer matrix
of the microsphere, the ratio of the melting point depression, ∆Tm, to the freezing point
depression, ∆Tf , lies between that for cylinders (
1
2
) and spheres (2
3
), as shown in Figure
5.17. This could suggest that the matrix contains both spherical and cylindrical pores, or
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Figure 5.17: Adjusted freezing curves for cylindrical and spherical pore shapes compared to melting
curve for microspheres batch MS043 after 1 day immersion
that the pores are neither spherical nor cylindrical, but some ellipsoidal shape. In either
case it is concluded that the polymer matrix does not have a simple nanoporous structure.
A comparison of the re-freeze curve with the melting curve also shows no correlation to
simple cylindrical or spherical geometry, see Figure 5.18.
Application of percolation theory to freezing water in PLGA microsphere matrix
The application of percolation theory to the freezing of liquid imbibed in porous media is
described earlier in Chapter 3. The freezing data collected for the initial freezing of the
matrix is considered as being synonymous with the whole silica pellet sample, where the
freezing front progression into the matrix is shielded by the small external and connecting
necks. Similarly the freezing data for the second freezing of the matrix contained water
after a partial thaw is considered synonymous with the powder silica sample, where shielding
effects have been removed and the freezing process is affected only by pore size. This
assumption is not entirely true as the distribution of the ice pockets within the polymer
matrix after the partial thaw are unknown and may not fully remove the shielding effects.
For the sake of this analysis, the ice pockets are considered to be in the larger matrix pores
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Figure 5.18: Adjusted freezing and re-freezing curves for cylindrical and spherical pore shapes
compared to melting curve for microspheres batch MS041 after 37 days immersion
that could have been shielded during the initial thawing. A shift in the second re-freeze
curve to larger pore sizes compared to the initial freeze is seen consistently for microsphere
samples as discussed earlier in this section, providing confidence that the shielding effect
is real. Percolation theory, as described for silica samples in Chapter 3, has been applied
to data for all batches of microspheres studied in this chapter. An example of a typical
probability of pore being frozen ,F , against probability a pore is below its freezing point,
f , plot can be seen in Figure 5.19. Some freezing of matrix contained water is seen below
the percolation threshold, but a significant increase in the number of pore that are frozen
is seen at the percolation threshold.
A summary of the threshold values determined for different microsphere batches at sim-
ilar immersion times are given in Table 5.4. The low molecular weight batches show higher
values of percolation threshold compared to the higher molecular weight batch studied. A
higher percolation threshold suggests poorer connectivity and, therefore, a more restricted
movement and release of an encapsulated molecule. Conversely, a lower percolation thresh-
old suggests greater connectivity which provides greater accessibility for movement through
and out of the matrix for an encapsulated molecule. The change in percolation threshold
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Figure 5.19: Example plot of the probability of a pore being frozen against the probability of a
pore water being below its freezing point for microsphere batch MS041, 37 days after immersion
Batch Immersion time Percolation threshold values
MS041 1 day 0.62–0.74
MS041 37 days 0.56-0.66
MS045 27 days 0.43
MS045 34 days 0.49–0.58
MS043 14 days 0.2-0.3
MS043 25 days 0.36-0.42
Table 5.4: Approximate percolation threshold values for microsphere matrix freezing of imbibed
water
over the time studied shows an increase for drug encapsulated microspheres and a decrease
for microspheres without encapsulation. This observation reaffirms the need to ascertain
the effect that the drug molecule of interest will have on the polymer microsphere in order
to gain a full understanding of the drug release mechanism for a given system. The methods
described in this chapter provide a wealth of information to assess the release mechanism
in terms of structural changes in the polymer matrix at the nanometer length scale.
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5.5 Conclusions
Cryoporometry has been applied to the investigation of the nanometer scale structure of
PLGA microspheres for drug delivery. Changes in the polymer matrix structure over time
have been observed and comparisons made between different batches of microspheres. Both
the freezing and thawing characteristics of water contained in the polymer matrix have been
used to determine the nominal pore neck and pore body sizes. Changes in pore neck sizes
with time show the opening and closing of entrances or access channels into the polymer
matrix as the freezing front progresses into the matrix from the outside. It is thought that
these access channels control the release of an entrapped drug molecule from the polymer
and, therefore, play a vital role in the drug release profile observed from such systems. After
a partial thaw and re-freeze, the access channels restricting the progression of the freezing
front are larger, the freezing front at this stage has begun within the matrix, therefore, the
smaller channels seen are likely to control the release of a molecule from the matrix into the
external medium rather than movement inside the matrix. The larger pore necks observed
in the re-freeze cycle determine the movement of the drug molecule within the polymer
matrix.
The low molecular weight batches studied initially show greater movement in the nominal
pore neck size over time, than is seen for the pore body size. At longer immersion times both
pore neck and pore body size distributions become broader. Some differences are seen in
the observed structural changes for the drug encapsulated microsphere batch compared to
that of the batch without encapsulated drug molecule. This highlights the need to consider
the effects a particular encapsulated molecule may have on the formation and evolution
of the polymer matrix structure. For the high molecular weight batch of microspheres,
changes seen in the observed pore body size are greater than those seen in the pore neck
size over the period of study and in such systems may, thus, provide additional pathways
or barriers to the transport of an encapsulated drug molecule.
It has been shown that porosimetry techniques such as scanning loops and percolation
theory can be applied to investigate the PLGA microsphere matrix structure. Single pore
hysteresis effects were investigated and have shown that pore geometry is more complex
than simple cylinders or spheres. Percolation theory has been applied and discussed in
terms of differences in percolation threshold that equates to the quality of the connectivity
within the pore network of the polymer matrix and, therefore, the ease of transport for
the encapsulated drug molecule moving through the polymer matrix. Cryoporometry has
been shown to provide a wealth of data relating to the structure of the polymer matrix, in
the next chapter these findings will be combined with diffusometry studies in an effort to
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further explain the causes of the drug release mechanisms and controls within the polymer
microspheres over time.
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Chapter6
Cryodiffusometry studies of PLGA
microspheres
6.1 Introduction
The diffusometry technique developed in Chapters 3 and 4 has been combined with the
cryoporometry study of PLGA microspheres described in Chapter 5, cryodiffusometry. The
technique has been used to investigate the longer term behaviour of PLGA microspheres
in aqueous media, the interpretation of the data collected can provide information on the
transport properties and structure of the porous material. The application of cryodiffusom-
etry to porous media is relatively new (Filippov and Skirda, 2000) and the work described
here contains developments made as the methods were applied to investigate the structure
of polymer materials; it provides a means of investigating the polymer matrix structure at
the nanometer scale. The polymer structure has been identified as an important feature in
determining the drug release profile (Batycky et al., 1997) but, until now, very little has
been done to investigate the structure at the nanoscale. Model interpretations of geometry
and diffusion regime previously used to study materials as diverse as sedimentary rocks
and dairy produce are applied to the diffusion of water within the polymer matrix. Three
batches of microspheres, low molecular weight with and without encapsulated model drug,
and high molecular weight with encapsulated model drug, will be compared in terms of
observed structural changes and mass transport considerations.
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6.2 Background and Theory
6.2.1 Diffusion models in porous systems
Chapter 4 has discussed how the non-linearity of the log-attenuation plot, determined
from PFG experiments, can be explained in terms of restricted, or restrained, diffusion and
anisotropy of diffusivity. By freezing the bulk water and water contained within the ‘bubble’
pores, the water contained within the matrix may be observed. The movement of water
provides information on transport properties within the matrix that can indicate the ability
of entrapped drug molecules, polymer degradation products and water to move within the
polymer matrix. By examining the diffusion behaviour of water within the polymer matrix it
may be possible to see the changes in tortuosity effects over time. Tortuosity is calculated
from the PFG measured diffusion coefficient and the bulk diffusivity as described earlier in
Chapter 3.
Restricted or constrained diffusion
According to Callaghan et al. (1979), the observed diffusion of a molecule within a porous
media may be effected by the dimensional constraints of the solid. The molecule may only
be able to travel in one dimension, along a tube, or in two dimensions, between two parallel
planes. The signal attenuation for molecular motion in one dimension and two dimensions

















). These equations are a simplification for the condition that
ζD  1. If the molecule is unrestricted and able to travel in three dimensions then the





From Chapter 4, the heterogeneity of diffusion coefficients may be expressed as a series of
discrete components, or phases, each with a characteristic diffusion coefficient, equation
4.1.
NMR Studies of Controlled Drug Release Devices 145
CHAPTER 6. CRYODIFFUSOMETRY . . . BACKGROUND AND THEORY
6.2.2 Pore geometry
Further to describing diffusion in terms of restricted or constrained motion, diffusion studies
by NMR PFG within porous media have been used to probe the geometry of the liquid
containing pores (Mitra and Sen, 1992; Mitra et al., 1993; Fordham et al., 1994). Simple
pore geometries of spheres, tubular and slab (flat planes) have been investigated (Mitra and
Sen, 1992). A recent review of diffusometry by Stallmach and Galvosas (2007) identifies
some of the work done. One dimensionally constrained diffusion described by Callaghan
et al. (1979) assumes an infinitesimal separation distance between the constraining walls,
such that diffusion perpendicular to the plates does not occur. In the interest of interpreting
this constraint in terms of microsphere structure, an estimate of the distance between
the constraining barriers is considered. To estimate the separation distance between the
constraining walls further models have been investigated: For plates perpendicular to the
magnetic field, the separation distance, as, can be calculated from the observed diffusion






The observed diffusion coefficient for the fast component adjusted for salt content can




line, of gradient a2s. The model is, however, limited as it considers only ‘slab-shaped’ pores
perpendicular to the applied magnetic field. For an anisotropic arrangement of ‘slab-shaped’
pores, therefore, an alternative model has been applied.
Fordham et al. (1994) have investigated the separation distance between pore walls in
anisotropically arranged connected slab-shaped pores within sandstone, using NMR PFG
echo attenuation. The model applied that relates the signal attenuation and the distance
between the pore walls, for slab-shaped interconnecting pores, is based on the work of Mitra
and Sen (1992) who derived models for slab-shape, tubular and spherical pores, considering




= −4pi2q2D0∆ + lnF (K) (6.5)
where q = γδg
2pi
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K is defined in terms of the free diffusion coefficient, D0, and the distance travelled,
perpendicular to the applied magnetic field, by a molecule, < r
2
2
>, such that K2 =
4pi2q2×(D0∆− < r22 >). The distance travelled by a molecule perpendicular to the applied
magnetic field, within the anisotropic arrangement of slab shaped pores separated by a







]. erf(K) is the error function
of K and erfi(K) = erf(iK)
i
. This is approximated using the first four terms of the Taylor
expansion for the error function and, therefore, F (K) simplifies to equation 6.7










For a given sample of microspheres, the free diffusion coefficient, D0, within the matrix
can be calculated by evaluating the change in effective diffusion coefficient at different
diffusion times as shown in Chapter 3. A plot of ln I
I0
+ 4pi2q2D0∆ against K should
see the data collapse onto the same line for different values of K for a given separation
distance, if the pores are connected and of slab-shaped geometry.
6.2.3 Relaxation effects
The relaxation behaviour of a nucleus under investigation by NMR can be affected by the
physical state of the nucleus, solid or liquid, and the environment in which the nucleus is
situated. Magnetic field inhomogeneities within a sample can cause an observable change
in the transverse relaxation behaviour of a nucleus, where T ∗2 is the measured relaxation
constant for a nucleus which would have a relaxation constant of T2 under magnetically
homogeneous conditions, and T ∗2 ≤ T2. A liquid within a porous material is usually consid-
ered to have a combination of two relaxation time constants, a bulk relaxation constant and
a relaxation constant affecting the nuclei in proximity to the wall surface. The measured
relaxation constant for such a system will be an average representation of the two time
constants and can be used to determine pore characteristics such as surface to volume
ratio and pore size. The relationship between the measured relaxation constant in a pore,
T2,pore, and the surface to volume ratio,
s
V
, is given by equation 6.8, where ρ is the surface
relaxivity and T2,bulk is the bulk relaxation constant for the imbibed liquid (Mitchell et al.,
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6.3 Experimental
Diffusometry experiments were carried out during the freezing and thawing process at
similar relative signal intensities within the cryoporometry cycles. The experiments were
carried out after all the bulk and ‘bubble’ pore contained water was frozen, and again
just before it melted. Signal attenuation greater than 50 % of the original signal (or
more than one half-life) is required for a good fit of an exponential curve. For the silica
sample investigated in Chapter 3, increasing the gradient strength, g, with a large diffusion
time, ∆, provided sufficient signal attenuation, however, similar experimental parameters
gave only small changes in signal attenuation for the microsphere samples. A series of
experiments were, therefore, conducted on a part frozen microsphere sample to test the
optimum parameter changes to achieve a sufficient change in signal attenuation.
From equation 3.5 it is known that signal attenuation is a function of gradient strength,
g, gyromagnetic radius, γ, diffusion time, ∆, the bipolar dephasing correction time, τ , and
gradient length, δ, each parameter was considered in turn. The maximum gradient strength
is an inherent characteristic of the spectrometer probe and could not be increased to any
greater strength than that already tested. The gyromagnetic ratio is characteristic of the
nucleus being studied, therefore, would require a change in solvent. This was rejected as the
objective of the study was to investigate the behaviour of the microspheres in an aqueous
environment. The diffusion time change showed some change in signal attenuation, how-
ever, increasing the diffusion time could change the diffusion regime observed, for example
from unrestricted diffusion at small diffusion times to restricted diffusion at long diffusion
times. The effect of changing the bipolar dephasing time is relatively small due to its first
order relationship with signal attenuation and the small values used. Changing the length
of the gradient, however, showed significant changes in signal attenuation, and providing
that the condition δ  ∆ remains, varying δ provides a valid alternative to changing the
gradient strength. For cryodiffusometry experiments, a series of 1 dimensional pulsed bipo-
lar gradient stimulated echo with longitudinal eddy delay experiments were conducted with
increasing gradient lengths, δ, in the range 0.001–0.02 s, with a fixed diffusion time, either
0.15, 0.2 or 0.25 s and a constant gradient strength of 20.229 Gcm−1.
Experiment cycles were conducted immediately after microsphere immersion in aqueous
media, then at varying intervals over a period upto 120 days. Batches of high (MS043)
and low molecular weight (MS045) PLGA microspheres with 5-FD encapsulated, and a
batch of low molecular weight PLGA blank microspheres (MS041) were tested. Modifi-
cations were made to the standard multiple temperature acquisition automatic program,
multi zgvt, to include multiple PFG experiments after pre-determined experiment numbers
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of the cryoporometry cycle. An example of one of these modified programs is included in
the appendix, Section A.8.
6.4 Results and Discussion
6.4.1 Diffusion in salt solution
Cryodiffusometry experiments were carried out during the cryoporometry experiments de-
scribed in Chapter 5. The microspheres are immersed in a 5 % w/v sodium chloride solution.
Consideration of the effect of salt concentration on the diffusion coefficient observed must
be made. During diffusion studies it is necessary to estimate the bulk diffusion coefficient
at each experimental temperature to calculate values of tortuosity within the matrix and
the addition of salt affects the bulk diffusion coefficient. Above the freezing point of water
the presence of salt in solution reduces the bulk diffusion coefficient, but in supercooled liq-
uid, the presence of salt has been shown to increase the bulk diffusion coefficient (Kim and
Yethiraj, 2008). The 5% w/v solution of sodium chloride is equivalent to a 0.86 M solution,
and from the work of Kim and Yethiraj (2008) the diffusion coefficient adjustment factor,
a, is plotted against temperature*, as shown in Figure 6.1. A second order polynomial fit
to this data gives the relationship in equation 6.9, where T is the experiment temperature
in Kelvin.
a = 1.092× 10−3T 2 − 6.144× 10−1T + 8.733× 101 (6.9)
The unadjusted free diffusion coefficient of bulk water, D0, and the adjusted diffusion
coefficient of water in the salt solution at low temperature, Dw, are related by the salt
adjustment factor, a, according to equation 6.10. The adjustment factor will be used to
convert the observed diffusion coefficient of salt solution in the polymer matrix, DPFG, into
an equivalent diffusion coefficient observed for pure water in the polymer matrix, D′PFG,
using equation 6.11.





*Data extracted from the reference using software available at http://www.datathief.org/ (14th Oc-
tober 2008)
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y = 1.092E-03x
2


































Literature data Poly. (Literature data)
Figure 6.1: Salt solution adjustment factor as a function of temperature
Figure 6.2 shows the relationship of the estimated diffusion coefficient of free water as
a function of temperature (as described in Chapter 3), the adjustment factor for diffusion
coefficient as a function of temperature and the estimated diffusion coefficient adjusted for
salt solution as a function of temperature. The experimental temperature range used for
the cryodiffusometry experiments, 244—256 K, is marked as the region of interest on Figure
6.2 and this range alone is plotted in Figure 6.3. Both diffusion coefficient as a function
of temperature, and the adjusted diffusion coefficient for salt solution as a function of
temperature can be approximated as a straight line relationship within this range, both
with similar gradients. It can, therefore, be said that, whilst the salt within the solution has
a significant effect on the overall value of the diffusion coefficient, it has negligible effect
on the relative change in the diffusion coefficient within the range of temperatures being
studied. The salt adjustment factor is significant, however, for the calculation of absolute
tortuosity.
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Temperature & salt adjusted diffusion coefficient
Salt adjustment factor
Region of interest
Figure 6.2: Diffusion coefficient, salt solution adjustment factor and adjusted diffusion coefficient
as a function of temperature
6.4.2 Determination of diffusion model for cryodiffusometry ex-
periments
Diffusometry was carried out at low temperature to study the diffusion of water molecules
within a partially frozen salt solution imbibed in the porous polymer matrix. The collected
data formed non-linear log attenuation plots, the cause of non-linearity must be determined
for accurate interpretation of the results. Restricted diffusion can cause non-linearity in the
log attenuation plot (Callaghan et al., 1983). Another cause of non-linearity is attributed
to molecules in different environments diffusing at different rates, the log attenuation curve
then has a combination of contributions from each of the different fractions of the studied
nucleus (Hollewand and Gladden, 1995).
An example data set is fitted to a one component and two component model, the
log attenuation plots of data and model estimates are shown in Figure 6.4. Fitting the
data to a single diffusion coefficient model, as expressed in equation 3.5 provides a single
diffusion coefficient, where the ‘goodness of fit’ is assessed by the reduced χ2 value and
the distribution of the residual values.
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Temperature & salt adjusted diffusion coefficient
Salt adjustment factor
Linear (Temperature & salt adjusted diffusion coefficient)
Linear (Diffusion coefficient)
Figure 6.3: Diffusion coefficient, salt solution adjustment factor and adjusted diffusion coefficient
as a function of temperature over the experimental temperature range
The applicability of a given diffusion model to the data may be assessed in terms of
the ‘goodness of fit’, how closely the model fits the experimental data. The statistical
parameter reduced χ2 is used to compare the quality of the goodness of fit for different
models. The definition of reduced χ2, χ2R, is given in equation 6.12, where E is the expected
value for a given data point (model), O is the corresponding observed value (experiment)
and ν is the number of degrees of freedom defined by, ν = n− p− 1, n is the number of
observations and p is the number of fitted parameters in the model. A satisfactory fit is







The quality of the model used to fit the unknown parameters to the experimental data is
also assessed by the distribution of the residuals. The residuals are the difference values
between the model data and the experimental data. A good model has both positive and
negative residuals randomly distributed at increasing values of the fitted data, and any
pattern in the residual values infers a systematic error within the model used.
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data 2 component fit 1 component fit
Figure 6.4: Example log attenuation plot for cryodiffusometry data collected MS041, day 37, ∆
0.20 s, freezing curve
For the single component model typical reduced χ2 values are of the order of 0.1–0.2
and the residuals show systematic deviation from the model. A two component model
fitted to the same data shows a reduced χ2 value in the order of 0.001 and residual values
distribution is less ordered. The residuals for the one and two component fit are shown in
Figure 6.5. Increasing the number of variables within a model will generally improve the
quality of the fit, but, to determine if this is genuinely the best model fit, the possibility of
restricted diffusion of a one component model will also be considered.
To test if the curve of the log attenuation plot is due to restricted diffusion of a single
fraction of molecules, a series of experiments with increasing diffusion times were carried
out. If restricted diffusion is present then the Stokes-Einstein relation should hold, equation
4.2, and for an increase in diffusion time, ∆, a decrease in diffusion coefficient should be
seen. A plot of the diffusion time multiplied by the diffusion coefficient against the diffusion
time should be linear with a zero gradient if restricted diffusion is occurring. The linear
regression analysis on data for batch MS041 showed that a zero gradient was within the
95 % confidence interval for the 1 component fit during the freezing curve, but not during
the thawing curve, see Figure 6.6. The upper and lower values for the 95 % confidence
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1 component fit 2 component fit
Reduced chi-squared values
1 component fit 0.130 to 3 s.f.
2 component fit 0.00107 to 3 s.f.
Figure 6.5: Residual values for 1 and 2 component fit to data for MS041, day 37, ∆ 0.20 s,
freezing curve
intervals, U95 and L95, were determined by equations 6.13 and 6.14 respectively,
U95 = E + t
5,d
stat × se (6.13)
L95 = E − t5,dstat × se (6.14)
where E is the estimated value of the gradient, se is the standard error of the estimated
gradient and t5,dstat is the value of the ‘t’ statistic for a 5 % two tailed test , with d degrees
of freedom.
Whilst both freezing and thawing curve plots had similar gradients, the standard error of
the gradient for the freezing curve was twice that for the thawing curve data. This suggests
a greater level of error in the estimate of the gradient for the freezing data than for the
thawing data. Differences seen in the diffusion behaviour during freezing to that seen during
thawing should be related to the different mechanisms involved in the liquid-to-solid and
solid-to-liquid phase changes. It is expected that during melting, there is a distribution of
ice pockets within the pores that are not present during freezing when the freezing front
NMR Studies of Controlled Drug Release Devices 154
CHAPTER 6. CRYODIFFUSOMETRY . . . RESULTS AND DISCUSSION
Freezing





































freeze 1 component fit thaw 1 component fit
Linear (freeze 1 component fit) Linear (thaw 1 component fit)
Figure 6.6: Test for restricted diffusion in freezing and thawing for a 1 component fit to data for
MS041, day 37
progresses from the outside of the matrix inward. These ice pockets provide more ‘walls’
that restrict the motion of the water diffusing within the matrix, therefore, more restricted
motion is expected during melting than during freezing. This theory is contrary to the
findings suggested from the data collected. It is, therefore, proposed that the curvature
of the log attenuation plot is not purely a consequence of restricted diffusion. A plot of
diffusion coefficient against the square root of the diffusion time may be used to determine
the free diffusion coefficient of water within the matrix material, as shown in Section 3.2.2,
equation 3.10. For the one component fit of the example data set, the diffusion coefficient
in the matrix estimated from the freezing data and the thawing data agree within 15 %,
see Figure 6.7.
The data is now fitted to a two-component model, equation 3.5. The first component is
defined as the component showing greater movement during the diffusion time. The second
component is the slow component, where diffusion is comparatively slower than the first
component. The two diffusion coefficients for the two components are denoted as D1 and
D2 respectively. The fraction of water in the first component is p and the fraction of water
in the second component is (1− p). As mentioned previously, the residuals from the fit of
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Freeze





























Freeze Thaw Linear (Freeze) Linear (Thaw)
Figure 6.7: Free diffusion of water in polymer matrix for 1 component model fit to freezing and
thawing data for MS041, day 37
this model shows random distribution and the reduced χ2 value is of the order of 0.001,
which suggests a better fit to the experimental data than that found from the 1 component
model. The calculated diffusion coefficients for both the fast and slow component for
several values of diffusion time are examined for restricted diffusion behaviour, Figure 6.8.
It is found that for both freezing and thawing the fast moving component is not totally
restricted, however the slow moving component is restricted and that the restricted cavity
size, assuming spherical cavities, for this component is around 1–5 µm. A possible cause
of this restriction may be the existence of regions of matrix material that are more dense
than others. In these more dense regions the polymer chains may be more tightly arranged
and, therefore, provide smaller spaces, or less, openings through which the water molecules
may pass. This restricts the movement of water within this region. As the structure
of the polymer changes after immersion in aqueous media, these regions change. From
calculated values of diffusion coefficients for fast and slow components, tortuosity values
are determined as described previously for silica materials in Chapter 3. The tortuosity
for microsphere structure is defined as the ratio of the free diffusion coefficient of water,
adjusted for temperature, DB, over the estimated diffusion coefficient in the polymer matrix,
NMR Studies of Controlled Drug Release Devices 156
CHAPTER 6. CRYODIFFUSOMETRY . . . RESULTS AND DISCUSSION
Fast component






































fast component (1) slow component (2)
Linear (fast component (1)) Linear (slow component (2))
(a) Freezing
Fast component


































fast component (1) slow component (2)
Linear (fast component (1)) Linear (slow component (2))
(b) Thawing
Figure 6.8: Test for restricted diffusion for 1 and 2 component fit to data for MS041, day 37,
freezing and thawing
adjusted for the presence of salt, D′PFG, equation 6.15. In the context of this work the
tortuosity is used as a quantitative assessment of water molecule mobility within the polymer
matrix.
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The effect of temperature on the diffusion coefficient and signal intensity have been pre-
viously discussed in Sections 3.2.2 and 5.4.2. During the diffusion experiments on molten
solution in PLGA microspheres, it was seen that the application of multiple radio frequency
pulses had a small effect on the signal attenuation observed. A similar set of experiments
were conducted on a partially frozen sample of PLGA microspheres, where a series of 1 di-
mensional experiments were conducted at increasing values of gradient length, δ, followed
by a the same experiments carried out with a random order in the change of the gradient
length. The results are shown in Figure 6.9, no significant difference is observed between
the two data sets. The residuals between the two data sets can be seen in the insert of
Figure 6.9 and are plotted in the order in which the experiments were conducted and in
order of increasing gradient length. The residual values are mostly small(  1%), only
one value is significantly larger (5 %). The residuals show random distribution about zero,
therefore, it can be said that the measured signal intensity is not affected by the application
of increased radio frequency pulses and temperature effects of such are negligible.
The observed water diffusion coefficients are a function of temperature, salt concen-
tration and the porous matrix in which the water is contained. Due to the freeze-thaw
hysteresis during cryoporometry, there was a significant difference between the tempera-
tures at which the freezing curve and thawing curve experiments were carried out. For
a valid comparison of the diffusion behaviour an adjustment for temperature was made.
The absolute tortuosity can be used as a comparative measure for change to the diffusion
behaviour at different times and temperatures. The absolute tortuosity is the ratio of the
free water diffusion coefficient determined from PFG experiments adjusted for temperature
over the measured diffusion coefficient in the matrix, adjusted for the presence of salt. The
diffusion coefficient for free water can be estimated at low temperatures, as described in
Chapter 3, and the measured diffusion coefficients from PFG experiments can be corrected
for salt at a given temperature as described in Section 6.4.1. A full table of the observed
diffusion coefficients and calculated tortuosities for all microsphere batches studied can be
found in the appendix, Section A.3.
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Increasing order gradient length
Order of experiments
Figure 6.9: Signal attenuation measured at increasing gradient length and in random order of
gradient length
6.4.4 Presence of monomers in solution
The presence of poly-lactide or poly-glycolide oligomers or monomers could also affect the
observed diffusion behaviour of freezing point characteristics. To determine if there were
oligomer or monomers free within solution, a two-dimensional carbon-hydrogen correlation
NMR experiment was carried out. This was done at room temperature, on a sample
of microspheres after a few weeks immersion in aqueous media. The hydrogen containing
molecules detected showed no correlation with carbon, therefore, no oligomers or monomers
could be detected in the sample.
6.4.5 Time-resolved cryodiffusometry studies of PLGA microspheres
Cryodiffusometry trial on PLGA microspheres
The first trial of cryoporometry on PLGA microspheres was after 34 days immersion on
batch MS045, low molecular weight polymer with 5-FD used in the preparation method.
Two experiments were conducted, one during the freezing process and one during the
melting process, and the relative signal intensities on the cryoporometry curve at which the
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two experiments were carried out were 0.68 for freezing and 0.55 for thawing. Firstly, the
non-linear log attenuation plots were evaluated in terms of single and two component fits
for the diffusion, as described in Section 6.4.2. Initial one and two component fits for this
data can be seen in Figures 6.10 and 6.11, the reduced χ2 values for these two fits were
0.57 and 0.0044 respectively. The residuals of the two fits show the same characteristics as





















data model(2 component) model(1 component)
Figure 6.10: Freezing curve cryodiffusometry log attenuation plots fitted to one and two compo-
nent models
The rms displacement of a water molecule calculated for water contained in the fast
moving component is of the order of 7–15 µm and for the slow moving component around
1–6 µm. The faster moving component could, therefore, probe the wall thickness between
the ‘bubble’ pores, and between the ‘bubble’ pores and the outside of the microspheres,
which from SEM images were found to be of the order of 10 µm thick, see Figures 4.8a,
4.8b, 4.8c, 4.8d, 4.9a and 4.9b. Whilst the slower moving component is less likely to see
the ice barriers in the ‘bubble’ pores and in the bulk, it could describe the structure within
the polymer matrix.
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data model(2 component) model(1 component)
Figure 6.11: Thawing curve cryodiffusometry log attenuation plots fitted to one and two compo-
nent models
Cryodiffusometry studies of low molecular weight PLGA microspheres with model
drug 5-FD encapsulated, batch MS045
The calculated tortuosities for both fast and slow components of water during freezing and
thawing over time are shown in Figure 6.12. Fast component tortuosities are around two
orders of magnitude smaller than for slow component and the fraction of water in the slow
component is upto 25 %. Also shown on Figure 6.12 are the relative signal intensities
at which the experiments were carried out and the calculated fraction of water in the fast
component. A relative signal intensity of 1 means all the matrix contained solution is molten,
less than 1, a fraction of the matrix contained solution is frozen. The fraction of water in
the fast component remains high, ≥ 80 %, of the molten solution, at shorter immersion
times. On average, during this time little or equal quantities of water exchange between
the two components. At long immersion times, ≈ 100 days, the fraction of water in the
fast component decreases to ≤ 80 %. Two possible causes for this change are suggested.
Firstly, an exchange of water from the slow to the fast component has occurred. Secondly,
a greater volume of water in the slow component is observed due to a change in the fraction
of molten water within the matrix during the experiment on day 109, than day 60.
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Tau (fast) freeze Tau (slow) freeze Tau (fast) thaw 
Tau (slow) thaw p freeze p thaw
Relative intensity freeze Relative intensity thaw
Figure 6.12: Tortuosities of fast and slow components, fraction of fast component and relative
signal intensities during freezing and thawing over time for microsphere batch MS045
Figure 6.12 also shows, that despite differences in the relative intensity between freezing
and thawing experiments, after 42 days the calculated diffusion coefficients are the same
for the two components within experimental error. At 34 days, some difference is seen
between freezing and thawing curve diffusion coefficient estimates for the fast and slow
components. The relative intensity on thawing is less than on freezing, therefore, a greater
fraction of the matrix contained water is frozen. The tortuosity of the fast component is
significantly lower on thawing than during freezing. This suggests more free movement for
the faster component during early stages of thawing than is experienced during the early
stages of freezing.
The error in the estimated tortuosity is a function of the error in the measured diffusion
constant, the error in the estimated diffusion coefficient of free water at the specified
temperature and the error in the salt adjustment factor. For an example calculation of
the errors and their analysis see the appendix, Section A.6. In addition to the individual
component tortuosities, the weighted tortuosity, τw, can also be used as a measure of
change in the average matrix structure. The weighted tortuosity can be calculated using
equation 6.16,
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τw = pτ1 + (1− p)τ2 (6.16)
where τ1 and τ2 are the tortuosities for the fast and slow component respectively and p
is the fraction of water in the fast component. The weighted tortuosities for both the
freezing and thawing curve experiments for microsphere batch MS045 are shown in Figure
6.13. The modal pore neck and pore body sizes are also shown with the weighted tortuosity
values in Figure 6.13, this brings together the cryoporometry and cryodiffusometry findings



















































Tortuosity freeze Tortuosity thaw Pore body size Pore neck size
Figure 6.13: Weighted tortuosity during freezing and thawing with modal pore body and pore
neck sizes over time for microsphere batch MS045
Between days 34 and 42 tortuosities in both components fall such that the weighted
tortuosity decreases to approximately a third of its previous value. This change corresponds
to a significant increase seen in the neck size determined from cryoporometry, as the necks
‘open’, the restriction of water movement within the matrix is reduced and tortuosity goes
down. Between days 42 and 60 no significant changes are seen in the individual component
tortuosities, the weighted tortuosity shows a slight increase, but this is within the calculated
error. This time period corresponds to both a reduction in the pore necks and an increase
in the pore body size, the net effect observed is no change in the mobility of the water
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molecules within the matrix. Between days 60 and 109 both pore bodies and pore necks
reduce in size and there is an increase in the weighted tortuosity seen. From Figure 6.12 an
increased relative signal intensity is seen for day 109 compared to that for day 60 showing a
smaller fraction of ice is present. The increased tortuosity seen is, therefore, a consequence
of a polymer structure change rather than an increased volume of ice. In addition to this, a
decrease in the fraction of water in the fast component for day 109 compared to day 60 is
seen, which will have the effect of increasing the weighted tortuosity. Whilst the individual
tortuosities for each component tend to follow a similar trend as the weighted tortuosity
over time, the inclusion of the fraction of water in each component highlights more subtle
changes in the average diffusion behaviour like that seen between days 60 and 109.
Cryodiffusometry studies of high molecular weight PLGA microspheres with model












































































Tau (fast) Freeze Tau (slow) Freeze Tau (fast) Thaw
Tau (slow) Thaw p freeze p thaw
Relative intensity freeze Relative intensity thaw
Figure 6.14: Tortuosity of fast and slow components during freezing and thawing over time for
microsphere batch MS043
Batch MS043 was made with high molecular weight 50:50 PLGA by the same preparation
method as MS045, which was made with the low molecular weight 50:50 PLGA. Both
batches used 5-FD as a model drug for encapsulation from the internal aqueous phase
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of the first emulsion. For this batch the fast component tortuosities were one order of
magnitude smaller than for the slow component and the fraction of water in the slow
component was less than for MS045, with values upto 15 %. Figures 6.14 and 6.15 show
single component and weighted tortuosity values over time for batch MS043.
From Figure 6.14 it can be seen that there was little change in the observed slow
component tortuosity values until long immersion times, where a slight increase is seen. A
small, but significant decrease is seen in the fast component tortuosity at 83 and 92 days
compared to earlier immersion times. This decrease corresponds in time with an increase in
the fraction of water in the fast component, suggesting an increase in the average diffusion
of the fast moving component. Between days 59 and 92 a significant increase is seen in the
tortuosity of the slow moving component, which suggests in this time the average diffusion
in the slow component has reduced.
The relative signal intensities, up until day 83, shown in Figure 6.14 show differences of
upto 20 % in the molten fraction of water during the freezing and thawing curve diffusometry
experiments, with no significant effect observed on the calculated tortuosity values for
freezing and thawing at a given immersion time. However, at day 92, a greater difference
in the relative signal intensities for freezing and thawing is seen, that coincides with a small
difference seen in the corresponding fast component tortuosities for freezing and thawing.
On thawing, more ice is present and the fast component tortuosity is less, implying that
fast component of water is, on average, less restricted during later stages of thawing than
for the initial stage of freezing. This agrees with earlier discussion for MS045 on day 34.
Figure 6.15 shows the calculated weighted tortuosities and nominal pore neck and pore
body sizes at increasing immersion times. Whilst there are small changes in the pore
neck, and pore body, size during the time studied, no significant changes can be seen in
the weighted tortuosity. This implies that there are changes in matrix structure at the
nanometer scale, but the average mass transport behaviour within the polymer matrix is
unchanged, or too small to be seen within the error. Initially pore necks open and close as
the average pore body size increases, after 25 days immersion, the changes in pore neck size
and pore body size oppose each other. In comparison to the low molecular weight PLGA
microspheres, batch MS045, the polymer matrix structure appears to be more stable over
a 90 day period after immersion, changes in nominal pore size are of lower magnitude and
weighted tortuosities do not show significant changes.
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freeze thaw Pore body Pore neck
Figure 6.15: Weighted tortuosity values during freezing and thawing over time for microsphere
batch MS043
Cryodiffusometry studies of low molecular weight PLGA microspheres without
encapsulated drug molecule, batch MS041
A third batch of microspheres made with low molecular weight 50:50 PLGA without encap-
sulated drug were investigated by cryodiffusometry over time after immersion in a 5 w/v
% sodium chloride solution. The tortuosity values calculated for fast and slow components
over time, for batch MS041, are shown in Figure 6.16, and the weighted tortuosity values
are shown in Figure 6.17. Considering the individual component tortuosities, water in the
slow component showed diffusion one to three orders of magnitude slower than that in the
fast component and constituted on average 11 % of the observable water. After day 1
there is a significant decrease in tortuosity for both components, but appears most preva-
lent in the slow component, despite the fraction of water in the slow component being very
small at day 1. From day 14 until long immersion times, around 100 days, the individual
component tortuosities remain constant, within the calculated error.
At day 116, a significant increase in slow component tortuosity and a decrease in the fast
component tortuosity is seen during freezing and not during thawing. The relative signal
intensity, fraction of water in the fast component and calculated tortuosities for day 116
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Tau (fast) freeze Tau (slow) freeze
Tau (fast) thaw Tau (slow) thaw
Relative intensity freeze Relative intensity thaw
p freeze p thaw
Figure 6.16: Tortuosity of fast and slow components during freezing and thawing over time for
microsphere batch MS041
are summarised in Table 6.1. The difference in the observed tortuosities may possibly be
Parameter Freeze Thaw
Relative signal intensity 0.51 0.76
Fraction water in fast component(1) 0.82 0.93
Weighted Tortuosity 8.1 3.7
Tortuosity fast component(1) 2.3 4.1
Tortuosity slow component(2) 77 50
Table 6.1: Cryodiffusometry summary for batch MS041 after 116 days immersion
due to the different relative signal intensities at which the freezing and thawing experiments
were carried out. More ice present during freezing could mean that a greater volume of
one, or both, components of water is frozen and introduces additional tortuosity by the
presence of more ice walls. A decreased fraction of water in the fast component during
freezing is also observed, suggesting that a greater volume of the fast component water is
frozen. The water that is not yet frozen has a greater average diffusion coefficient, or lower
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tortuosity. The opposite effect was seen between the freezing and melting tortuosities for
Batch MS043 at day 92, where the relative signal intensity was higher during freezing and
a decrease in the fast component tortuosity was observed.
At day 142, a significant decrease in the slow component tortuosity is seen as the relative
signal intensities increase. Compared to day 14 with similarly high relative signal intensities,
there is still a significant decrease in tortuosity seen for the slow component. The decrease
in tortuosity of the slow component implies that the water in the slow component has
increased mobility, one cause may be that there are less restrictions within the polymer









































































Tortuosity freeze Tortuosity thaw Pore body Pore neck
Figure 6.17: Weighted tortuosity during freezing and thawing over time for microsphere batch
MS041
The weighted tortuosities and nominal pore neck and pore body sizes for batch MS041
are shown in Figure 6.17. In addition to an increase in the relative signal intensity at which
diffusometry experiments were carried out, the decrease in weighted tortuosity observed
between days 1 and 14 coincides with an increase in both pore body and pore neck size.
At day 37 the relative signal intensity is a similar level to that of day 1, and the pore body
and pore neck size have decreased to similar values to those of day 1, but no significant
change is seen in the weighted tortuosity from that of day 14. Therefore, the change in
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tortuosity seen between days 1 and 14 is thought to be the effect of pore size changes
and an increase in the fraction of water in the slow component, rather than relative signal
intensity changes. At day 116 the weighted tortuosity during freezing shows a significant
increase, driven by the increased fraction of water in the slow component, and the increase







































70 day freeze 93 day freeze 70 day thaw 93 day thaw
Figure 6.18: Freeze-thaw hysteresis cycles for days 70 and 93 after immersion for batch MS041
The freeze-thaw hystereses, of microsphere batch MS041, for days 70 and 93 are shown
in Figure 6.18. No difference is observed in the thawing curve, whilst there is a significant
change to the freezing curve between the two experiments. In Chapter 5 the changes in
the freezing curve are attributed to changes in the pore neck size distribution and espe-
cially the modal pore neck size. To identify any changes in connectivity during this time,
cryodiffusometry experiments were carried out at multiple relative signal intensities (molten
fractions), the fast component tortuosities determined are shown in Figure 6.19. The fast
component tortuosities determined at similar molten fractions at days 70 and 93 during
both freezing and thawing are close in value. This suggests that the changes observed in
the freezing curve are related to the pore neck size and are not a function of connectivity.
The apparent maxima of the fast component tortuosities, at a molten volume fraction
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Day 70  freeze Day 70  thaw Day 93 freeze Day 93 thaw
Day 105 freeze Day 105 thaw Day 116 freeze Day 116 thaw
Figure 6.19: Change in the fast component tortuosity during freezing and thawing for batch
MS041 at longer immersion times
of around 0.5 to 0.6, corresponds to a sharp knee feature in the melting curves for days 70
and 93, and a wide plateau in the freezing curve for day 93. This suggests the possibility
of a more complex situation within the fast component, such that there are two different
regions within the fast component. The first region consisting of a broad distribution of
large pores, the second region consisting of a narrow distribution of well connected small
pores. As the larger pore are frozen out the observed tortuosity increases, once this whole
region has become ice, the tortuosity observed is dominated by the second region which
has a lower tortuosity. On thawing, the tortuosity at low molten fraction is dominated by
the second region, which has a lower tortuosity. Then, as the first region begins to melt
the tortuosity increases to a maximum, and finally, as more of the first region melts, the
tortuosity decreases again.
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6.4.6 Comparison of cryodiffusometry results for three batches of
microspheres
Table 6.2 gives the range of values for the calculated diffusion coefficients from PFG exper-
iments adjusted for salt, fraction of water in the fast component and calculated tortuosities
for the three microsphere batches studied. The range of calculated tortuosities for the fast
component of the water, contained within the matrix, is the same order of magnitude for all
three batches. However, the low molecular weight polymer batches (MS041 and MS045)
show a greater range of values of tortuosity for the slower component, and are higher in
value than those determined for the high molecular weight batch (MS043).
Batch T D1 D2 p τ1 τ2 τw
/K ×109/m2s−1 ×109/m2s−1
MS045 248—255 0.040—0.13 0.0019—0.0042 0.76—0.93 3.4—11 62—250 13—120
MS043 253—256 0.045—0.091 0.0033—0.013 0.83—0.95 5.7—11 40—-160 9.4—21
MS041 244—256 0.064—0.13 0.00092—0.029 0.82—0.98 2.3—6.4 16—470 5.3—16
Table 6.2: Summary of cryodiffusometry parameters calculated for PLGA microsphere batches
MS045, MS043 and MS041
From the SEM images, described in Chapter 4, one significant difference observed
between the two batches of low molecular weight polymer, without drug encapsulated,
MS041, and the drug encapsulated batch, MS045, is a comparative increase in the thickness
of the matrix walls between the ‘bubble’ pores for the drug encapsulated batch, Figures 6.20a
and 6.20b show this. Moreover, the cryodiffusometry results show a significant difference
in the range of the weighted tortuosities for these two batches, the range being greater for
the batch with encapsulated drug (MS045). This difference is driven by the higher value
of the fast component tortuosity and larger fraction of water in the slow component for
the batch with the encapsulated drug (MS045), which has thicker polymer matrix walls
between the ‘bubble’ pores and at the external surface of the microspheres. Together these
observations suggest a more significant presence of dense polymer regions within the matrix
in the drug encapsulated batch than the blank batch. These dense polymer regions have,
within this work, been assigned to the restricted diffusional behaviour observed as the slow
component. These differences between the two low molecular weight batches highlights
that changes can be seen when a model drug molecule is encapsulated within the polymer,
the effect of which is thought to be drug dependent.
The batch of high molecular weight polymer microspheres with encapsulated drug
molecule (MS043) shows similar characteristic ranges in weighted tortuosity and fraction
of free water as those seen for the low molecular weight batch without the encapsulated
drug (MS041). However, the individual component tortuosities for the high molecular
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(a) MS041 without drug
(b) MS045 with drug
Figure 6.20: SEM images of typical low molecular weight PLGA microspheres
weight batch show similar ranges as the low molecular weight batch with encapsulated drug
(MS045), which shows that the difference in the weighted tortuosity is driven by the fraction
of water in the fast component alone. At long immersion times the trend of the fraction
of free water for the high molecular weight batch increases, whilst it decreases for the low
molecular weight batch, indicating a difference in the overall degradation mechanism for
the change in molecular weight of the polymer.
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6.4.7 Further interpretation of cryodiffusometry results for batch
MS041
The contributions to the signal attenuation made by the two components are considered
separately, to assess if the diffusion of the fast component is totally free, or restrained in
one, or two dimensions. From the calculation of the signal attenuation of each component,
it can be seen that the fast component is dominant at lower values of ζ, and the slower
component is dominant for higher values of ζ, in agreement with Callaghan et al. (1979).
An estimate of free diffusion, one dimension and two dimensionally constrained models for




















fast component unrestained 3d diffusion
Both components 2d constrained
1d constrained
Figure 6.21: Fast component contribution to signal attenuation, comparing 1 and 2 dimensionally
constrained and free diffusion models for MS041, day 37, ∆ 0.20 s, freezing curve
It is observed that a good fit to the actual data comes from a 2 dimensional motion (1
dimensionally constrained) fast component for low values of ζ and 3 dimensional diffusion
of the slow component at higher values of ζ, shown in Figure 6.23. The slow component
diffusion, is 3 dimensional, and restricted, as determined earlier in section 6.4.2. In terms
of the transport of a small molecule within the polymer matrix, this suggests the presence
of two types of regions within the matrix structure. The fast component represents regions
NMR Studies of Controlled Drug Release Devices 173




































slow component unrestrained 3d diffusion 
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1d constrained
Figure 6.22: Slow component contribution to signal attenuation, comparing 1 and 2 dimensionally
constrained and free diffusion models for MS041, day 37, ∆ 0.20 s, freezing curve
of faster transport, better diffusion and lower tortuosity, that is restrained within planes
bounded by impenetrable walls. These walls are thought to be the ice walls formed when
the bulk and ‘bubble’ pore contained water is frozen. The other regions represented by
the slower diffusion water have three dimensionally restricted motion, which are thought to
be regions of more dense polymer that take longer to evolve and release the encapsulated
molecule. This follows from the findings of Messaritaki et al. (2005) where different regions
of polymer within the microsphere were observed to have different drug release profiles.
Modelling anisotropic slab geometry
Models for ‘slab-shaped’ pores or plate geometry from literature are fitted to the data col-
lected for microsphere batch MS041 (Fordham et al., 1994) as described earlier in Section
6.2.1. Data collected on day 37 for microsphere batch MS041 is shown in Figure 6.24. It
is hoped that an estimate of the slab thickness, or separation distance, between restrict-
ing walls may help to identify the scale of the fast component regions within the matrix
and determine the likely source of the restriction to motion within the matrix. The corre-
sponding separation distance is found by minimising the sum of the least squares between
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fit fast constrained in 1d & slow free real
Figure 6.23: Combined signal attenuation model for MS041, day 37, ∆ 0.20 s, freezing curve
the estimated log-attenuation and the observed log attenuation determined for two dimen-
sional motion of the fast component. The slab separation distance at 37 days immersion, of
MS041, is 4.8×10−6 m. The calculated separation distance between anisotropic plates over
the first 37 days immersion of microsphere batch MS041 are given in Table 6.3. This model
assumes both fast diffusion with zero relaxation at the wall, and slow diffusion with strong
relaxation at the wall. An exact solution to calculate the echo signal intensity, M(K,∆),
for the slow diffusing limit was given by Mitra and Sen (1992), equation 6.17. The results










where k = γδg.
The general trend seen in the separation distance for this batch of microspheres during
the first 37 days immersion follow the trend seen in the pore neck size and pore body size for
the same period of time. The separation distance determined for anisotropically arranged
slab-shaped pores begins at around 3 µm which is of the order of size observed in SEM
images for the matrix wall thickness between the ‘bubble’ pores of the dry microspheres be-
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Diffusion time 0.16 s Diffusion time 0.2 s
Diffusion time 0.24 s Model
Figure 6.24: Microsphere batch MS041 day 37 plot of ln II0 + 4pi
2q2D0∆ against K to estimate
separation distance between plates
Immersion time Calculated separation distance / µm Calculated separation distance / µm
(Fordham et al., 1994) Slow diffusion limit (Mitra and Sen, 1992)
Day 1 2.7 8.4
Day 14(freeze) 7.2 10.1
Day 14(thaw) 7.4 10.2
Day 25 3.9 9.7
Day 32 2.1* 7.3
Day 37 4.8 8.9
*Manual fit
Table 6.3: Separation distance determined for anisotropically arranged plates with increasing
immersion times for MS041
fore immersion. There is good agreement in the estimated slab thickness values determined
for day 14 during freezing and thawing. An estimate for slab thickness based on data for
one value of diffusion time at day 42 for the low molecular weight drug encapsulated batch
of microspheres is around 6 µm, which is similar to that for the non-drug encapsulated
batch at similar immersion times. Analysis of high molecular weight drug encapsulated
microspheres at days 1 and 31 indicate slab separations of 8 and 7 µm respectively; these
values are also based on data for just one value of diffusion time. Caution must be taken,
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however, in evaluating these results as absolute values, but at this time, a proof of concept
and applicability of the models is being made. Therefore, it is possible to say that the slab
separation distance calculated from cryodiffusometry data is of the correct order of mag-
nitude to that expected from the inspection of SEM images of dry microsphere samples.
A difference is seen between the estimated values of slab separation determined from the
model for a range of relaxation behaviour and that of strong relaxation behaviour, but the
two estimates show similar trends.
6.5 Conclusions
By combining cryoporometry and diffusometry it is possible to simultaneously study changes
in the matrix structure at the nanometer scale and changes in the mass transport proper-
ties seen over time after immersion in an aqueous media. Whilst cryoporometry provides
time-resolved pore size distributions in terms of pore bodies and pore necks, diffusometry
experiments provide a means of investigating diffusion characteristics of water contained in
the polymer matrix, after the bulk medium has been frozen. Diffusometry, using water as
the probe molecule, can be used to identify the transport characteristics of a small molecule
within the matrix. Water plays a vital role in the degradation process within the polymer
structure, therefore, the transport of water into, within and out of the matrix is of interest
in terms of polymer degradation in addition to acting as a probe molecule, or model ‘drug’.
Studies on the low molecular weight batches show more changes in the neck sizes ob-
served at early immersion times, at long immersion times, both pore neck and pore body
size distributions broaden, a possible sign of structural breakdown. Both low molecular
weight batches have similar values for fast component tortuosity, although the drug encap-
sulated batch have higher values of tortuosity for the slow moving component, suggesting
a more complex path for water in the drug encapsulated batch to that seen for the blank
microspheres.
For high molecular weight microspheres more changes are seen in the pore body size
at earlier immersion times, possibly due to the polymer chain degradation occurring at the
backbone of the polymer chain, rather than at the end of the polymer chains at this stage.
The tortuosity of the fast component for the high molecular weight batch microspheres is
higher than that for the low molecular weight batches. Combined with percolation analysis
that suggests relatively good connectivity, this shows that the higher molecular weight
polymer matrix provides more complex pathways for molecular transport which could have
a significant effect on the drug release mechanism. The slow component tortuosity for
high molecular weight polymer microspheres with encapsulated drug is greater than that
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for blank low molecular weight microspheres and less than that for drug encapsulated low
molecular weight microspheres.
The transport of water molecules through the polymer matrix is indicative of potential
pathways for small drug molecules to travel through the matrix and eventually out of
the matrix via the pore necks in to the release medium. This is often thought to be
one of the determining factors within the drug release mechanism from such a system.
Cryodiffusometry has been used to identify change in the pore openings and changes in
the tortuosity for small molecule transport over time in an aqueous medium. Observable
differences between the three batches of microspheres studied over time that can be related
to the structural and mass transport changes within the polymer matrix have been identified
and discussed. These observations relating to pore size and restricted diffusion are indicative
of the different mechanisms involved in the microsphere evolution, and the subsequent drug
release behaviour from such systems. By combining the two techniques a more refined
understanding of the matrix structure evolution can be made than by either technique
alone.
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Chapter7
Conclusions and future direction
7.1 Conclusions
A robust cryoporometry method has been developed which has significant improvements
on the methods previously discussed in the literature. These improvements are an accurate
sample temperature measurement using a ‘t’ type thermocouple and a reduction in the
temperature gradient through reducing the sample depth requirements. Both of these
improvements provide confidence in the sample temperature accuracy and increase the
accuracy of the pore size distribution determined from cryoporometry.
Investigations of sol-gel silica materials have shown the freeze-thaw hysteresis is re-
peatable after supercooling effects have been removed. By comparison of the freeze-thaw
hysteresis with other porosimetry methods such as nitrogen sorption and mercury intrusion-
extrusion an estimate of the Gibbs-Thomson parameter can be made. Studying whole and
powder samples of the silica material it has been shown, that similar to mercury intrusion-
extrusion, the causes for the freeze thaw hysteresis are attributed to single pore hysteresis
and shielding effects. The single pore hysteresis for this system can be shown to follow
the theory of Petrov and Furo (2006) for cylindrical pores. Heterogeneous nucleation is
identified for the freezing mechanism within the silica material, such that a freezing front
travels from the bulk at the surface of the pellet toward the centre of the pellet through
the pore network. This mechanism has been described in terms of percolation theory. The
cryoporometry freezing curve has been shown to represent the size distribution of the pore
necks, or entrances, whilst the thawing curve represents the pore body size distribution.
To this end, the freezing curve has been shown to provide additional information to the
melting curve, previously not identified.
PLGA microspheres have been made with both high and low molecular weight PLGA,
181
CHAPTER 7. CONCLUSIONS AND . . . CONCLUSIONS
some containing model drug molecules. SEM micrographs of different batches have been
compared to identify micrometer length scale differences between batches. The presence
of a model drug molecule can be seen to affect the micrometer scale structure of the
microspheres. Diffusometry experiments conducted at room temperature have been used
to calculate average cavity sizes for the ‘bubble’ pore observed in the microsphere structure.
Agreement between SEM observed ‘bubble’ pore size and estimated cavity size, provides
confidence in the application of PFG methods and their interpretation for microsphere
structure investigations. Other traditional porosimetry techniques such as gas sorption and
mercury porosimetry are not appropriate for analysis of microspheres, therefore, diffusometry
techniques provide an alternative means for their investigation.
Cryoporometry of PLGA microspheres has identified changes in the pore neck and pore
body sizes over time at the nanometer length scale. At this scale the investigations are
probing the structure of the polymer matrix, the evolution of which is thought to play a
key role in the release of a drug molecule. Changes in nominal pore sizes and the observed
distribution of pore sizes are seen over time. Differences between batches of high and low
molecular weight, and drug encapsulated and non-drug encapsulated microspheres are seen.
Cryoporometry scanning loops suggest the presence of shielding effects during the freezing
process of the water contained within the polymer matrix. The restricting pore structure of
the microspheres that prevent the progress of the freezing front into the polymer matrix are
thought to play a role in preventing the movement and release of a drug molecule out of the
polymer matrix. Percolation theory has been applied to some of the microsphere batches
studied and differences in the observed percolation threshold are seen between batches, and
with increased immersion time.
Cryodiffusometry experiments of matrix contained water was best modelled as water
contained in two components, the fast component which appeared to have free motion
in two dimensions, and the slow component which appeared to suffer restricted diffusion.
Applying models for anisotropically arranged slab geometry pores for the fast component,
the pore width was found to be of the same order of magnitude as the polymer matrix walls
between the ‘bubble’ pores and between the bubble pores and the external surface. The
confining barriers are, therefore, thought to be the ice walls of the frozen fraction of water.
The restricted cavity size determined for the slow component was smaller than the observed
walls thickness and, therefore, thought to be a characteristic of regions within the polymer
matrix where the matrix is more dense. Over time, after immersion, significant changes in
the tortuosity of both components were seen and when compared to changes seen in the
pore neck and body sizes, correlations can be seen. When put together, the cryoporometry
and the diffusometry experiments carried out have shown that a wealth of information can
NMR Studies of Controlled Drug Release Devices 182
CHAPTER 7. CONCLUSIONS AND . . . FUTURE DIRECTION
be gained from combining these NMR techniques. The possibility to combine techniques
provides a non-invasive real time method to probe the transport and structure properties
of these dynamic systems. These techniques also have potential for investigating nanoscale
characteristics of other materials where structural changes are observed with time.
7.2 Future direction
The work that has been carried out on cryoporometry development and the use of cryodif-
fusometry to investigate drug release systems has shown that valuable information can be
gained from the combination of these techniques. In this section ideas for further studies
are considered.
7.2.1 Other materials
The application of cryodiffusometry to alternative materials used for drug release devices
has potential to highlight the different behaviour in the structures and how they evolve in an
aqueous environment with time. The methods used here could be applied to other silica or
polymeric materials, or materials that are a combination of the two base materials. Provided
that a material is suitable for use in a strong magnetic field, structural information can be
gained from the cryoporometry and diffusometry that may be useful to identify transport
properties which have an impact not only for drug delivery devices, but also, within catalysis
and adsorption systems.
7.2.2 Other nuclei NMR PFG, relaxometry
The versatility of NMR techniques provides the opportunity to combine the cryodiffusometry
technique developed for studying water with other NMR experiments such as relaxometry
or the diffusion of alternative nuclei such as Fluorine-19 or Sodium-23. The results of a
preliminary experiment looking at sodium diffusion in solution are shown in Figure 7.1.
7.2.3 Model alternative administration methods
The potential use for an oral drug delivery device with controlled release characteristics
requires a more in depth study of the effect of acid conditions on the drug delivery device.
The cryodiffusometry methods applied to study PLGA microspheres have been applied to
investigate the early immersion behaviour of acid treated and non-acid treated microspheres
to identify any initial effect of acid treatment.
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Figure 7.1: Log attenuation plot for Sodium-23 diffusion in a partially frozen PLGA microsphere
sample
Microspheres (batch MS041) were pre-treated with hydrochloric acid at a pH of 2.0 for
3 hours to simulate passing through the stomach after oral delivery. For the acid treatment,
a 5 ml filter pipette tip had the tip cut-off and a small magnetic stirrer was attached using
sticky tape. The microspheres were placed on top of the filter and approximately 2 ml of
0.01 M hydrochloric acid was added to the pipette tip. The top of the pipette tip was
sealed with parafilm and the whole tip placed inside a scintillation vial that was secured in
place on a magnetic stirrer plate. The stirrer plate was switched on to half maximum speed,
providing enough movement to agitate the pipette tip containing the microspheres and acid
as to simulate movement within the stomach. After 3 hours of agitation, the pipette tip was
removed from the vial, the stirrer bar removed and a vacuum pump was used to remove the
acid through the filter of the tip, leaving the microspheres on the filter. The microspheres
were then washed three times with phosphate buffer before being transferred to the 100 µl
pipette tip as described previously for the microsphere cryodiffusometry experiments. The
aqueous medium used for these experiments was a phosphate buffer (pH 7.4). As a control
experiment, a sample of the same batch of microspheres was ‘treated’ with buffer solution
in place of acid, non-acid treated sample. The two samples were analysed in parallel, at
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varying times of immersion.
No significant difference is seen in the cryoporometry data for acid treated and non-
acid treated microsphere samples at early immersion times. Diffusometry results carried
out at equal signal intensities for the two samples on day 1 show a much lower relative
tortuosity for the batch treated with acid than that not treated. This further demonstrates
the additional benefits for combining the two techniques for the investigations of these
types of system.
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EXAMPLE OF CRYOPOROMETRY CYCLES FOR MICROSPHERE BATCH MS045
ONE DAY AFTER IMMERSION IN WATER FOR TWO INDEPENDENT SAMPLES
A.2 Example of cryoporometry cycles for microsphere
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TABLES OF MICROSPHERE CRYODIFFUSOMETRY RESULTS MS045
A.3 Tables of microsphere cryodiffusometry results MS045
A.4 Tables of microsphere cryodiffusometry results MS043
NMR Studies of Controlled Drug Release Devices 189
TABLES OF MICROSPHERE CRYODIFFUSOMETRY RESULTS MS041
A.5 Tables of microsphere cryodiffusometry results MS041
A.6 Calculation of errors
Error in the diffusion coefficients of fitting PFG data to a one or two component model are
determined from non-linear curve fitting function within Origin *. The standard error for
each of the fitting parameters is calculated within the fitting process, e(D1) and e(D2).
Standard error in the salt adjustment factor, e(a) was calculated as the standard error
in the known values of temperature and adjustment factor using equation A.1, where x is
the independent observation, y is the dependent observation, x¯ and y¯ are the mean values
for x and y respectively and n is the number of observations. The value for the standard




n− 2[Σ(y − y¯)
2 − (Σ(x− x¯)(y − y¯))
2
Σ(x− x¯2) ] (A.1)
By combining the error in the estimated diffusion coefficient and the salt adjustment fac-
tor, therefore, the error in the adjusted diffusion coefficient for component i was calculated
using equation A.2.
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As discussed in chapter 3, the error in calculating free diffusion coefficient of water at low
temperature, e(Dw) was determined to be less than 3 % of the calculated value.Therefore,
the error in tortuosity for component i, e(τi) is given in equation A.3.









Similarly, the error in weighted tortuosity, e(τw), is given in equation A.4













A.7 NMR pulse sequences
 Pulse acquire
The sample is subjected to a single radio frequency pulse equivalent to a 90 °flip into
Figure A.1: Pulse acquire sequence
1H:
the x-y plane and after a wait period the emitted signal is acquired by the receiver
coil. The disadvantage of this type of acquisition is that the signal is subject to T2
relaxation and, therefore, may be lower in intensity.
 Spin echo
In the simplest spin echo sequence the sample is subjected to a single 90 °pulse,
which flips the nuclei spin into the x-y plane. The nuclei precess with different angular
NMR Studies of Controlled Drug Release Devices 191
NMR PULSE SEQUENCES
Figure A.2: Spin echo sequence
1H:
frequency and de-phase, after a short time, t, the sample is subject to a 180 °pulse,
often about the y-axis, which flips the nuclei into the reverse position with respect
to the z direction. After an equal time t, the nuclei have re-phased and the emitted
echo signal is now acquired by the receiver coil. Thus, the spin echo maximises the
signal observed by rephasing the nuclei.
 Pulsed gradient spin echo
Magnetic field gradients are added to the simple spin echo, mid-way between the 90
°and 180 °pulse the magnetic field gradient is applied for a short period, the same
gradient is applied mid-way between the 180 °pulse and the acquisition. The effect of
the gradients is to identify locational changes during the observation time, between
the two magnetic field gradients, if no diffusion has occurred the signal is the same
as if the gradients had not been applied, diffusional motion of the nuclei reduces the
signal intensity of the observed echo.
 Pulsed gradient stimulated echo
The stimulated echo is a gradient spin echo sequence with the 180 °pulse separated
into two 90 °pulses, the two gradients are separated in time by an observation time, ∆.
The second 90 °pulse stores the signal in the z direction to allow for longer observation
times to be used, therefore the sequence is particularly useful when T2  T1 of if
diffusivity is small (Hollewand and Gladden, 1995). The shape of the magnetic field
gradient may be varied, for the experiments conducted in this work, the shape of the
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Figure A.3: Pulsed gradient spin echo sequence
1H:
G:





 Bipolar pulsed gradient stimulated echo with longitudinal eddy delay
A development of the stimulated pulsed gradient spin echo, each applied magnetic
field gradient is split into two shorter gradients of the same magnitude, first positive,
then negative with an additional 180 °pulse in between the two gradients. A small
time delay between the gradients is used, the bipolar correction time, τ . After the last
gradient is applied, eddy currents within the sample may affect the observed signal,
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therefore, the magnetisation is stored in the z direction with the application of a 90
°pulse, and after a time delay another 90 °pulse returns the magnetisation into the
x-y plane and the acquisition is taken.
 Addition of spoil currents
The addition of two small gradients after each of the bipolar field gradients removes
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any unwanted fractions of magnetisation in the x-y plane, whilst the desired phases




/* multi_integtime 12.11.2001 */
/****************************************************************/
/* Short Description : */
/* AU program for automatic integration of a series of 1D */
/* spectra with AI calibration. The output is written in */
/* a format suitable for import in excel or similar */
/* desktop publishing programs. */
/****************************************************************/
/* Keywords : */
/* integration of a series of data sets */
/****************************************************************/
/* Description/Usage : */
/* AU program for automatic integration of a series of 1D */
/* spectra with AI calibration. The output is written in */
/* a format suitable for import in excel or similar */
/* desktop publishing programs. In addition, a parameter */
/* has been added to the listing. This allows to correlate */
/* the integral changes with the change of a parameter. */
/* The spectra can either be stored in a series of EXPNOs */
/* or in a series of PROCNOs. */
/* The AU program works as follows : */
/* 1. Switch to the first experiment to be integrated. */
/* 2. Define the integral region(s) you want to use */
/* in the interactive integration menu. Calibrate the */
/* integrals with an appropriate calibration factor */
/* (calibrate button) and store the intrng file (write */
/* return button). */
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/* 3. Store the intrng file with the ’wmisc’ command */
/* under a name of your choice. */
/* 5. Start the AU program. */
/* The individual integration results are stored in the */
/* file integrals.txt in each dataset, the summary of */
/* all results is stored in the file dataset-name_int.txt */
/* in the first dataset. */
/* If you want to print a different parameter than GPZ 1,*/
/* then you have to change the corresponding lines with */
/* the FETCHPARS calls. Depending on the parameter type,*/
/* you must also change the variable into which the */
/* parameter is read (currently f1 for float). In that */
/* case, also the following sprintf lines need to be */
/* changed. */
/****************************************************************/
/* Author(s) : */
/* Name : Mike Engelhardt */
/* Organisation : Bruker Analytik */
/* Email : eng@bruker.de */
/****************************************************************/
/* Name Date Modification: */
/* eng 001011 created */
/* eng 001214 handle CURPRIN internally */
/* eng 011112 bug fix 2784 */
/* E. Perkins - Combine integral output with experiment time */
/****************************************************************/
/*




char intrngfile[256], printname[256], newline[256];





NMR Studies of Controlled Drug Release Devices 196
AUTOMATIC PROGRAMS













GETINT ("Enter number of experiments :",i2)
(void) strcpy (intrngfile,"integ-ai");












Proc_err(DEF_ERR_OPT, "No integral result file :\n%s\n\




disk, user, type, name, expno, procno, name);









/* Get parameter to be written into the result file */
FETCHPARS("DATE", &t)
/* Discard first five lines of integral result file */
for (iii = 0; iii < 5; iii++)
fgets(dummystr, 120, fpnt);
sprintf (newline,"%d %f ",loopcount1+1,f1);
while (fgets(dummystr, 120, fpnt) != NULL)
{





























Proc_err(DEF_ERR_OPT, "No integral result file :\n%s", intresult);
return(-1);
}
/* Discard first five lines of integral result file */
for (iii = 0; iii < 5; iii++)
fgets(dummystr, 120, fpnt);
FETCHPARS("DATE", &t)
/* convert seconds into proper units */
timestring=asctime(localtime(&t));
sprintf (newline, timestring ,loopcount1+2,f1);
while (fgets(dummystr, 120, fpnt) != NULL)
{









NMR Studies of Controlled Drug Release Devices 199
AUTOMATIC PROGRAMS
(void) sprintf (text,"--- multi_integtime finished ---\n\
All results summarized in :\n%s",intallresult);
QUITMSG (text)
cryopfgDELTA10
Example program for multiple ∆ cryodiffusometry experiments during cryoporometry freeze-
thaw cycle
/*** ˆˆA -*-C++-*- **********************************************/
/* cryopfg&RTpfg&T2 15.05.2008 */
/****************************************************************/
/* Short Description : */
/* Performs multiple acquisitions on increasing expnos */
/* with temperatures that are read from a vtlist file. */
/* At two user defined experiment numbers, pfg */
/* experiments are carried out with increasing gradient */
/* lengths, at three different diffusion times. */
/****************************************************************/
/* Keywords : */
/* serial acquisitions, variable temperature, VT , DOSY */
/****************************************************************/
/* Description/Usage : */
/* This AU program performs multiple acquisitions on */
/* increasing expnos in much the same way as multizg. If */
/* datasets do not yet exist, the current dataset and its */
/* parameters are copied. If the data sets already exist,*/
/* then the experiments are executed as they are. */
/* But in addition to multizg, this AU program asks for a */
/* variable temperature list and sets the temperature for */
/* each experiment according to the list entry from the */
/* VTLIST file. */
/* The number of experiments is calculated from the number */
/* of temperature values in the VTLIST. The user can ask */
/* for a reduced number of experiments, though. */
NMR Studies of Controlled Drug Release Devices 200
AUTOMATIC PROGRAMS
/* A security check is implemented that asks for a */
/* confirmation of the highest and lowest temperature of */
/* the variable temperature list. */
/* Temperatures are in Kelvin K ! */
/* You will be asked for the temperature equilibration */
/* time. The AU program will wait at as long as defined */
/* by this time for the temperature to settle. */
/* The total experiment time is estimated and printed out. */
/****************************************************************/
/* This is a modification of multi_zgvt */
/* Author(s) : */
/* Name : Emily Perkins */
/* Organisation : University of Bath */
/* Email : E.L.Perkins@bath.ac.uk */
/****************************************************************/




$Id: multi_cryo_1cycle&thaw ,v 1.0 $
*/
char vtlistname[PATH_MAX], vtlistpath[PATH_MAX], line[PATH_MAX];
char *envpnt, tmpfile[PATH_MAX];
char del[PATH_MAX], path[PATH_MAX], curp[PATH_MAX];
double sf, sfo1;
float acttemp[500], hightemp, lowtemp;
float PSH, PSP, IPS, maxpsh, maxpsp, maxips;
int noofscans, pscal_save;
int startExpno, start2Expno, start3Expno;
int fptr, fptr1, numtemp, waittime, tdiff, t, t1;
int pfgexpt, pfgexpt2;
int rem, rem2;
int ret, expTime, zgsafety;
static void PrintExpTime();
GETCURDATA;




GETSTRING("Enter name of vtlist : ",vtlistname)
(void) sprintf (vtlistpath,"%s/lists/vt/%s",getstan(0,0),vtlistname);
if ( (fptr1 = fopen (vtlistpath,"r")) == NULL )
{
Proc_err (DEF_ERR_OPT,"Could not open VT list file\n\
%s\nPlease use ’edlist vt’ to check for valid files.",vtlistpath);
ABORT
}
/* Read first temperature value, scan for highest and lowest */
/* temperature and the total number of temperature values. */
if ( fgets (line,PATH_MAX-1,fptr1) == NULL )
{
Proc_err (DEF_ERR_OPT,"No VT list entry found.\n\





if ( (ret = sscanf (line,"%f",&acttemp[0])) != 1 )
{
STOPMSG ("--- temperature list has no valid entries ---")
}
hightemp = lowtemp = acttemp[0];
numtemp = 1;
/* Check for more temperature values */
while ( fgets (line,PATH_MAX-1,fptr1) != NULL )
{
if ( (ret = sscanf (line,"%f",&acttemp[numtemp])) != 1 )
break;
if ( acttemp[numtemp] > hightemp )
{
hightemp = acttemp[numtemp];
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}







if ( Proc_err(QUESTION_OPT,"Highest temperature : %f OK?",hightemp) != ERR_OK )
STOPMSG ("--- highest temperature not OK ---")
if ( Proc_err(QUESTION_OPT,"Lowest temperature : %f OK?",lowtemp) != ERR_OK )




GETINT("Enter number of experiments : ",i1)
} while ( (i1 > numtemp) || (i1 == 0) );
waittime = 540;
GETINT("Enter temperature equilibration period (secs) : ",waittime)
pfgexpt = 16;
GETINT("Enter experiment number for pfg experiment 1 : ",pfgexpt)
pfgexpt2 = 37;

























if(strcmp(envpnt, "on") == 0)
{
zgsafety = 1;




































































































































































































CPR_exec("env set UXNMR_SAFETY=on", WAIT_TERM);
QUITMSG("--- cryopfgDELTA finished ---");
#include <inc/exptUtil>/* utilities for printing and calculation of
experiment time */
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